LOKIASV2_3899_ESMFold_N-A	4n57-assembly1.cif.gz_A	4n57-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase APH(2'')-IVa ADP complex	3.553E-18	1.000	648	9	307	317	1	294	296	310	0.943	0.993
LOKIASV2_3899_ESMFold_N-A	4dfb-assembly2.cif.gz_B	4dfb-assembly2.cif.gz_B Crystal structure of aminoglycoside phosphotransferase aph(2")-id/aph(2")-iva in complex with kanamycin	6.627E-18	1.000	648	8	307	317	1	295	301	312	0.946	0.980
LOKIASV2_3899_ESMFold_N-A	4dfb-assembly1.cif.gz_A	4dfb-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase aph(2")-id/aph(2")-iva in complex with kanamycin	1.444E-17	1.000	638	8	307	317	1	293	297	308	0.946	0.987
LOKIASV2_3899_ESMFold_N-A	6ctz-assembly1.cif.gz_A	6ctz-assembly1.cif.gz_A Structure of the GDP and kanamycin complex of APH(2")-IIia	1.153E-16	1.000	629	15	312	317	3	294	297	305	0.940	0.983
LOKIASV2_3899_ESMFold_N-A	3tdv-assembly2.cif.gz_B	3tdv-assembly2.cif.gz_B Structure of the GDP complex of wild-type aminoglycoside 2'-phosphotransferase-IIIa	2.647E-16	1.000	629	11	312	317	1	296	299	309	0.953	0.990
LOKIASV2_3899_ESMFold_N-A	3n4v-assembly2.cif.gz_B	3n4v-assembly2.cif.gz_B apo APH(2")-IVa form III	2.188E-17	1.000	627	8	307	317	1	295	298	311	0.946	0.990
LOKIASV2_3899_ESMFold_N-A	3tdw-assembly1.cif.gz_A	3tdw-assembly1.cif.gz_A The GDP complex of the aminoglycoside 2'-phosphotransfere-IIIa F108L mutant	3.258E-16	1.000	624	12	314	317	1	297	302	310	0.956	0.983
LOKIASV2_3899_ESMFold_N-A	4dtb-assembly2.cif.gz_B	4dtb-assembly2.cif.gz_B Crystal Structure of F95Y Aminoglycoside-2''-Phosphotransferase Type IVa in Complex with Guanosine	3.874E-17	1.000	621	8	307	317	1	295	297	311	0.946	0.993
LOKIASV2_3899_ESMFold_N-A	4dta-assembly1.cif.gz_A	4dta-assembly1.cif.gz_A Crystal Structure of F95M Aminoglycoside-2''-Phosphotransferase Type IVa in Complex with Adenosine	1.419E-16	1.000	599	8	307	317	1	295	298	312	0.946	0.990
LOKIASV2_3899_ESMFold_N-A	5iqg-assembly1.cif.gz_A	5iqg-assembly1.cif.gz_A Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GDP, Magnesium, and Gentamicin C1	5.199E-16	1.000	586	14	311	317	5	289	292	306	0.940	0.976
LOKIASV2_3899_ESMFold_N-A	6c5u-assembly1.cif.gz_A	6c5u-assembly1.cif.gz_A Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Ribostamycin, Alternate form	8.739E-16	1.000	570	14	311	317	7	290	293	307	0.940	0.969
LOKIASV2_3899_ESMFold_N-A	6cey-assembly1.cif.gz_A	6cey-assembly1.cif.gz_A Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Lividomycin moieties	3.040E-15	1.000	560	12	312	317	1	287	288	313	0.950	0.997
LOKIASV2_3899_ESMFold_N-A	4ork-assembly4.cif.gz_D	4ork-assembly4.cif.gz_D Crystal Structure of the Phosphotransferase Domain of the Bifunctional Aminoglycoside Resistance Enzyme AAC(6')-Ie-APH(2'')-Ia	9.696E-16	1.000	559	14	311	317	5	292	295	307	0.940	0.976
LOKIASV2_3899_ESMFold_N-A	4ork-assembly2.cif.gz_B	4ork-assembly2.cif.gz_B Crystal Structure of the Phosphotransferase Domain of the Bifunctional Aminoglycoside Resistance Enzyme AAC(6')-Ie-APH(2'')-Ia	3.093E-16	1.000	559	14	312	317	8	295	296	309	0.943	0.973
LOKIASV2_3899_ESMFold_N-A	4ork-assembly3.cif.gz_C	4ork-assembly3.cif.gz_C Crystal Structure of the Phosphotransferase Domain of the Bifunctional Aminoglycoside Resistance Enzyme AAC(6')-Ie-APH(2'')-Ia	7.479E-16	1.000	558	14	312	317	5	292	293	308	0.943	0.983
LOKIASV2_3899_ESMFold_N-A	5iqc-assembly3.cif.gz_C	5iqc-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Gentamicin C1	1.193E-15	1.000	558	14	311	317	5	294	297	307	0.940	0.976
LOKIASV2_3899_ESMFold_N-A	6cgg-assembly1.cif.gz_A	6cgg-assembly1.cif.gz_A Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Arbekacin	3.372E-15	1.000	550	14	311	317	6	293	296	307	0.940	0.973
LOKIASV2_3899_ESMFold_N-A	6ch4-assembly3.cif.gz_C	6ch4-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia S376N mutant in complex with GMPPNP and Magnesium	4.851E-15	1.000	550	14	311	317	5	294	297	307	0.940	0.976
LOKIASV2_3899_ESMFold_N-A	5iqb-assembly1.cif.gz_A	5iqb-assembly1.cif.gz_A Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Kanamycin A	3.202E-15	1.000	546	14	312	317	4	291	292	308	0.943	0.986
LOKIASV2_3899_ESMFold_N-A	5iqe-assembly3.cif.gz_C	5iqe-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Neomycin B	3.552E-15	1.000	545	14	311	317	5	289	292	307	0.940	0.976
LOKIASV2_3899_ESMFold_N-A	5iqh-assembly1.cif.gz_A	5iqh-assembly1.cif.gz_A Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) S214A mutant in complex with GMPPNP and Magnesium	1.547E-15	1.000	542	14	312	317	6	293	294	308	0.943	0.980
LOKIASV2_3899_ESMFold_N-A	5iqc-assembly4.cif.gz_D	5iqc-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Gentamicin C1	3.202E-15	1.000	540	14	311	317	9	289	290	306	0.940	0.969
LOKIASV2_3899_ESMFold_N-A	5iqi-assembly3.cif.gz_C	5iqi-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) Y237F mutant in complex with GMPPNP and Magnesium	2.469E-15	1.000	540	14	311	317	5	294	297	310	0.940	0.976
LOKIASV2_3899_ESMFold_N-A	5iqd-assembly2.cif.gz_B	5iqd-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Ribostamycin	3.040E-15	1.000	532	14	311	317	9	296	299	307	0.940	0.963
LOKIASV2_3899_ESMFold_N-A	5iqh-assembly3.cif.gz_C	5iqh-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) S214A mutant in complex with GMPPNP and Magnesium	5.109E-15	1.000	528	14	312	317	5	287	288	307	0.943	0.983
LOKIASV2_3899_ESMFold_N-A	5iqf-assembly2.cif.gz_B	5iqf-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia (CTD of APH(6')-Ie/APH(2'')-Ia) in complex with GDP and Magnesium	4.372E-15	1.000	528	14	312	317	9	295	296	308	0.943	0.970
LOKIASV2_3899_ESMFold_N-A	6cav-assembly3.cif.gz_C	6cav-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Dibekacin	8.588E-15	1.000	527	13	311	317	1	284	285	308	0.943	0.996
LOKIASV2_3899_ESMFold_N-A	6cav-assembly2.cif.gz_B	6cav-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Dibekacin	5.971E-15	1.000	523	14	311	317	5	291	292	307	0.940	0.983
LOKIASV2_3899_ESMFold_N-A	5iqc-assembly2.cif.gz_B	5iqc-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Gentamicin C1	4.151E-15	1.000	523	7	311	317	4	297	299	316	0.962	0.983
LOKIASV2_3899_ESMFold_N-A	5iqe-assembly4.cif.gz_D	5iqe-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Neomycin B	4.372E-15	1.000	522	14	312	317	9	291	292	310	0.943	0.969
LOKIASV2_3899_ESMFold_N-A	6cgd-assembly2.cif.gz_B	6cgd-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Amikacin	6.289E-15	1.000	522	14	311	317	9	294	297	307	0.940	0.963
LOKIASV2_3899_ESMFold_N-A	5iqg-assembly2.cif.gz_B	5iqg-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GDP, Magnesium, and Gentamicin C1	6.624E-15	1.000	520	14	312	317	8	289	290	307	0.943	0.972
LOKIASV2_3899_ESMFold_N-A	5iqi-assembly2.cif.gz_B	5iqi-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) Y237F mutant in complex with GMPPNP and Magnesium	4.151E-15	1.000	520	14	312	317	9	293	294	311	0.943	0.969
LOKIASV2_3899_ESMFold_N-A	4dca-assembly1.cif.gz_A	4dca-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase APH(2'')-Ib, ADP-bound	2.601E-15	1.000	517	12	306	317	1	289	296	310	0.931	0.976
LOKIASV2_3899_ESMFold_N-A	6ch4-assembly2.cif.gz_B	6ch4-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia S376N mutant in complex with GMPPNP and Magnesium	9.528E-15	1.000	517	14	311	317	9	294	297	307	0.940	0.963
LOKIASV2_3899_ESMFold_N-A	3ham-assembly1.cif.gz_A	3ham-assembly1.cif.gz_A Structure of the gentamicin-APH(2")-IIa complex	2.113E-15	1.000	517	8	308	317	1	290	299	315	0.950	0.970
LOKIASV2_3899_ESMFold_N-A	6cgg-assembly4.cif.gz_D	6cgg-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Arbekacin	2.304E-14	1.000	513	14	308	317	7	286	289	303	0.931	0.969
LOKIASV2_3899_ESMFold_N-A	6cav-assembly4.cif.gz_D	6cav-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Dibekacin	4.767E-14	1.000	505	14	308	317	5	281	284	303	0.931	0.975
LOKIASV2_3899_ESMFold_N-A	5iqb-assembly4.cif.gz_D	5iqb-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Kanamycin A	2.556E-14	1.000	504	14	308	317	8	286	289	303	0.931	0.965
LOKIASV2_3899_ESMFold_N-A	5iqh-assembly4.cif.gz_D	5iqh-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) S214A mutant in complex with GMPPNP and Magnesium	1.602E-14	1.000	504	14	311	317	5	290	291	311	0.940	0.983
LOKIASV2_3899_ESMFold_N-A	3hav-assembly1.cif.gz_A	3hav-assembly1.cif.gz_A Structure of the streptomycin-ATP-APH(2")-IIa ternary complex	7.349E-15	1.000	500	9	311	317	1	292	296	317	0.956	0.986
LOKIASV2_3899_ESMFold_N-A	5iqi-assembly4.cif.gz_D	5iqi-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) Y237F mutant in complex with GMPPNP and Magnesium	5.021E-14	1.000	491	14	312	317	9	290	291	308	0.943	0.969
LOKIASV2_3899_ESMFold_N-A	6ch4-assembly4.cif.gz_D	6ch4-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia S376N mutant in complex with GMPPNP and Magnesium	1.839E-13	1.000	458	14	308	317	5	279	282	307	0.931	0.975
LOKIASV2_3899_ESMFold_N-A	3hav-assembly3.cif.gz_C	3hav-assembly3.cif.gz_C Structure of the streptomycin-ATP-APH(2")-IIa ternary complex	6.857E-14	1.000	450	8	301	317	1	276	284	304	0.927	0.972
LOKIASV2_3899_ESMFold_N-A	3hav-assembly2.cif.gz_B	3hav-assembly2.cif.gz_B Structure of the streptomycin-ATP-APH(2")-IIa ternary complex	1.494E-13	1.000	450	8	293	317	1	275	297	297	0.902	0.926
LOKIASV2_3899_ESMFold_N-A	7f0f-assembly1.cif.gz_A	7f0f-assembly1.cif.gz_A Crystal structure of capreomycin phosphotransferase in complex with CMN IIB	1.193E-12	1.000	414	12	305	317	1	277	282	309	0.927	0.982
LOKIASV2_3899_ESMFold_N-A	5ih0-assembly1.cif.gz_A	5ih0-assembly1.cif.gz_A Macrolide 2'-phosphotransferase type II Y92M mutant - complex with GDP and erythromycin	1.871E-11	1.000	386	13	307	317	1	297	299	320	0.931	0.993
LOKIASV2_3899_ESMFold_N-A	5uxb-assembly2.cif.gz_B	5uxb-assembly2.cif.gz_B Crystal structure of macrolide 2'-phosphotransferase MphH from Brachybacterium faecium, apoenzyme	4.295E-11	1.000	375	15	307	317	2	291	297	318	0.924	0.976
LOKIASV2_3899_ESMFold_N-A	4fev-assembly1.cif.gz_A	4fev-assembly1.cif.gz_A Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP1	2.468E-12	1.000	367	6	279	317	3	259	263	294	0.864	0.977
LOKIASV2_3899_ESMFold_N-A	4fex-assembly3.cif.gz_C	4fex-assembly3.cif.gz_C Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor tyrphostin AG1478	6.622E-12	1.000	365	8	280	317	5	255	261	288	0.861	0.962
LOKIASV2_3899_ESMFold_N-A	4gkh-assembly2.cif.gz_B	4gkh-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	2.468E-12	1.000	365	6	279	317	12	264	268	292	0.864	0.944
LOKIASV2_3899_ESMFold_N-A	4gkh-assembly17.cif.gz_I	4gkh-assembly17.cif.gz_I Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	3.371E-12	1.000	364	6	279	317	7	262	266	294	0.864	0.962
LOKIASV2_3899_ESMFold_N-A	4gki-assembly6.cif.gz_F	4gki-assembly6.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NM-PP1	6.622E-12	1.000	352	6	279	317	6	257	261	292	0.864	0.966
LOKIASV2_3899_ESMFold_N-A	4few-assembly7.cif.gz_B	4few-assembly7.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP2	1.686E-11	1.000	350	28	279	317	13	252	256	270	0.795	0.938
LOKIASV2_3899_ESMFold_N-A	4fev-assembly9.cif.gz_F	4fev-assembly9.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP1	3.675E-11	1.000	349	26	279	317	7	248	252	269	0.801	0.960
LOKIASV2_3899_ESMFold_N-A	4few-assembly9.cif.gz_F	4few-assembly9.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP2	1.370E-11	1.000	347	26	279	317	17	262	266	274	0.801	0.925
LOKIASV2_3899_ESMFold_N-A	4feu-assembly6.cif.gz_F	4feu-assembly6.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	7.604E-11	1.000	343	28	279	317	2	241	245	268	0.795	0.980
LOKIASV2_3899_ESMFold_N-A	4few-assembly8.cif.gz_D	4few-assembly8.cif.gz_D Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP2	1.113E-11	1.000	343	1	280	317	1	262	266	298	0.883	0.985
LOKIASV2_3899_ESMFold_N-A	4gkh-assembly10.cif.gz_J	4gkh-assembly10.cif.gz_J Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	1.686E-11	1.000	342	6	279	317	12	263	267	292	0.864	0.944
LOKIASV2_3899_ESMFold_N-A	4fex-assembly2.cif.gz_B	4fex-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor tyrphostin AG1478	3.871E-11	1.000	341	26	279	317	15	257	261	271	0.801	0.931
LOKIASV2_3899_ESMFold_N-A	4ej7-assembly2.cif.gz_B	4ej7-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, ATP-bound	3.489E-11	1.000	336	26	280	317	16	259	265	270	0.804	0.921
LOKIASV2_3899_ESMFold_N-A	4gkh-assembly18.cif.gz_K	4gkh-assembly18.cif.gz_K Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	2.555E-11	1.000	336	6	279	317	12	265	269	291	0.864	0.944
LOKIASV2_3899_ESMFold_N-A	4fev-assembly7.cif.gz_B	4fev-assembly7.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP1	8.010E-11	1.000	332	28	279	317	11	250	254	270	0.795	0.945
LOKIASV2_3899_ESMFold_N-A	6fuc-assembly1.cif.gz_A	6fuc-assembly1.cif.gz_A Structure of aminoglycoside phosphotransferase APH(3'')-Id from Streptomyces rimosus ATCC10970	4.524E-11	1.000	327	15	280	317	3	268	270	290	0.839	0.985
LOKIASV2_3899_ESMFold_N-A	4feu-assembly3.cif.gz_C	4feu-assembly3.cif.gz_C Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	1.346E-10	1.000	322	8	279	317	7	258	262	292	0.858	0.962
LOKIASV2_3899_ESMFold_N-A	1nd4-assembly1.cif.gz_B	1nd4-assembly1.cif.gz_B Crystal structure of aminoglycoside-3'-phosphotransferase-IIa	1.418E-10	1.000	321	22	280	317	5	251	255	274	0.817	0.969
LOKIASV2_3899_ESMFold_N-A	6fux-assembly1.cif.gz_A	6fux-assembly1.cif.gz_A Structure of aminoglycoside phosphotransferase APH(3'')-Id from Streptomyces rimosus ATCC10970 in complex with ADP and streptomycin	3.091E-10	1.000	314	15	280	317	3	265	267	291	0.839	0.985
LOKIASV2_3899_ESMFold_N-A	4feu-assembly4.cif.gz_D	4feu-assembly4.cif.gz_D Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	6.736E-10	1.000	311	31	279	317	1	238	242	267	0.785	0.983
LOKIASV2_3899_ESMFold_N-A	4feu-assembly2.cif.gz_B	4feu-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	3.612E-10	1.000	307	6	279	317	12	259	263	292	0.864	0.943
LOKIASV2_3899_ESMFold_N-A	3w0m-assembly1.cif.gz_A	3w0m-assembly1.cif.gz_A Crystal structure of a thermostable mutant of aminoglycoside phosphotransferase APH(4)-Ia, apo form	5.106E-09	1.000	299	20	310	317	1	286	293	308	0.918	0.976
LOKIASV2_3899_ESMFold_N-A	1l8t-assembly1.cif.gz_A	1l8t-assembly1.cif.gz_A Crystal Structure Of 3',5"-Aminoglycoside Phosphotransferase Type IIIa ADP Kanamycin A Complex	2.884E-09	1.000	274	9	279	317	1	259	263	293	0.855	0.985
LOKIASV2_3899_ESMFold_N-A	4h05-assembly1.cif.gz_A	4h05-assembly1.cif.gz_A Crystal structure of aminoglycoside-3'-phosphotransferase of type VIII	7.735E-09	1.000	267	13	280	317	4	270	270	297	0.845	0.989
LOKIASV2_3899_ESMFold_N-A	6iy9-assembly2.cif.gz_B	6iy9-assembly2.cif.gz_B Crystal structure of aminoglycoside 7"-phoshotransferase-Ia (APH(7")-Ia/HYG) from Streptomyces hygroscopicus complexed with hygromycin B	1.003E-08	1.000	254	5	303	317	7	302	324	333	0.943	0.914
LOKIASV2_3899_ESMFold_N-A	2bkk-assembly1.cif.gz_A	2bkk-assembly1.cif.gz_A Crystal structure of Aminoglycoside Phosphotransferase APH(3')-IIIa in complex with the inhibitor AR_3a	7.602E-08	1.000	244	9	279	317	1	243	247	292	0.855	0.984
LOKIASV2_3899_ESMFold_N-A	2qg7-assembly1.cif.gz_A	2qg7-assembly1.cif.gz_A Plasmodium vivax ethanolamine kinase Pv091845	2.554E-08	1.000	227	12	310	317	34	359	368	358	0.943	0.886
LOKIASV2_3899_ESMFold_N-A	4ocv-assembly1.cif.gz_A	4ocv-assembly1.cif.gz_A N-acetylhexosamine 1-phosphate kinase_ATCC15697 in complex with GlcNAc and AMPPNP	2.933E-07	1.000	221	15	315	317	3	341	355	365	0.950	0.955
LOKIASV2_3899_ESMFold_N-A	4wh3-assembly1.cif.gz_A	4wh3-assembly1.cif.gz_A N-acetylhexosamine 1-kinase in complex with ATP	2.933E-07	1.000	206	14	315	317	2	341	356	370	0.953	0.955
LOKIASV2_3899_ESMFold_N-A	6sv5-assembly1.cif.gz_A	6sv5-assembly1.cif.gz_A Amicoumacin kinase AmiN in complex with ATP	1.132E-06	1.000	185	11	312	317	8	317	329	351	0.953	0.942
LOKIASV2_3899_ESMFold_N-A	2olc-assembly1.cif.gz_B	2olc-assembly1.cif.gz_B Crystal structure of 5-methylthioribose kinase in complex with ADP-2Ho	5.762E-07	1.000	179	9	310	317	4	313	376	353	0.953	0.824
LOKIASV2_3899_ESMFold_N-A	6sul-assembly2.cif.gz_D	6sul-assembly2.cif.gz_D Amicoumacin kinase AmiN in complex with AMP-PNP, Mg2+ and Ami	8.579E-06	1.000	161	11	312	317	9	317	334	351	0.953	0.925
LOKIASV2_3899_ESMFold_N-A	3ppz-assembly1.cif.gz_A	3ppz-assembly1.cif.gz_A Crystal structure of CTR1 kinase domain in complex with staurosporine	8.880E-05	1.000	125	30	313	317	12	265	267	337	0.896	0.951
LOKIASV2_3899_ESMFold_N-A	5s82-assembly1.cif.gz_A	5s82-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with XS035128c	1.093E-04	1.000	119	27	284	317	4	191	279	270	0.814	0.674
LOKIASV2_3899_ESMFold_N-A	6b2q-assembly2.cif.gz_C	6b2q-assembly2.cif.gz_C Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	7.866E-04	1.000	111	27	291	317	8	258	265	328	0.836	0.947
LOKIASV2_3899_ESMFold_N-A	7up4-assembly1.cif.gz_A	7up4-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 20 (co-crystal)	4.929E-04	1.000	111	25	294	317	4	233	273	309	0.852	0.842
LOKIASV2_3899_ESMFold_N-A	6oyt-assembly1.cif.gz_A	6oyt-assembly1.cif.gz_A ASK1 kinase domain in complex with GS-4997	1.322E-03	1.000	105	26	278	317	2	201	222	283	0.798	0.901
LOKIASV2_3899_ESMFold_N-A	7up8-assembly1.cif.gz_A	7up8-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 27 (co-crystal)	1.074E-03	1.000	105	25	279	317	4	218	273	294	0.804	0.788
LOKIASV2_3899_ESMFold_N-A	6vvg-assembly1.cif.gz_B	6vvg-assembly1.cif.gz_B Structure of the Cydia pomonella Granulovirus kinase, PK-1	9.192E-04	1.000	104	14	307	317	2	243	264	328	0.927	0.917
LOKIASV2_3899_ESMFold_N-A	7up7-assembly2.cif.gz_B	7up7-assembly2.cif.gz_B Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound with literature RSK2 inhibitor indazole cyanoacrylamide compound 26 (soak)	9.192E-04	1.000	104	25	315	317	3	278	280	354	0.918	0.986
LOKIASV2_3899_ESMFold_N-A	7a52-assembly2.cif.gz_B	7a52-assembly2.cif.gz_B Structure of DYRK1A in complex with compound 6	1.074E-03	1.000	104	28	278	317	16	231	333	286	0.792	0.649
LOKIASV2_3899_ESMFold_N-A	8sap-assembly2.cif.gz_B	8sap-assembly2.cif.gz_B Crystal structure of class III lanthipeptide synthetase ThurKC	7.599E-05	1.000	104	11	310	317	188	452	842	339	0.946	0.315
LOKIASV2_3899_ESMFold_N-A	7uiq-assembly2.cif.gz_B	7uiq-assembly2.cif.gz_B Cocrystal structure of human CaMKII-alpha (CAMK2A)kinase domain and Tiam1	1.322E-03	1.000	103	27	289	317	3	240	261	317	0.830	0.912
LOKIASV2_3899_ESMFold_N-A	8guw-assembly1.cif.gz_C	8guw-assembly1.cif.gz_C Structure of Aurora Kinase A in complex with activator peptide	1.093E-04	1.000	103	8	310	317	1	268	270	359	0.956	0.993
LOKIASV2_3899_ESMFold_N-A	1v0o-assembly1.cif.gz_A	1v0o-assembly1.cif.gz_A Structure of P. falciparum PfPK5-Indirubin-5-sulphonate ligand complex	8.285E-04	1.000	103	29	283	317	1	205	276	293	0.804	0.743
LOKIASV2_3899_ESMFold_N-A	3d2k-assembly1.cif.gz_A	3d2k-assembly1.cif.gz_A Crystal structure of mouse Aurora A (Asn186->Gly, Lys240->Arg, Met302->Leu) in complex with [7-(2-{2-[3-(3-chloro-phenyl)-ureido]-thiazol-5-yl}-ethylamino)-pyrazolo[4,3-d]pyrimidin-1-yl]-acetic acid	1.192E-03	1.000	102	30	289	317	6	221	245	298	0.820	0.882
LOKIASV2_3899_ESMFold_N-A	5wnj-assembly1.cif.gz_A	5wnj-assembly1.cif.gz_A Crystal structure of murine receptor-interacting protein kinase 4 (Ripk4) D143N in complex with lestaurtinib	1.545E-03	1.000	102	27	303	317	10	261	264	328	0.874	0.955
LOKIASV2_3899_ESMFold_N-A	7up7-assembly1.cif.gz_A	7up7-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound with literature RSK2 inhibitor indazole cyanoacrylamide compound 26 (soak)	9.192E-04	1.000	102	25	279	317	4	220	277	296	0.804	0.783
LOKIASV2_3899_ESMFold_N-A	6v6a-assembly1.cif.gz_A	6v6a-assembly1.cif.gz_A Inhibitory scaffolding of the ancient MAPK, ERK7	4.679E-04	1.000	102	25	312	317	5	269	317	348	0.909	0.836
LOKIASV2_3899_ESMFold_N-A	5wvd-assembly1.cif.gz_A	5wvd-assembly1.cif.gz_A Structure of Mnk1 in complex with DS12881479	2.222E-03	1.000	101	26	275	317	4	228	241	302	0.789	0.934
LOKIASV2_3899_ESMFold_N-A	3qgy-assembly2.cif.gz_B	3qgy-assembly2.cif.gz_B Crystal structure of ITK inhibitor complex	2.341E-03	1.000	101	28	301	317	6	243	245	325	0.864	0.971
LOKIASV2_3899_ESMFold_N-A	3p86-assembly1.cif.gz_A	3p86-assembly1.cif.gz_A Crystal structure of CTR1 kinase domain mutant D676N in complex with staurosporine	1.074E-03	1.000	101	30	313	317	8	248	250	318	0.896	0.964
LOKIASV2_3899_ESMFold_N-A	4ysm-assembly2.cif.gz_B	4ysm-assembly2.cif.gz_B Calcium-Dependent Protein Kinase from Eimeria tenella	2.262E-04	1.000	101	27	310	317	19	282	475	338	0.896	0.556
LOKIASV2_3899_ESMFold_N-A	5hu3-assembly1.cif.gz_A	5hu3-assembly1.cif.gz_A Drosophila CaMKII-D136N in complex with a phosphorylated fragment of the Eag potassium channel and Mg2+/ADP	2.222E-03	1.000	100	24	307	317	2	261	266	336	0.896	0.977
LOKIASV2_3899_ESMFold_N-A	2qoc-assembly1.cif.gz_A	2qoc-assembly1.cif.gz_A Human EphA3 kinase domain, phosphorylated, AMP-PNP bound structure	4.004E-04	1.000	100	26	317	317	5	262	283	338	0.921	0.912
LOKIASV2_3899_ESMFold_N-A	6ilz-assembly1.cif.gz_A	6ilz-assembly1.cif.gz_A Crystal structure of PKCiota in complex with inhibitor	4.218E-04	1.000	100	29	312	317	2	266	320	345	0.896	0.828
LOKIASV2_3899_ESMFold_N-A	3qgw-assembly2.cif.gz_B	3qgw-assembly2.cif.gz_B Crystal Structure of ITK kinase bound to an inhibitor	1.806E-03	0.999	99	28	308	317	4	237	240	321	0.886	0.975
LOKIASV2_3899_ESMFold_N-A	1ol6-assembly1.cif.gz_A	1ol6-assembly1.cif.gz_A Structure of unphosphorylated D274N mutant of Aurora-A	1.192E-03	0.999	99	30	289	317	6	222	245	299	0.820	0.886
LOKIASV2_3899_ESMFold_N-A	6oyt-assembly2.cif.gz_D	6oyt-assembly2.cif.gz_D ASK1 kinase domain in complex with GS-4997	8.727E-04	0.999	99	26	279	317	2	231	253	309	0.801	0.909
LOKIASV2_3899_ESMFold_N-A	5uhn-assembly2.cif.gz_B	5uhn-assembly2.cif.gz_B Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring a N549H/E565A Double Gain-of-Function Mutation	2.597E-03	0.999	99	28	309	317	11	268	269	337	0.890	0.959
LOKIASV2_3899_ESMFold_N-A	6ya8-assembly1.cif.gz_A	6ya8-assembly1.cif.gz_A Cdc7-Dbf4 bound to ADP-BeF3	3.547E-03	0.999	99	14	269	317	4	182	340	269	0.808	0.526
LOKIASV2_3899_ESMFold_N-A	7up6-assembly1.cif.gz_A	7up6-assembly1.cif.gz_A Crystal structure of C-terminal domain of MSK1 in complex with in covalently bound literature RSK2 inhibitor pyrrolopyrimidine cyanoacrylamide compound 25 (co-crystal)	2.597E-03	0.999	97	25	279	317	3	218	257	293	0.804	0.840
LOKIASV2_3899_ESMFold_N-A	6ruu-assembly1.cif.gz_A	6ruu-assembly1.cif.gz_A Pseudokinase domain of human IRAK3	9.192E-04	0.999	97	11	312	317	1	283	285	367	0.953	0.993
LOKIASV2_3899_ESMFold_N-A	2vz6-assembly2.cif.gz_B	2vz6-assembly2.cif.gz_B Structure of human calcium calmodulin dependent protein kinase type II alpha (CAMK2A) in complex with Indirubin E804	1.627E-03	0.999	97	26	279	317	3	246	294	317	0.801	0.830
LOKIASV2_3899_ESMFold_N-A	5de2-assembly2.cif.gz_B	5de2-assembly2.cif.gz_B Structural mechanism of Nek7 activation by Nek9-induced dimerisation	1.627E-03	0.999	96	25	289	317	5	237	262	316	0.836	0.889
LOKIASV2_3899_ESMFold_N-A	3ma6-assembly2.cif.gz_B	3ma6-assembly2.cif.gz_B Crystal structure of kinase domain of TgCDPK1 in presence of 3BrB-PP1	1.192E-03	0.999	96	26	310	317	2	265	266	340	0.899	0.992
LOKIASV2_3899_ESMFold_N-A	3orx-assembly5.cif.gz_E	3orx-assembly5.cif.gz_E PDK1 mutant bound to allosteric disulfide fragment inhibitor 1F8	1.074E-03	0.999	96	30	289	317	7	232	274	304	0.820	0.825
LOKIASV2_3899_ESMFold_N-A	7jus-assembly1.cif.gz_B	7jus-assembly1.cif.gz_B Crystal Structure of KSR2:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor Cobimetinib	5.660E-03	0.999	96	28	141	317	13	126	276	121	0.360	0.413
LOKIASV2_3899_ESMFold_N-A	6eir-assembly2.cif.gz_B	6eir-assembly2.cif.gz_B DYRK1A in complex with XMD15-27-2	3.367E-03	0.999	96	28	279	317	25	241	335	288	0.795	0.648
LOKIASV2_3899_ESMFold_N-A	3uzs-assembly1.cif.gz_A	3uzs-assembly1.cif.gz_A Structure of the C13.28 RNA Aptamer Bound to the G Protein-Coupled Receptor Kinase 2-Heterotrimeric G Protein Beta 1 and Gamma 2 Subunit Complex	9.192E-04	0.999	96	12	280	317	139	381	609	322	0.849	0.399
LOKIASV2_3899_ESMFold_N-A	8sap-assembly1.cif.gz_A	8sap-assembly1.cif.gz_A Crystal structure of class III lanthipeptide synthetase ThurKC	9.353E-05	0.999	96	7	311	317	175	444	833	348	0.962	0.324
LOKIASV2_3899_ESMFold_N-A	8sam-assembly1.cif.gz_A	8sam-assembly1.cif.gz_A Crystal structure of class III lanthipeptide synthetase LP-GS-ThurKC in complex with ATP	1.151E-04	0.999	96	12	310	317	202	470	859	343	0.943	0.313
LOKIASV2_3899_ESMFold_N-A	7uir-assembly2.cif.gz_B	7uir-assembly2.cif.gz_B Cocrystal structure of human CaMKII-alpha (CAMK2A)kinase domain and Tiam1 in complex with ATP	2.222E-03	0.998	95	27	284	317	4	214	261	298	0.814	0.808
LOKIASV2_3899_ESMFold_N-A	7umb-assembly1.cif.gz_B	7umb-assembly1.cif.gz_B NanoBRET tracer Tram-bo bound to a KSR2-MEK1 complex	6.614E-03	0.998	95	28	141	317	13	126	277	121	0.360	0.412
LOKIASV2_3899_ESMFold_N-A	6bab-assembly1.cif.gz_A	6bab-assembly1.cif.gz_A The structure of human CamKII with bound inhibitor	3.547E-03	0.998	95	28	289	317	2	243	290	317	0.826	0.834
LOKIASV2_3899_ESMFold_N-A	6ya7-assembly1.cif.gz_A	6ya7-assembly1.cif.gz_A Cdc7-Dbf4 bound to an Mcm2-S40 derived bivalent substrate	5.962E-03	0.998	95	12	270	317	1	183	350	272	0.817	0.523
LOKIASV2_3899_ESMFold_N-A	3zxt-assembly1.cif.gz_B	3zxt-assembly1.cif.gz_B Dimeric structure of DAPK-1 catalytic domain in complex with AMPPCP- Mg	5.660E-03	0.998	94	27	289	317	4	233	253	312	0.830	0.909
LOKIASV2_3899_ESMFold_N-A	2hel-assembly1.cif.gz_A	2hel-assembly1.cif.gz_A Crystal structure of a mutant EphA4 kinase domain (Y742A)	1.074E-03	0.998	94	8	317	317	1	253	256	349	0.978	0.988
LOKIASV2_3899_ESMFold_N-A	4krd-assembly1.cif.gz_A	4krd-assembly1.cif.gz_A Crystal Structure of Pho85-Pcl10 Complex	1.467E-03	0.998	94	27	280	317	3	215	294	291	0.801	0.724
LOKIASV2_3899_ESMFold_N-A	5izj-assembly1.cif.gz_A	5izj-assembly1.cif.gz_A Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1411	5.468E-04	0.998	94	12	284	317	1	238	330	321	0.861	0.721
LOKIASV2_3899_ESMFold_N-A	2h34-assembly2.cif.gz_B	2h34-assembly2.cif.gz_B Apoenzyme crystal structure of the tuberculosis serine/threonine kinase, PknE	1.234E-02	0.998	93	29	141	317	4	118	243	124	0.356	0.473
LOKIASV2_3899_ESMFold_N-A	7b8w-assembly3.cif.gz_C	7b8w-assembly3.cif.gz_C Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470	1.131E-03	0.998	93	30	305	317	10	274	276	340	0.871	0.960
LOKIASV2_3899_ESMFold_N-A	5lpy-assembly1.cif.gz_A	5lpy-assembly1.cif.gz_A Crystal structure of the BRI1 kinase domain (865-1160) in complex with ATP from Arabidopsis thaliana	1.322E-03	0.998	93	9	310	317	3	260	286	348	0.953	0.902
LOKIASV2_3899_ESMFold_N-A	4jdk-assembly1.cif.gz_A	4jdk-assembly1.cif.gz_A Crystal structure of Serine/threonine-protein kinase PAK 4 F461V mutant in complex with Paktide S peptide substrate	1.467E-03	0.998	93	12	280	317	1	229	290	308	0.849	0.790
LOKIASV2_3899_ESMFold_N-A	2r0i-assembly2.cif.gz_B	2r0i-assembly2.cif.gz_B Crystal structure of a kinase MARK2/Par-1 mutant	1.192E-03	0.998	93	30	292	317	6	221	300	297	0.830	0.720
LOKIASV2_3899_ESMFold_N-A	6so4-assembly1.cif.gz_A	6so4-assembly1.cif.gz_A Fragment RZ132 in complex with MAP kinase p38-alpha	5.102E-03	0.998	93	28	145	317	18	141	343	132	0.372	0.362
LOKIASV2_3899_ESMFold_N-A	5tkd-assembly3.cif.gz_B	5tkd-assembly3.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH 6-[(3,5-DIMETHYLPHE NYL)AMINO]-8- (METHYLAMINO)IMIDAZO[1,2-B]PYRIDAZINE-3-CARBO XAMIDE	2.003E-03	0.997	92	31	299	317	11	246	247	321	0.849	0.955
LOKIASV2_3899_ESMFold_N-A	5up3-assembly1.cif.gz_A	5up3-assembly1.cif.gz_A Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	1.545E-03	0.997	92	29	289	317	1	237	258	322	0.823	0.919
LOKIASV2_3899_ESMFold_N-A	3kul-assembly1.cif.gz_A	3kul-assembly1.cif.gz_A Kinase domain of human ephrin type-A receptor 8 (EPHA8)	2.466E-03	0.997	92	27	317	317	6	266	267	346	0.918	0.978
LOKIASV2_3899_ESMFold_N-A	3zfx-assembly1.cif.gz_A	3zfx-assembly1.cif.gz_A Crystal structure of EphB1	3.197E-03	0.997	92	26	312	317	5	258	267	335	0.905	0.951
LOKIASV2_3899_ESMFold_N-A	5n1m-assembly1.cif.gz_A	5n1m-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule (5-chloro-2-methoxyphenyl)methanamine	7.468E-04	0.997	92	14	279	317	19	274	351	333	0.839	0.729
LOKIASV2_3899_ESMFold_N-A	6oyt-assembly2.cif.gz_B	6oyt-assembly2.cif.gz_B ASK1 kinase domain in complex with GS-4997	2.003E-03	0.997	91	31	279	317	3	218	238	302	0.785	0.908
LOKIASV2_3899_ESMFold_N-A	2clq-assembly2.cif.gz_B	2clq-assembly2.cif.gz_B Structure of mitogen-activated protein kinase kinase kinase 5	8.285E-04	0.997	91	29	316	317	1	218	259	324	0.909	0.842
LOKIASV2_3899_ESMFold_N-A	6bl8-assembly1.cif.gz_A	6bl8-assembly1.cif.gz_A Predicting the Conformational Variability of Abl Tyrosine Kinase Using Molecular Dynamics Simulations and Markov State Models	2.736E-03	0.997	91	30	298	317	10	267	270	345	0.849	0.956
LOKIASV2_3899_ESMFold_N-A	1xo2-assembly1.cif.gz_B	1xo2-assembly1.cif.gz_B Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin	5.962E-03	0.997	91	31	241	317	2	157	289	228	0.666	0.540
LOKIASV2_3899_ESMFold_N-A	3tl8-assembly1.cif.gz_A	3tl8-assembly1.cif.gz_A The AvrPtoB-BAK1 complex reveals two structurally similar kinaseinteracting domains in a single type III effector	1.255E-03	0.997	91	21	302	317	11	302	304	367	0.890	0.961
LOKIASV2_3899_ESMFold_N-A	3oz6-assembly1.cif.gz_B	3oz6-assembly1.cif.gz_B Crystal structure of MapK from Cryptosporidium Parvum, cgd2_1960	3.367E-03	0.997	91	25	312	317	5	248	341	330	0.909	0.716
LOKIASV2_3899_ESMFold_N-A	8sam-assembly2.cif.gz_B	8sam-assembly2.cif.gz_B Crystal structure of class III lanthipeptide synthetase LP-GS-ThurKC in complex with ATP	2.784E-04	0.997	91	12	310	317	201	469	858	348	0.943	0.314
LOKIASV2_3899_ESMFold_N-A	5vio-assembly4.cif.gz_D	5vio-assembly4.cif.gz_D Crystal structure of ASK1 kinase domain with a potent inhibitor (analog 13)	2.736E-03	0.996	90	29	240	317	1	159	271	235	0.669	0.587
LOKIASV2_3899_ESMFold_N-A	7b8w-assembly1.cif.gz_A	7b8w-assembly1.cif.gz_A Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470	2.341E-03	0.996	90	30	291	317	10	190	279	274	0.826	0.649
LOKIASV2_3899_ESMFold_N-A	5hvj-assembly1.cif.gz_A	5hvj-assembly1.cif.gz_A Crystal structure of LIMK1 D460N mutant in complex with AMP-PNP	1.902E-03	0.996	90	25	291	317	8	194	283	281	0.842	0.661
LOKIASV2_3899_ESMFold_N-A	4f9c-assembly1.cif.gz_A	4f9c-assembly1.cif.gz_A Human CDC7 kinase in complex with DBF4 and XL413	4.598E-03	0.996	90	14	289	317	2	209	306	301	0.871	0.680
LOKIASV2_3899_ESMFold_N-A	4f9b-assembly1.cif.gz_A	4f9b-assembly1.cif.gz_A Human CDC7 kinase in complex with DBF4 and PHA767491	4.844E-03	0.996	90	12	288	317	1	218	318	309	0.874	0.686
LOKIASV2_3899_ESMFold_N-A	4azt-assembly1.cif.gz_A	4azt-assembly1.cif.gz_A Co-crystal structure of WbdD and kinase inhibitor LY294002.	5.962E-03	0.996	90	29	279	317	217	410	435	269	0.792	0.446
LOKIASV2_3899_ESMFold_N-A	5u6y-assembly1.cif.gz_B	5u6y-assembly1.cif.gz_B Pseudo-atomic model of the CaMKIIa holoenzyme.	2.003E-03	0.996	90	29	279	317	1	241	459	315	0.792	0.525
LOKIASV2_3899_ESMFold_N-A	6cjw-assembly1.cif.gz_A	6cjw-assembly1.cif.gz_A Crystal Structure of Mnk2-D228G in Complex With Inhibitor	9.033E-03	0.996	89	29	141	317	14	127	270	122	0.356	0.422
LOKIASV2_3899_ESMFold_N-A	3kul-assembly2.cif.gz_B	3kul-assembly2.cif.gz_B Kinase domain of human ephrin type-A receptor 8 (EPHA8)	1.902E-03	0.996	89	27	317	317	6	272	272	352	0.918	0.982
LOKIASV2_3899_ESMFold_N-A	7ukz-assembly6.cif.gz_F	7ukz-assembly6.cif.gz_F CDK11 in complex with small molecule inhibitor OTS964	1.131E-03	0.996	89	30	280	317	3	212	295	297	0.792	0.712
LOKIASV2_3899_ESMFold_N-A	5n1o-assembly1.cif.gz_A	5n1o-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule 2-chloro-4-(chloromethyl)-5-hydroxyphenyl)ethan-1-one	1.714E-03	0.996	89	14	292	317	10	262	340	335	0.880	0.744
LOKIASV2_3899_ESMFold_N-A	6ya6-assembly1.cif.gz_A	6ya6-assembly1.cif.gz_A Minimal construct of Cdc7-Dbf4 bound to XL413	9.514E-03	0.996	89	14	269	317	4	183	344	269	0.808	0.523
LOKIASV2_3899_ESMFold_N-A	5r9w-assembly1.cif.gz_A	5r9w-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13598a in complex with MAP kinase p38-alpha	1.171E-02	0.996	89	28	145	317	18	144	348	135	0.372	0.365
LOKIASV2_3899_ESMFold_N-A	5v19-assembly1.cif.gz_A	5v19-assembly1.cif.gz_A Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead optimization strategy	1.192E-03	0.995	88	31	316	317	12	210	250	313	0.902	0.796
LOKIASV2_3899_ESMFold_N-A	4bic-assembly1.cif.gz_A	4bic-assembly1.cif.gz_A Crystal Structures of Ask1-inhibitor Complexes	3.547E-03	0.995	88	29	292	317	1	239	260	323	0.833	0.919
LOKIASV2_3899_ESMFold_N-A	3bhy-assembly1.cif.gz_A	3bhy-assembly1.cif.gz_A Crystal structure of human death associated protein kinase 3 (DAPK3) in complex with a beta-carboline ligand	5.962E-03	0.995	88	26	317	317	2	267	268	346	0.921	0.993
LOKIASV2_3899_ESMFold_N-A	7juz-assembly1.cif.gz_A	7juz-assembly1.cif.gz_A Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor Selumetinib	1.902E-03	0.995	88	28	301	317	11	270	273	339	0.864	0.952
LOKIASV2_3899_ESMFold_N-A	7up8-assembly2.cif.gz_B	7up8-assembly2.cif.gz_B Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 27 (co-crystal)	5.102E-03	0.995	88	27	316	317	14	280	280	348	0.915	0.954
LOKIASV2_3899_ESMFold_N-A	6ilz-assembly2.cif.gz_C	6ilz-assembly2.cif.gz_C Crystal structure of PKCiota in complex with inhibitor	4.598E-03	0.995	88	29	279	317	2	229	317	301	0.792	0.719
LOKIASV2_3899_ESMFold_N-A	6s14-assembly1.cif.gz_A	6s14-assembly1.cif.gz_A Crystal Structure of DYRK1A with small molecule inhibitor	2.597E-03	0.995	88	3	278	317	2	238	340	321	0.871	0.697
LOKIASV2_3899_ESMFold_N-A	7ejv-assembly1.cif.gz_A	7ejv-assembly1.cif.gz_A The co-crystal structure of DYRK2 with YK-2-69	5.962E-03	0.995	88	29	278	317	71	283	385	285	0.789	0.553
LOKIASV2_3899_ESMFold_N-A	6oyt-assembly1.cif.gz_C	6oyt-assembly1.cif.gz_C ASK1 kinase domain in complex with GS-4997	2.222E-03	0.994	87	31	279	317	2	217	236	293	0.785	0.915
LOKIASV2_3899_ESMFold_N-A	4pp9-assembly3.cif.gz_B	4pp9-assembly3.cif.gz_B ITK kinase domain with compound 1 (N-[1-(3-CYANOBENZYL)-1H-PYRAZOL-4-YL]-2H-INDAZOLE-3-CARBOXAMIDE)	6.280E-03	0.994	87	32	308	317	11	241	247	321	0.874	0.935
LOKIASV2_3899_ESMFold_N-A	4bie-assembly1.cif.gz_A	4bie-assembly1.cif.gz_A Crystal Structures of Ask1-inhibitor Complexes	2.341E-03	0.994	87	29	279	317	1	236	257	319	0.792	0.918
LOKIASV2_3899_ESMFold_N-A	4agu-assembly3.cif.gz_C	4agu-assembly3.cif.gz_C CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	5.660E-03	0.994	87	28	283	317	1	203	278	282	0.808	0.730
LOKIASV2_3899_ESMFold_N-A	1uu7-assembly1.cif.gz_A	1uu7-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with BIM-2	2.222E-03	0.994	87	30	289	317	10	240	281	310	0.820	0.822
LOKIASV2_3899_ESMFold_N-A	5vlo-assembly1.cif.gz_A	5vlo-assembly1.cif.gz_A The structure of human CamKII with bound inhibitor	6.967E-03	0.994	87	27	289	317	4	243	290	317	0.830	0.828
LOKIASV2_3899_ESMFold_N-A	4ian-assembly1.cif.gz_B	4ian-assembly1.cif.gz_B Crystal Structure of apo Human PRPF4B kinase domain	1.192E-03	0.994	87	28	283	317	10	228	320	300	0.808	0.684
LOKIASV2_3899_ESMFold_N-A	4ifc-assembly1.cif.gz_A	4ifc-assembly1.cif.gz_A Crystal Structure of ADP-bound Human PRPF4B kinase domain	5.760E-04	0.994	87	28	283	317	18	236	328	294	0.808	0.668
LOKIASV2_3899_ESMFold_N-A	3vuk-assembly1.cif.gz_A	3vuk-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M5 in MAP kinase JNK1	6.614E-03	0.994	87	28	283	317	18	230	355	292	0.808	0.600
LOKIASV2_3899_ESMFold_N-A	3k2l-assembly1.cif.gz_A	3k2l-assembly1.cif.gz_A Crystal Structure of dual-specificity tyrosine phosphorylation regulated kinase 2 (DYRK2)	1.112E-02	0.994	87	29	278	317	85	297	407	287	0.789	0.523
LOKIASV2_3899_ESMFold_N-A	3mwu-assembly1.cif.gz_A	3mwu-assembly1.cif.gz_A Activated Calcium-Dependent Protein Kinase 1 from Cryptosporidium parvum (CpCDPK1) in complex with bumped kinase inhibitor RM-1-95	2.003E-03	0.994	87	27	307	317	8	244	447	316	0.886	0.530
LOKIASV2_3899_ESMFold_N-A	6e2m-assembly1.cif.gz_B	6e2m-assembly1.cif.gz_B ASK1 kinase domain complex with inhibitor	2.003E-03	0.993	86	31	279	317	12	227	248	296	0.785	0.871
LOKIASV2_3899_ESMFold_N-A	4d2s-assembly1.cif.gz_A	4d2s-assembly1.cif.gz_A Human TTK in complex with a Dyrk1B inhibitor	1.627E-03	0.993	86	30	279	317	13	228	249	293	0.789	0.867
LOKIASV2_3899_ESMFold_N-A	5uox-assembly2.cif.gz_B	5uox-assembly2.cif.gz_B Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	4.145E-03	0.993	86	29	292	317	1	232	252	314	0.833	0.921
LOKIASV2_3899_ESMFold_N-A	3zfx-assembly6.cif.gz_F	3zfx-assembly6.cif.gz_F Crystal structure of EphB1	4.598E-03	0.993	86	26	312	317	4	245	254	324	0.905	0.953
LOKIASV2_3899_ESMFold_N-A	6oyw-assembly2.cif.gz_B	6oyw-assembly2.cif.gz_B ASK1 kinase domain in complex with Compound 11	7.866E-04	0.993	86	31	292	317	12	235	256	296	0.826	0.875
LOKIASV2_3899_ESMFold_N-A	4agu-assembly2.cif.gz_B	4agu-assembly2.cif.gz_B CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	6.614E-03	0.993	86	29	283	317	1	200	276	281	0.804	0.725
LOKIASV2_3899_ESMFold_N-A	6bab-assembly3.cif.gz_C	6bab-assembly3.cif.gz_C The structure of human CamKII with bound inhibitor	6.614E-03	0.993	86	29	289	317	1	237	284	313	0.823	0.835
LOKIASV2_3899_ESMFold_N-A	5uiu-assembly1.cif.gz_A	5uiu-assembly1.cif.gz_A Crystal structure of IRAK4 in complex with compound 30	2.881E-03	0.993	86	17	310	317	6	288	289	366	0.927	0.979
LOKIASV2_3899_ESMFold_N-A	5xvf-assembly1.cif.gz_A	5xvf-assembly1.cif.gz_A Crystal Structure of PAK4 in complex with inhibitor CZH062	3.367E-03	0.993	86	11	289	317	1	255	290	334	0.880	0.879
LOKIASV2_3899_ESMFold_N-A	7dh9-assembly1.cif.gz_A	7dh9-assembly1.cif.gz_A The co-crystal structure of DYRK2 with a small molecule inhibitor 7	5.660E-03	0.993	86	29	278	317	7	219	324	287	0.789	0.657
LOKIASV2_3899_ESMFold_N-A	7e11-assembly1.cif.gz_A	7e11-assembly1.cif.gz_A Crystal structure of PKAc-PLN R9C complex	1.902E-03	0.993	86	13	292	317	3	259	337	342	0.883	0.763
LOKIASV2_3899_ESMFold_N-A	5ztn-assembly1.cif.gz_B	5ztn-assembly1.cif.gz_B The crystal structure of human DYRK2 in complex with Curcumin	4.844E-03	0.993	86	29	278	317	89	301	397	285	0.789	0.537
LOKIASV2_3899_ESMFold_N-A	7jij-assembly1.cif.gz_A	7jij-assembly1.cif.gz_A ATP-bound AMP-activated protein kinase	1.020E-03	0.993	86	28	289	317	4	235	407	313	0.826	0.570
LOKIASV2_3899_ESMFold_N-A	3zfx-assembly3.cif.gz_C	3zfx-assembly3.cif.gz_C Crystal structure of EphB1	7.730E-03	0.992	85	26	312	317	2	240	248	322	0.905	0.964
LOKIASV2_3899_ESMFold_N-A	2h6d-assembly1.cif.gz_A	2h6d-assembly1.cif.gz_A Protein Kinase Domain of the Human 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK alpha-2 chain)	4.145E-03	0.992	85	28	289	317	5	223	256	300	0.826	0.855
LOKIASV2_3899_ESMFold_N-A	7kx6-assembly1.cif.gz_A	7kx6-assembly1.cif.gz_A Crystal structure of DCLK1-KD in complex with XMD8-85	4.598E-03	0.992	85	24	289	317	4	238	258	319	0.839	0.911
LOKIASV2_3899_ESMFold_N-A	3zew-assembly1.cif.gz_A	3zew-assembly1.cif.gz_A Crystal structure of EphB4 in complex with staurosporine	1.902E-03	0.992	85	26	315	317	3	263	270	345	0.915	0.967
LOKIASV2_3899_ESMFold_N-A	6brj-assembly1.cif.gz_A	6brj-assembly1.cif.gz_A DDR1 bound to VX-680	4.844E-03	0.992	85	30	278	317	6	218	274	296	0.785	0.777
LOKIASV2_3899_ESMFold_N-A	1v0o-assembly2.cif.gz_B	1v0o-assembly2.cif.gz_B Structure of P. falciparum PfPK5-Indirubin-5-sulphonate ligand complex	5.102E-03	0.992	85	29	283	317	1	203	274	296	0.804	0.741
LOKIASV2_3899_ESMFold_N-A	2ac3-assembly1.cif.gz_A	2ac3-assembly1.cif.gz_A Structure of human Mnk2 Kinase Domain	2.110E-03	0.992	85	26	312	317	10	272	277	343	0.905	0.949
LOKIASV2_3899_ESMFold_N-A	5hvj-assembly2.cif.gz_B	5hvj-assembly2.cif.gz_B Crystal structure of LIMK1 D460N mutant in complex with AMP-PNP	3.935E-03	0.992	85	30	291	317	10	191	284	278	0.826	0.641
LOKIASV2_3899_ESMFold_N-A	5lpw-assembly1.cif.gz_A	5lpw-assembly1.cif.gz_A Crystal structure of the apo-BRI1 kinase domain (865-1160)	1.234E-02	0.992	85	9	240	317	4	165	284	240	0.732	0.570
LOKIASV2_3899_ESMFold_N-A	3e87-assembly2.cif.gz_B	3e87-assembly2.cif.gz_B Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors	1.393E-03	0.992	85	28	303	317	5	276	323	345	0.871	0.842
LOKIASV2_3899_ESMFold_N-A	6k0j-assembly1.cif.gz_A	6k0j-assembly1.cif.gz_A The co-crystal structure of DYRK2 with a small molecule inhibitor	5.102E-03	0.992	85	29	278	317	10	222	327	288	0.789	0.651
LOKIASV2_3899_ESMFold_N-A	5tbe-assembly1.cif.gz_A	5tbe-assembly1.cif.gz_A Human p38alpha MAP Kinase in Complex with Dibenzosuberone Compound 2	1.806E-03	0.992	85	30	301	317	20	243	332	308	0.858	0.675
LOKIASV2_3899_ESMFold_N-A	2vag-assembly1.cif.gz_A	2vag-assembly1.cif.gz_A Crystal structure of di-phosphorylated human CLK1 in complex with a novel substituted indole inhibitor	2.074E-02	0.992	85	27	142	317	12	135	332	129	0.366	0.373
LOKIASV2_3899_ESMFold_N-A	6hdr-assembly1.cif.gz_A	6hdr-assembly1.cif.gz_A Human DYRK2 bound to Curcumin	1.369E-02	0.992	85	29	278	317	94	306	407	290	0.789	0.523
LOKIASV2_3899_ESMFold_N-A	8tb6-assembly2.cif.gz_B	8tb6-assembly2.cif.gz_B TYK2 JH2 bound to Compound14	3.935E-03	0.991	84	31	307	317	12	253	254	327	0.874	0.953
LOKIASV2_3899_ESMFold_N-A	4bid-assembly2.cif.gz_B	4bid-assembly2.cif.gz_B Crystal Structures of Ask1-inhibitor Complexes	2.736E-03	0.991	84	29	316	317	1	217	258	319	0.909	0.841
LOKIASV2_3899_ESMFold_N-A	7n9g-assembly2.cif.gz_B	7n9g-assembly2.cif.gz_B Crystal structure of the Abl 1b Kinase domain in complex with Dasatinib and Imatinib	5.374E-03	0.991	84	30	296	317	10	263	264	339	0.842	0.962
LOKIASV2_3899_ESMFold_N-A	2j90-assembly1.cif.gz_A	2j90-assembly1.cif.gz_A Crystal structure of human ZIP kinase in complex with a tetracyclic pyridone inhibitor (Pyridone 6)	9.514E-03	0.991	84	26	289	317	5	243	265	323	0.833	0.902
LOKIASV2_3899_ESMFold_N-A	6qau-assembly2.cif.gz_B	6qau-assembly2.cif.gz_B Crystal structure of ULK2 in complexed with MRT67307	7.730E-03	0.991	84	33	279	317	14	243	265	304	0.779	0.868
LOKIASV2_3899_ESMFold_N-A	5xff-assembly1.cif.gz_A	5xff-assembly1.cif.gz_A Crystal structure of LY2874455 in complex of FGFR4 gatekeeper mutation (V550L)	4.366E-03	0.991	84	27	308	317	12	267	269	339	0.890	0.952
LOKIASV2_3899_ESMFold_N-A	3s95-assembly2.cif.gz_B	3s95-assembly2.cif.gz_B Crystal structure of the human LIMK1 kinase domain in complex with staurosporine	7.730E-03	0.991	84	30	291	317	12	197	290	280	0.826	0.641
LOKIASV2_3899_ESMFold_N-A	7ake-assembly1.cif.gz_A	7ake-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 58	4.145E-03	0.991	84	28	278	317	17	230	333	290	0.792	0.643
LOKIASV2_3899_ESMFold_N-A	3p4k-assembly1.cif.gz_A	3p4k-assembly1.cif.gz_A The third conformation of p38a MAP kinase observed in phosphorylated p38a and in solution	6.614E-03	0.991	84	31	283	317	23	222	338	282	0.798	0.592
LOKIASV2_3899_ESMFold_N-A	6ytw-assembly2.cif.gz_B	6ytw-assembly2.cif.gz_B CLK3 bound with benzothiazole Tg003 (Cpd 2)	3.671E-02	0.991	84	29	152	317	22	154	339	139	0.391	0.392
LOKIASV2_3899_ESMFold_N-A	4y5q-assembly1.cif.gz_A	4y5q-assembly1.cif.gz_A Activated Calcium-Dependent Protein Kinase 1 from Cryptosporidium parvum (CpCDPK1) in complex with AMP	3.736E-03	0.991	84	26	289	317	7	245	449	316	0.833	0.532
LOKIASV2_3899_ESMFold_N-A	5m53-assembly1.cif.gz_A	5m53-assembly1.cif.gz_A Nek2 bound to arylaminopurine inhibitor 11	1.171E-02	0.990	83	29	270	317	1	198	255	275	0.763	0.776
LOKIASV2_3899_ESMFold_N-A	7chn-assembly1.cif.gz_A	7chn-assembly1.cif.gz_A Crystal structure of TTK kinase domain in complex with compound 9	1.902E-03	0.990	83	28	279	317	14	242	266	307	0.795	0.861
LOKIASV2_3899_ESMFold_N-A	2iw8-assembly2.cif.gz_C	2iw8-assembly2.cif.gz_C STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR	7.730E-03	0.990	83	27	307	317	2	251	266	336	0.886	0.940
LOKIASV2_3899_ESMFold_N-A	7quf-assembly1.cif.gz_A	7quf-assembly1.cif.gz_A The STK17A (DRAK1) Kinase Domain Bound to CK156	1.442E-02	0.990	83	27	306	317	9	266	270	339	0.883	0.956
LOKIASV2_3899_ESMFold_N-A	7b8w-assembly4.cif.gz_D	7b8w-assembly4.cif.gz_D Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470	3.935E-03	0.990	83	29	305	317	11	271	273	347	0.874	0.956
LOKIASV2_3899_ESMFold_N-A	6egd-assembly1.cif.gz_D	6egd-assembly1.cif.gz_D Crystal structure of the unphosphorylated IRAK4 kinase domain Bound to a type I inhibitor	2.736E-03	0.990	83	24	310	317	24	275	276	345	0.905	0.913
LOKIASV2_3899_ESMFold_N-A	2y7j-assembly1.cif.gz_C	2y7j-assembly1.cif.gz_C Structure of human phosphorylase kinase, gamma 2	7.730E-03	0.990	83	16	289	317	4	263	284	333	0.864	0.915
LOKIASV2_3899_ESMFold_N-A	5lpv-assembly1.cif.gz_A	5lpv-assembly1.cif.gz_A Crystal structure of the BRI1 kinase domain (865-1160) in complex with AMPPNP and Mn from Arabidopsis thaliana	1.599E-02	0.990	83	9	240	317	3	163	285	240	0.732	0.565
LOKIASV2_3899_ESMFold_N-A	3bhh-assembly2.cif.gz_B	3bhh-assembly2.cif.gz_B Crystal structure of human calcium/calmodulin-dependent protein kinase IIB isoform 1 (CAMK2B)	7.338E-03	0.990	83	27	306	317	2	257	289	331	0.883	0.886
LOKIASV2_3899_ESMFold_N-A	5hvk-assembly2.cif.gz_C	5hvk-assembly2.cif.gz_C Crystal structure of LIMK1 mutant D460N in complex with full-length cofilin-1	5.374E-03	0.990	83	25	289	317	9	201	292	285	0.836	0.661
LOKIASV2_3899_ESMFold_N-A	7ukz-assembly1.cif.gz_A	7ukz-assembly1.cif.gz_A CDK11 in complex with small molecule inhibitor OTS964	5.962E-03	0.990	83	28	280	317	1	212	296	288	0.798	0.716
LOKIASV2_3899_ESMFold_N-A	6gvx-assembly2.cif.gz_B	6gvx-assembly2.cif.gz_B Crystal structure of Maternal Embryonic Leucine Zipper Kinase (MELK) in complex with dorsomorphin (Compound C)	6.614E-03	0.990	83	9	279	317	1	228	319	319	0.855	0.715
LOKIASV2_3899_ESMFold_N-A	5o90-assembly1.cif.gz_A	5o90-assembly1.cif.gz_A Crystal structure of a P38alpha T185G mutant in complex with TAB1 peptide.	2.341E-03	0.990	83	28	283	317	18	224	330	297	0.808	0.627
LOKIASV2_3899_ESMFold_N-A	3lhj-assembly1.cif.gz_A	3lhj-assembly1.cif.gz_A Crystal Structure of p38a Mitogen-Activated Protein Kinase in Complex with a Pyrazolopyridinone Inhibitor.	4.598E-03	0.990	83	28	242	317	18	164	341	230	0.678	0.431
LOKIASV2_3899_ESMFold_N-A	6sot-assembly1.cif.gz_A	6sot-assembly1.cif.gz_A Fragment N11290a in complex with MAP kinase p38-alpha	1.299E-02	0.990	83	28	145	317	18	140	342	132	0.372	0.360
LOKIASV2_3899_ESMFold_N-A	5ezv-assembly2.cif.gz_C	5ezv-assembly2.cif.gz_C X-ray crystal structure of AMP-activated protein kinase alpha-2/alpha-1 RIM chimaera (alpha-2(1-347)/alpha-1(349-401)/alpha-2(397-end) beta-1 gamma-1) co-crystallized with C2 (5-(5-hydroxyl-isoxazol-3-yl)-furan-2-phosphonic acid)	9.514E-03	0.990	83	30	240	317	8	155	441	221	0.666	0.336
LOKIASV2_3899_ESMFold_N-A	3qgy-assembly1.cif.gz_A	3qgy-assembly1.cif.gz_A Crystal structure of ITK inhibitor complex	1.002E-02	0.988	82	28	316	317	7	246	246	324	0.912	0.976
LOKIASV2_3899_ESMFold_N-A	7vjl-assembly2.cif.gz_B	7vjl-assembly2.cif.gz_B The crystal structure of FGFR4 kinase domain in complex with N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-(2,2,2-trifluoroacetyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide	6.614E-03	0.988	82	28	312	317	13	265	266	338	0.899	0.951
LOKIASV2_3899_ESMFold_N-A	6jlr-assembly1.cif.gz_A	6jlr-assembly1.cif.gz_A Crystal structure of wild type MNK2 in complex with inhibitor	5.962E-03	0.988	82	29	292	317	14	247	268	307	0.833	0.873
LOKIASV2_3899_ESMFold_N-A	5ia4-assembly1.cif.gz_A	5ia4-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with foretinib (XL880)	1.056E-02	0.988	82	29	316	317	10	269	269	344	0.909	0.967
LOKIASV2_3899_ESMFold_N-A	7du9-assembly1.cif.gz_B	7du9-assembly1.cif.gz_B Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with Pralsetinib	5.660E-03	0.988	82	18	307	317	2	266	273	347	0.915	0.971
LOKIASV2_3899_ESMFold_N-A	3udb-assembly7.cif.gz_A	3udb-assembly7.cif.gz_A Crystal structure of SnRK2.6	1.171E-02	0.988	82	26	144	317	6	124	275	129	0.375	0.433
LOKIASV2_3899_ESMFold_N-A	3kk9-assembly1.cif.gz_A	3kk9-assembly1.cif.gz_A CaMKII Substrate Complex B	9.514E-03	0.988	82	27	289	317	4	245	276	319	0.830	0.877
LOKIASV2_3899_ESMFold_N-A	5lpb-assembly1.cif.gz_A	5lpb-assembly1.cif.gz_A Crystal structure of the BRI1 kinase domain (865-1160) in complex with ADP from Arabidopsis thaliana	1.442E-02	0.988	82	9	240	317	3	164	284	242	0.732	0.570
LOKIASV2_3899_ESMFold_N-A	4rmz-assembly2.cif.gz_B	4rmz-assembly2.cif.gz_B Crystal Structure of IRAK-4	5.374E-03	0.988	82	17	303	317	6	283	284	361	0.905	0.979
LOKIASV2_3899_ESMFold_N-A	6f3d-assembly2.cif.gz_B	6f3d-assembly2.cif.gz_B IRAK4 IN COMPLEX WITH inhibitor	8.142E-03	0.988	82	17	310	317	7	284	285	367	0.927	0.975
LOKIASV2_3899_ESMFold_N-A	2wnt-assembly1.cif.gz_B	2wnt-assembly1.cif.gz_B Crystal Structure of the Human Ribosomal protein S6 kinase	5.660E-03	0.988	82	27	279	317	1	232	285	311	0.798	0.814
LOKIASV2_3899_ESMFold_N-A	3hgk-assembly3.cif.gz_C	3hgk-assembly3.cif.gz_C crystal structure of effect protein AvrptoB complexed with kinase Pto	7.338E-03	0.988	82	28	289	317	8	202	286	294	0.826	0.682
LOKIASV2_3899_ESMFold_N-A	4eok-assembly1.cif.gz_A	4eok-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 H84S, Q85M, K89D - human cyclin A3 complex with the inhibitor NU6102	6.614E-03	0.988	82	28	283	317	3	215	294	298	0.808	0.724
LOKIASV2_3899_ESMFold_N-A	4eop-assembly1.cif.gz_A	4eop-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 Q131E - human cyclin A3 complex with the inhibitor RO3306	2.423E-02	0.988	82	27	142	317	4	121	298	128	0.366	0.396
LOKIASV2_3899_ESMFold_N-A	4nw6-assembly1.cif.gz_A	4nw6-assembly1.cif.gz_A Rsk2 N-terminal kinase in complex with 2-amino-7-substituted benzoxazole compound 27	5.102E-03	0.988	82	26	290	317	14	250	302	316	0.836	0.785
LOKIASV2_3899_ESMFold_N-A	4e6c-assembly1.cif.gz_A	4e6c-assembly1.cif.gz_A p38a-perifosine Complex	5.102E-03	0.988	82	28	283	317	19	216	330	281	0.808	0.600
LOKIASV2_3899_ESMFold_N-A	2y8o-assembly1.cif.gz_A	2y8o-assembly1.cif.gz_A Crystal structure of human p38alpha complexed with a MAPK docking peptide	2.341E-03	0.988	82	28	283	317	19	223	339	289	0.808	0.605
LOKIASV2_3899_ESMFold_N-A	4l7f-assembly1.cif.gz_A	4l7f-assembly1.cif.gz_A Co-crystal Structure of JNK1 and AX13587	6.967E-03	0.988	82	31	283	317	24	222	354	282	0.798	0.562
LOKIASV2_3899_ESMFold_N-A	4kio-assembly3.cif.gz_C	4kio-assembly3.cif.gz_C Kinase domain mutant of human Itk in complex with a covalently-binding inhibitor	9.033E-03	0.986	81	32	308	317	12	244	251	315	0.874	0.928
LOKIASV2_3899_ESMFold_N-A	4o0u-assembly1.cif.gz_A	4o0u-assembly1.cif.gz_A Crystal structures of human kinase Aurora A	1.806E-03	0.986	81	30	310	317	8	254	259	325	0.886	0.954
LOKIASV2_3899_ESMFold_N-A	6qat-assembly1.cif.gz_A	6qat-assembly1.cif.gz_A Crystal structure of ULK2 in complexed with hesperadin	1.171E-02	0.986	81	28	279	317	5	237	259	306	0.795	0.900
LOKIASV2_3899_ESMFold_N-A	6cpy-assembly2.cif.gz_B	6cpy-assembly2.cif.gz_B Structure of apo GRMZM2G135359 pseudokinase	5.102E-03	0.986	81	11	317	317	8	261	262	339	0.968	0.969
LOKIASV2_3899_ESMFold_N-A	8our-assembly1.cif.gz_A	8our-assembly1.cif.gz_A CRYSTAL STRUCTURE OF DLK IN COMPLEX WITH COMPOUND 16	5.102E-03	0.986	81	31	312	317	10	256	264	335	0.890	0.936
LOKIASV2_3899_ESMFold_N-A	4xli-assembly2.cif.gz_B	4xli-assembly2.cif.gz_B Crystal structure of Abl2/Arg kinase in complex with dasatinib	1.442E-02	0.986	81	30	314	317	10	261	264	334	0.899	0.955
LOKIASV2_3899_ESMFold_N-A	5ia5-assembly1.cif.gz_A	5ia5-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with golvatinib (E7050)	2.983E-02	0.986	81	25	141	317	6	124	273	130	0.369	0.436
LOKIASV2_3899_ESMFold_N-A	3qd0-assembly1.cif.gz_A	3qd0-assembly1.cif.gz_A Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with (2R,5S)-1-[2-Amino-6-(3-amino-1H-indazol-6-yl)-4-pyrimidinyl]-6-methyl-N-phenyl-3-piperidinecarboxamide	4.366E-03	0.986	81	30	289	317	10	233	274	303	0.820	0.818
LOKIASV2_3899_ESMFold_N-A	4agu-assembly1.cif.gz_A	4agu-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	1.299E-02	0.986	81	28	283	317	1	202	277	282	0.808	0.729
LOKIASV2_3899_ESMFold_N-A	8ho6-assembly1.cif.gz_A	8ho6-assembly1.cif.gz_A ScRIPK WT	3.367E-03	0.986	81	34	302	317	22	278	281	335	0.849	0.915
LOKIASV2_3899_ESMFold_N-A	2biy-assembly1.cif.gz_A	2biy-assembly1.cif.gz_A Structure of PDK1-S241A mutant kinase domain	3.035E-03	0.986	81	30	289	317	11	246	287	315	0.820	0.822
LOKIASV2_3899_ESMFold_N-A	7ukz-assembly4.cif.gz_D	7ukz-assembly4.cif.gz_D CDK11 in complex with small molecule inhibitor OTS964	6.280E-03	0.986	81	29	280	317	1	209	294	288	0.795	0.711
LOKIASV2_3899_ESMFold_N-A	6ilz-assembly4.cif.gz_G	6ilz-assembly4.cif.gz_G Crystal structure of PKCiota in complex with inhibitor	5.102E-03	0.986	81	29	279	317	2	230	315	303	0.792	0.727
LOKIASV2_3899_ESMFold_N-A	2onl-assembly1.cif.gz_A	2onl-assembly1.cif.gz_A Crystal Structure of the p38a-MAPKAP kinase 2 Heterodimer	1.112E-02	0.986	81	30	281	317	21	223	338	280	0.795	0.601
LOKIASV2_3899_ESMFold_N-A	5n32-assembly1.cif.gz_A	5n32-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule 4-chlorobenzyl carbamimidothioate	3.736E-03	0.986	81	14	292	317	17	270	348	334	0.880	0.730
LOKIASV2_3899_ESMFold_N-A	5he1-assembly1.cif.gz_A	5he1-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG224062	6.280E-03	0.986	81	13	279	317	122	401	618	354	0.842	0.453
LOKIASV2_3899_ESMFold_N-A	4bf2-assembly1.cif.gz_A	4bf2-assembly1.cif.gz_A Crystal Structures of Ask1-inhibitor Complexes	5.962E-03	0.984	80	31	279	317	2	233	253	317	0.785	0.917
LOKIASV2_3899_ESMFold_N-A	2clq-assembly1.cif.gz_A-2	2clq-assembly1.cif.gz_A-2 Structure of mitogen-activated protein kinase kinase kinase 5	1.020E-03	0.984	80	29	309	317	1	220	263	312	0.886	0.837
LOKIASV2_3899_ESMFold_N-A	2g2i-assembly1.cif.gz_A	2g2i-assembly1.cif.gz_A A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain	6.614E-03	0.984	80	32	295	317	14	265	271	327	0.833	0.930
LOKIASV2_3899_ESMFold_N-A	5nxd-assembly2.cif.gz_B	5nxd-assembly2.cif.gz_B LIM Domain Kinase 2 (LIMK2) In Complex With TH-300	4.598E-03	0.984	80	29	313	317	1	243	271	321	0.899	0.897
LOKIASV2_3899_ESMFold_N-A	4qqc-assembly1.cif.gz_A	4qqc-assembly1.cif.gz_A Crystal Structure of FGF Receptor (FGFR) 4 Kinase Domain in Complex with FIIN-2, an Irreversible Tyrosine Kinase Inhibitor Capable of Overcoming FGFR Kinase Gate-Keeper Mutations	8.576E-03	0.984	80	27	308	317	22	271	273	334	0.890	0.916
LOKIASV2_3899_ESMFold_N-A	5lpz-assembly1.cif.gz_A	5lpz-assembly1.cif.gz_A Crystal structure of the BRI1 kinase domain (865-1196) in complex with ADP from Arabidopsis thaliana	1.002E-02	0.984	80	9	303	317	4	284	286	367	0.931	0.983
LOKIASV2_3899_ESMFold_N-A	7up5-assembly2.cif.gz_B	7up5-assembly2.cif.gz_B Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 23 (co-crystal)	1.545E-03	0.984	80	25	315	317	4	284	286	358	0.918	0.983
LOKIASV2_3899_ESMFold_N-A	5hez-assembly1.cif.gz_A	5hez-assembly1.cif.gz_A JAK2 kinase (JH1 domain) mutant P1057A in complex with TG101209	8.142E-03	0.984	80	30	313	317	8	287	289	362	0.896	0.969
LOKIASV2_3899_ESMFold_N-A	7ukz-assembly2.cif.gz_B	7ukz-assembly2.cif.gz_B CDK11 in complex with small molecule inhibitor OTS964	1.627E-03	0.984	80	30	280	317	3	213	296	300	0.792	0.713
LOKIASV2_3899_ESMFold_N-A	7ukz-assembly5.cif.gz_E	7ukz-assembly5.cif.gz_E CDK11 in complex with small molecule inhibitor OTS964	3.197E-03	0.984	80	28	280	317	2	214	299	298	0.798	0.712
LOKIASV2_3899_ESMFold_N-A	4eol-assembly2.cif.gz_C	4eol-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 H84S, Q85M, K89D - human cyclin A3 complex with the inhibitor RO3306	1.112E-02	0.984	80	30	280	317	7	219	300	295	0.792	0.710
LOKIASV2_3899_ESMFold_N-A	1wmk-assembly4.cif.gz_B	1wmk-assembly4.cif.gz_B Human death-associated kinase DRP-1, mutant S308D d40	1.869E-02	0.984	80	30	238	317	12	164	314	224	0.659	0.487
LOKIASV2_3899_ESMFold_N-A	6l21-assembly1.cif.gz_A	6l21-assembly1.cif.gz_A Crystal structure of CK2a1 H160A with hematein	1.599E-02	0.984	80	30	288	317	38	257	331	300	0.817	0.665
LOKIASV2_3899_ESMFold_N-A	2okr-assembly2.cif.gz_D	2okr-assembly2.cif.gz_D Crystal Structure of the P38a-MAPKAP kinase 2 Heterodimer	6.614E-03	0.984	80	31	283	317	22	221	339	283	0.798	0.590
LOKIASV2_3899_ESMFold_N-A	6z2v-assembly1.cif.gz_A	6z2v-assembly1.cif.gz_A CLK3 A319V mutant bound with beta-carboline KH-CARB13 (Cpd 3)	1.056E-02	0.984	80	29	277	317	22	244	339	301	0.785	0.658
LOKIASV2_3899_ESMFold_N-A	5r96-assembly1.cif.gz_A	5r96-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL095 in complex with MAP kinase p38-alpha	2.074E-02	0.984	80	28	145	317	18	144	347	135	0.372	0.366
LOKIASV2_3899_ESMFold_N-A	3pvu-assembly1.cif.gz_A	3pvu-assembly1.cif.gz_A Bovine GRK2 in complex with Gbetagamma subunits and a selective kinase inhibitor (CMPD101)	6.967E-03	0.984	80	4	292	317	150	399	609	346	0.912	0.411
LOKIASV2_3899_ESMFold_N-A	4csv-assembly1.cif.gz_A	4csv-assembly1.cif.gz_A Tyrosine kinase AS - a common ancestor of Src and Abl bound to Gleevec	1.685E-02	0.981	79	30	277	317	9	198	244	273	0.782	0.779
LOKIASV2_3899_ESMFold_N-A	2xne-assembly1.cif.gz_A	2xne-assembly1.cif.gz_A Structure of Aurora-A bound to an imidazopyrazine inhibitor	1.112E-02	0.981	79	30	310	317	7	244	246	325	0.886	0.967
LOKIASV2_3899_ESMFold_N-A	6c83-assembly1.cif.gz_B	6c83-assembly1.cif.gz_B Structure of Aurora A (122-403) bound to inhibitory Monobody Mb2 and AMPPCP	8.576E-03	0.981	79	30	279	317	7	223	247	292	0.789	0.879
LOKIASV2_3899_ESMFold_N-A	4bid-assembly1.cif.gz_A	4bid-assembly1.cif.gz_A Crystal Structures of Ask1-inhibitor Complexes	1.002E-02	0.981	79	29	292	317	1	234	254	322	0.833	0.921
LOKIASV2_3899_ESMFold_N-A	8tb5-assembly1.cif.gz_A	8tb5-assembly1.cif.gz_A TYK2 JH2 bound to Compound7	2.184E-02	0.981	79	32	140	317	10	120	257	124	0.344	0.432
LOKIASV2_3899_ESMFold_N-A	2hz4-assembly3.cif.gz_C	2hz4-assembly3.cif.gz_C Abl kinase domain unligated and in complex with tetrahydrostaurosporine	1.599E-02	0.981	79	32	298	317	9	258	259	334	0.842	0.965
LOKIASV2_3899_ESMFold_N-A	7kxw-assembly2.cif.gz_B	7kxw-assembly2.cif.gz_B Crystal structure of DCLK1-KD in complex with DCLK1-IN-1	8.142E-03	0.981	79	25	289	317	4	238	259	319	0.836	0.907
LOKIASV2_3899_ESMFold_N-A	5v19-assembly2.cif.gz_B	5v19-assembly2.cif.gz_B Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead optimization strategy	5.102E-03	0.981	79	29	309	317	1	217	260	311	0.886	0.835
LOKIASV2_3899_ESMFold_N-A	6vre-assembly2.cif.gz_B	6vre-assembly2.cif.gz_B Structure of ASK1 bound to BIO-1772961	4.844E-03	0.981	79	28	316	317	1	219	260	325	0.912	0.842
LOKIASV2_3899_ESMFold_N-A	3fdn-assembly1.cif.gz_A	3fdn-assembly1.cif.gz_A Structure-based drug design of novel Aurora kinase A inhibitors: Structure basis for potency and specificity	1.234E-02	0.981	79	30	280	317	8	209	261	281	0.792	0.774
LOKIASV2_3899_ESMFold_N-A	6eas-assembly1.cif.gz_A	6eas-assembly1.cif.gz_A Co-crystal of pseudokinase DRIK1 (drought responsive inactive kinase 1) bound to ENMD-2076	2.736E-03	0.981	79	6	317	317	4	262	263	348	0.984	0.985
LOKIASV2_3899_ESMFold_N-A	6mnh-assembly1.cif.gz_A	6mnh-assembly1.cif.gz_A ULK1 Unc-51 like autophagy activating kinase in complex with inhibitor BTC	5.962E-03	0.981	79	29	276	317	6	208	267	281	0.782	0.760
LOKIASV2_3899_ESMFold_N-A	3kf4-assembly2.cif.gz_B	3kf4-assembly2.cif.gz_B Structural analysis of DFG-in and DFG-out dual Src-Abl inhibitors sharing a common vinyl purine template	1.518E-02	0.981	79	32	298	317	14	268	270	342	0.842	0.944
LOKIASV2_3899_ESMFold_N-A	7ats-assembly1.cif.gz_A	7ats-assembly1.cif.gz_A The LIMK1 Kinase Domain Bound To LIJTF500127	6.967E-03	0.981	79	25	305	317	9	271	275	343	0.886	0.956
LOKIASV2_3899_ESMFold_N-A	6fer-assembly6.cif.gz_F	6fer-assembly6.cif.gz_F Crystal Structure of human DDR2 kinase in complex with 2-[4,5-difluoro-2-oxo-1'-(1H-pyrazolo[3,4-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide	1.869E-02	0.981	79	27	158	317	8	146	275	148	0.416	0.505
LOKIASV2_3899_ESMFold_N-A	3orz-assembly3.cif.gz_C	3orz-assembly3.cif.gz_C PDK1 mutant bound to allosteric disulfide fragment activator 2A2	9.033E-03	0.981	79	30	289	317	9	235	277	307	0.820	0.819
LOKIASV2_3899_ESMFold_N-A	4l00-assembly3.cif.gz_B	4l00-assembly3.cif.gz_B Crystal structure of the apo Jak1 pseudokinase domain	1.234E-02	0.981	79	18	140	317	5	133	278	141	0.388	0.464
LOKIASV2_3899_ESMFold_N-A	6bab-assembly2.cif.gz_B	6bab-assembly2.cif.gz_B The structure of human CamKII with bound inhibitor	9.514E-03	0.981	79	29	279	317	1	237	285	312	0.792	0.832
LOKIASV2_3899_ESMFold_N-A	3bhh-assembly3.cif.gz_C	3bhh-assembly3.cif.gz_C Crystal structure of human calcium/calmodulin-dependent protein kinase IIB isoform 1 (CAMK2B)	1.112E-02	0.981	79	32	289	317	5	238	285	310	0.814	0.821
LOKIASV2_3899_ESMFold_N-A	2pwl-assembly1.cif.gz_B	2pwl-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic N549H Mutation Responsible for Crouzon Syndrome.	6.614E-03	0.981	79	28	309	317	12	284	286	349	0.890	0.955
LOKIASV2_3899_ESMFold_N-A	7up4-assembly2.cif.gz_B	7up4-assembly2.cif.gz_B Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 20 (co-crystal)	6.967E-03	0.981	79	27	307	317	14	283	286	359	0.886	0.944
LOKIASV2_3899_ESMFold_N-A	2hak-assembly4.cif.gz_D	2hak-assembly4.cif.gz_D Catalytic and ubiqutin-associated domains of MARK1/PAR-1	4.366E-03	0.981	79	30	292	317	7	229	309	301	0.830	0.722
LOKIASV2_3899_ESMFold_N-A	4f9a-assembly1.cif.gz_A	4f9a-assembly1.cif.gz_A Human CDC7 kinase in complex with DBF4 and nucleotide	1.685E-02	0.981	79	12	288	317	1	215	315	309	0.874	0.683
LOKIASV2_3899_ESMFold_N-A	6una-assembly2.cif.gz_B	6una-assembly2.cif.gz_B Crystal structure of inactive p38gamma	1.518E-02	0.981	79	31	283	317	21	222	331	277	0.798	0.610
LOKIASV2_3899_ESMFold_N-A	2onl-assembly2.cif.gz_B	2onl-assembly2.cif.gz_B Crystal Structure of the p38a-MAPKAP kinase 2 Heterodimer	1.056E-02	0.981	79	30	283	317	21	224	339	282	0.801	0.602
LOKIASV2_3899_ESMFold_N-A	1lew-assembly1.cif.gz_A	1lew-assembly1.cif.gz_A CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS NUCLEAR SUBSTRATE MEF2A	4.366E-03	0.981	79	30	283	317	20	224	341	287	0.801	0.601
LOKIASV2_3899_ESMFold_N-A	5r94-assembly1.cif.gz_A	5r94-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL081 in complex with MAP kinase p38-alpha	1.774E-02	0.981	79	28	145	317	19	143	346	134	0.372	0.361
LOKIASV2_3899_ESMFold_N-A	4ewq-assembly1.cif.gz_A	4ewq-assembly1.cif.gz_A Human p38 alpha MAPK in complex with a pyridazine based inhibitor	9.033E-03	0.981	79	31	283	317	22	231	347	292	0.798	0.605
LOKIASV2_3899_ESMFold_N-A	7ejv-assembly1.cif.gz_B	7ejv-assembly1.cif.gz_B The co-crystal structure of DYRK2 with YK-2-69	3.736E-03	0.981	79	29	278	317	69	281	391	285	0.789	0.545
LOKIASV2_3899_ESMFold_N-A	4azs-assembly1.cif.gz_A	4azs-assembly1.cif.gz_A High resolution (2.2 A) crystal structure of WbdD.	2.423E-02	0.981	79	29	279	317	217	415	442	273	0.792	0.450
LOKIASV2_3899_ESMFold_N-A	4yga-assembly3.cif.gz_E	4yga-assembly3.cif.gz_E CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	3.547E-03	0.981	79	27	307	317	4	256	442	336	0.886	0.572
LOKIASV2_3899_ESMFold_N-A	3krw-assembly1.cif.gz_A	3krw-assembly1.cif.gz_A Human GRK2 in complex with Gbetgamma subunits and balanol (soak)	9.033E-03	0.981	79	12	310	317	136	434	618	380	0.943	0.484
LOKIASV2_3899_ESMFold_N-A	5uor-assembly1.cif.gz_A	5uor-assembly1.cif.gz_A Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	1.545E-03	0.978	78	31	275	317	12	205	249	266	0.773	0.779
LOKIASV2_3899_ESMFold_N-A	7k7q-assembly1.cif.gz_B	7k7q-assembly1.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH COMPOUND-12 AKA:6-[(cyclopropanecarbonyl)amino]-4-({3-[6-(dimethylcarbamoyl)pyridazin-3-yl]-2-methoxyphenyl}amino)-N-methylpyridazine-3-carboxamide	3.935E-03	0.978	78	32	317	317	10	217	251	310	0.902	0.829
LOKIASV2_3899_ESMFold_N-A	3zon-assembly1.cif.gz_A	3zon-assembly1.cif.gz_A Human TYK2 pseudokinase domain bound to a kinase inhibitor	3.547E-03	0.978	78	31	317	317	15	228	261	314	0.905	0.820
LOKIASV2_3899_ESMFold_N-A	2xyn-assembly3.cif.gz_C	2xyn-assembly3.cif.gz_C HUMAN ABL2 IN COMPLEX WITH AURORA KINASE INHIBITOR VX-680	1.599E-02	0.978	78	32	314	317	8	261	262	336	0.893	0.969
LOKIASV2_3899_ESMFold_N-A	5nxc-assembly1.cif.gz_L	5nxc-assembly1.cif.gz_L LIM Domain Kinase 1 (LIMK1) In Complex With PF-00477736	1.442E-02	0.978	78	30	305	317	12	272	274	338	0.871	0.953
LOKIASV2_3899_ESMFold_N-A	1fpu-assembly1.cif.gz_A	1fpu-assembly1.cif.gz_A CRYSTAL STRUCTURE OF ABL KINASE DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR	8.576E-03	0.978	78	1	311	317	1	274	275	369	0.981	0.996
LOKIASV2_3899_ESMFold_N-A	7up5-assembly1.cif.gz_A	7up5-assembly1.cif.gz_A Crystal structure of C-terminal Domain of MSK1 in complex with covalently bound pyrrolopyrimidine compound 23 (co-crystal)	1.467E-03	0.978	78	25	279	317	4	220	275	295	0.804	0.789
LOKIASV2_3899_ESMFold_N-A	3h9o-assembly1.cif.gz_A	3h9o-assembly1.cif.gz_A Phosphoinositide-dependent protein kinase 1 (PDK-1) in complex with compound 9	5.660E-03	0.978	78	30	289	317	8	234	276	306	0.820	0.822
LOKIASV2_3899_ESMFold_N-A	4tpt-assembly1.cif.gz_A	4tpt-assembly1.cif.gz_A Crystal Structure of the Human LIMK2 Kinase Domain In Complex With a Non-ATP Competitive Inhibitor	4.598E-03	0.978	78	31	313	317	15	252	279	325	0.893	0.853
LOKIASV2_3899_ESMFold_N-A	7c2v-assembly1.cif.gz_C	7c2v-assembly1.cif.gz_C Crystal Structure of IRAK4 kinase in complex with the inhibitor CA-4948	4.145E-03	0.978	78	7	303	317	1	280	283	369	0.937	0.989
LOKIASV2_3899_ESMFold_N-A	4ks8-assembly1.cif.gz_A	4ks8-assembly1.cif.gz_A PAK6 kinase domain in complex with sunitinib	1.299E-02	0.978	78	11	280	317	1	230	287	309	0.852	0.801
LOKIASV2_3899_ESMFold_N-A	4c0t-assembly1.cif.gz_A	4c0t-assembly1.cif.gz_A Candida albicans PKh Kinase Domain	4.145E-03	0.978	78	30	279	317	8	251	291	316	0.789	0.838
LOKIASV2_3899_ESMFold_N-A	3eid-assembly1.cif.gz_A	3eid-assembly1.cif.gz_A CDK2/CyclinA complexed with a pyrazolopyridazine inhibitor	1.234E-02	0.978	78	30	283	317	4	212	292	296	0.801	0.716
LOKIASV2_3899_ESMFold_N-A	6lxy-assembly3.cif.gz_D	6lxy-assembly3.cif.gz_D IRAK4 in complex with inhibitor	1.056E-02	0.978	78	7	311	317	3	292	293	377	0.962	0.990
LOKIASV2_3899_ESMFold_N-A	4eoo-assembly1.cif.gz_A	4eoo-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 Q131E - human cyclin A3 complex with ATP	1.002E-02	0.978	78	30	283	317	6	216	295	296	0.801	0.715
LOKIASV2_3899_ESMFold_N-A	1o6k-assembly1.cif.gz_A	1o6k-assembly1.cif.gz_A Structure of activated form of PKB kinase domain S474D with GSK3 peptide and AMP-PNP	4.844E-03	0.978	78	28	302	317	5	275	318	344	0.868	0.852
LOKIASV2_3899_ESMFold_N-A	8p04-assembly1.cif.gz_A	8p04-assembly1.cif.gz_A Crystal structure of human CLK1 in complex with Leucettinib-92	8.001E-02	0.978	78	27	142	317	12	135	321	129	0.366	0.386
LOKIASV2_3899_ESMFold_N-A	6una-assembly1.cif.gz_A	6una-assembly1.cif.gz_A Crystal structure of inactive p38gamma	1.518E-02	0.978	78	31	283	317	20	222	329	278	0.798	0.617
LOKIASV2_3899_ESMFold_N-A	6ytw-assembly1.cif.gz_A	6ytw-assembly1.cif.gz_A CLK3 bound with benzothiazole Tg003 (Cpd 2)	2.688E-02	0.978	78	29	283	317	31	256	349	307	0.804	0.648
LOKIASV2_3899_ESMFold_N-A	4wot-assembly2.cif.gz_B	4wot-assembly2.cif.gz_B ROCK2 IN COMPLEX WITH 1426382-07-1	3.367E-03	0.978	78	14	292	317	48	311	394	346	0.880	0.670
LOKIASV2_3899_ESMFold_N-A	8ie5-assembly1.cif.gz_A	8ie5-assembly1.cif.gz_A Crystal structure of DAPK1 in complex with oxyresveratrol	2.074E-02	0.975	77	26	312	317	8	265	271	346	0.905	0.952
LOKIASV2_3899_ESMFold_N-A	7jv1-assembly1.cif.gz_D	7jv1-assembly1.cif.gz_D Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor APS-9-95-1	9.033E-03	0.975	77	28	301	317	12	272	275	343	0.864	0.949
LOKIASV2_3899_ESMFold_N-A	8xfm-assembly1.cif.gz_A	8xfm-assembly1.cif.gz_A The Crystal Structure of MNK2 from Biortus.	2.222E-03	0.975	77	29	292	317	12	197	276	281	0.833	0.674
LOKIASV2_3899_ESMFold_N-A	3orz-assembly4.cif.gz_D	3orz-assembly4.cif.gz_D PDK1 mutant bound to allosteric disulfide fragment activator 2A2	4.844E-03	0.975	77	30	289	317	10	237	279	310	0.820	0.817
LOKIASV2_3899_ESMFold_N-A	7qhg-assembly2.cif.gz_B	7qhg-assembly2.cif.gz_B LIM domain kinase 2 (LIMK2) in complex with TH-470	3.736E-03	0.975	77	30	291	317	4	192	283	281	0.826	0.668
LOKIASV2_3899_ESMFold_N-A	6lvl-assembly2.cif.gz_B	6lvl-assembly2.cif.gz_B Crystal structure of FGFR2 in complex with 1,3,5-triazine derivative	5.102E-03	0.975	77	28	309	317	12	284	286	350	0.890	0.955
LOKIASV2_3899_ESMFold_N-A	1f3m-assembly1.cif.gz_C	1f3m-assembly1.cif.gz_C CRYSTAL STRUCTURE OF HUMAN SERINE/THREONINE KINASE PAK1	1.545E-03	0.975	77	12	313	317	1	285	287	366	0.953	0.993
LOKIASV2_3899_ESMFold_N-A	3kxx-assembly4.cif.gz_D	3kxx-assembly4.cif.gz_D Structure of the mutant Fibroblast Growth Factor receptor 1	1.171E-02	0.975	77	28	309	317	21	286	288	347	0.890	0.924
LOKIASV2_3899_ESMFold_N-A	4y73-assembly3.cif.gz_C	4y73-assembly3.cif.gz_C Crystal structure of IRAK4 kinase domain with inhibitor	6.967E-03	0.975	77	33	310	317	27	290	293	347	0.877	0.901
LOKIASV2_3899_ESMFold_N-A	2hak-assembly1.cif.gz_A	2hak-assembly1.cif.gz_A Catalytic and ubiqutin-associated domains of MARK1/PAR-1	6.500E-02	0.975	77	30	138	317	6	117	309	119	0.344	0.362
LOKIASV2_3899_ESMFold_N-A	5r9j-assembly1.cif.gz_A	5r9j-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N14231a in complex with MAP kinase p38-alpha	2.688E-02	0.975	77	28	145	317	19	141	344	132	0.372	0.358
LOKIASV2_3899_ESMFold_N-A	6yu1-assembly2.cif.gz_c	6yu1-assembly2.cif.gz_c CLK3 bound with beta-carboline KH-CARB13 (Cpd 3)	7.596E-02	0.975	77	29	152	317	31	163	350	139	0.391	0.380
LOKIASV2_3899_ESMFold_N-A	2vd5-assembly1.cif.gz_A-2	2vd5-assembly1.cif.gz_A-2 Structure of Human Myotonic Dystrophy Protein Kinase in Complex with the Bisindoylmaleide inhibitor BIM VIII	2.466E-03	0.975	77	6	289	317	30	304	390	360	0.896	0.705
LOKIASV2_3899_ESMFold_N-A	5otf-assembly1.cif.gz_A-2	5otf-assembly1.cif.gz_A-2 MRCK beta in complex with BDP-00009066	3.197E-03	0.975	77	2	280	317	44	296	411	336	0.880	0.616
LOKIASV2_3899_ESMFold_N-A	4azw-assembly1.cif.gz_A	4azw-assembly1.cif.gz_A Crystal structure of monomeric WbdD.	1.234E-02	0.975	77	39	267	317	229	413	413	255	0.722	0.448
LOKIASV2_3899_ESMFold_N-A	4ax8-assembly1.cif.gz_A	4ax8-assembly1.cif.gz_A Medium resolution structure of the bifunctional kinase- methyltransferase WbdD	1.685E-02	0.975	77	39	279	317	237	423	450	261	0.760	0.416
LOKIASV2_3899_ESMFold_N-A	4jai-assembly1.cif.gz_A	4jai-assembly1.cif.gz_A Crystal Structure of Aurora Kinase A in complex with N-{4-[(6-oxo-5,6-dihydrobenzo[c][1,8]naphthyridin-1-yl)amino]phenyl}benzamide	1.112E-02	0.971	76	30	310	317	8	245	249	318	0.886	0.956
LOKIASV2_3899_ESMFold_N-A	4bic-assembly2.cif.gz_B	4bic-assembly2.cif.gz_B Crystal Structures of Ask1-inhibitor Complexes	3.367E-03	0.971	76	29	279	317	1	237	259	312	0.792	0.915
LOKIASV2_3899_ESMFold_N-A	6oyw-assembly1.cif.gz_A-2	6oyw-assembly1.cif.gz_A-2 ASK1 kinase domain in complex with Compound 11	1.056E-02	0.971	76	31	279	317	2	241	261	315	0.785	0.920
LOKIASV2_3899_ESMFold_N-A	8tb6-assembly1.cif.gz_A	8tb6-assembly1.cif.gz_A TYK2 JH2 bound to Compound14	4.145E-03	0.971	76	32	317	317	16	228	263	311	0.902	0.810
LOKIASV2_3899_ESMFold_N-A	2v7a-assembly1.cif.gz_A	2v7a-assembly1.cif.gz_A Crystal structure of the T315I Abl mutant in complex with the inhibitor PHA-739358	2.552E-02	0.971	76	30	298	317	10	267	270	338	0.849	0.956
LOKIASV2_3899_ESMFold_N-A	2xck-assembly1.cif.gz_A-2	2xck-assembly1.cif.gz_A-2 Crystal structure of PDK1 in complex with a pyrazoloquinazoline inhibitor	1.685E-02	0.971	76	30	289	317	7	234	276	305	0.820	0.826
LOKIASV2_3899_ESMFold_N-A	7vdp-assembly2.cif.gz_B	7vdp-assembly2.cif.gz_B The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 1	1.969E-02	0.971	76	31	283	317	1	208	279	289	0.798	0.746
LOKIASV2_3899_ESMFold_N-A	4ypd-assembly1.cif.gz_A	4ypd-assembly1.cif.gz_A Crystal Structure of DAPK1 catalytic domain in complex with the hinge binding fragment 4-methylpyridazine	2.300E-02	0.971	76	26	289	317	8	255	281	323	0.833	0.883
LOKIASV2_3899_ESMFold_N-A	7eef-assembly1.cif.gz_A	7eef-assembly1.cif.gz_A Crystal structure of EphA7 mutant G656E	1.112E-02	0.971	76	15	317	317	7	278	283	353	0.956	0.961
LOKIASV2_3899_ESMFold_N-A	6thz-assembly2.cif.gz_B	6thz-assembly2.cif.gz_B IRAK4 IN COMPLEX WITH inhibitor	7.338E-03	0.971	76	7	310	317	1	282	283	375	0.959	0.996
LOKIASV2_3899_ESMFold_N-A	7atu-assembly2.cif.gz_B	7atu-assembly2.cif.gz_B The LIMK1 Kinase Domain Bound To LIJTF500025	5.660E-03	0.971	76	27	289	317	8	193	287	280	0.830	0.648
LOKIASV2_3899_ESMFold_N-A	7s47-assembly1.cif.gz_A	7s47-assembly1.cif.gz_A Integrin beta5(743-774)-linker-PAK4cat(D440N/S474E)	6.614E-03	0.971	76	12	289	317	1	254	290	332	0.877	0.876
LOKIASV2_3899_ESMFold_N-A	7vds-assembly1.cif.gz_A	7vds-assembly1.cif.gz_A The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 24	1.774E-02	0.971	76	33	283	317	7	216	290	291	0.792	0.724
LOKIASV2_3899_ESMFold_N-A	6bfn-assembly2.cif.gz_B	6bfn-assembly2.cif.gz_B Crystal structure of human IRAK1	1.056E-02	0.971	76	34	289	317	24	200	294	273	0.808	0.602
LOKIASV2_3899_ESMFold_N-A	4d2t-assembly4.cif.gz_D	4d2t-assembly4.cif.gz_D Structure of MELK in complex with inhibitors	3.935E-03	0.971	76	20	292	317	2	233	319	324	0.861	0.727
LOKIASV2_3899_ESMFold_N-A	4hys-assembly1.cif.gz_A	4hys-assembly1.cif.gz_A Crystal structure of JNK1 in complex with JIP1 peptide and 4-(4-Indazol-1-yl-pyrimidin-2-ylamino)-cyclohexan	1.774E-02	0.971	76	28	275	317	17	214	321	278	0.782	0.617
LOKIASV2_3899_ESMFold_N-A	8pqh-assembly1.cif.gz_A	8pqh-assembly1.cif.gz_A PDGFRA T674I mutant kinase domain in complex with avapritinib	8.576E-03	0.971	76	30	313	317	38	303	321	343	0.896	0.829
LOKIASV2_3899_ESMFold_N-A	4dgm-assembly1.cif.gz_A	4dgm-assembly1.cif.gz_A Crystal Structure of maize CK2 in complex with the inhibitor apigenin	6.614E-03	0.971	76	9	300	317	1	267	326	347	0.921	0.819
LOKIASV2_3899_ESMFold_N-A	1uki-assembly1.cif.gz_A	1uki-assembly1.cif.gz_A Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125	8.142E-03	0.971	76	28	302	317	16	241	328	302	0.868	0.689
LOKIASV2_3899_ESMFold_N-A	6q8p-assembly3.cif.gz_C	6q8p-assembly3.cif.gz_C Structure of CLK1 with bound N-methyl-10-nitropyrido[3,4-g]quinazolin-2-amine	6.171E-02	0.971	76	27	142	317	12	135	334	129	0.366	0.371
LOKIASV2_3899_ESMFold_N-A	4l8m-assembly1.cif.gz_A	4l8m-assembly1.cif.gz_A Human p38 MAP kinase in complex with a Dibenzoxepinone	7.338E-03	0.971	76	30	281	317	20	224	339	288	0.795	0.605
LOKIASV2_3899_ESMFold_N-A	1wfc-assembly1.cif.gz_A	1wfc-assembly1.cif.gz_A STRUCTURE OF APO, UNPHOSPHORYLATED, P38 MITOGEN ACTIVATED PROTEIN KINASE P38 (P38 MAP KINASE) THE MAMMALIAN HOMOLOGUE OF THE YEAST HOG1 PROTEIN	1.442E-02	0.971	76	31	235	317	20	163	340	219	0.647	0.424
LOKIASV2_3899_ESMFold_N-A	5oat-assembly1.cif.gz_D	5oat-assembly1.cif.gz_D PINK1 structure	1.599E-02	0.971	76	28	236	317	5	176	360	241	0.659	0.478
LOKIASV2_3899_ESMFold_N-A	4uak-assembly1.cif.gz_A-2	4uak-assembly1.cif.gz_A-2 MRCK beta in complex with ADP	4.145E-03	0.971	76	10	280	317	51	296	404	328	0.855	0.609
LOKIASV2_3899_ESMFold_N-A	5up3-assembly2.cif.gz_B	5up3-assembly2.cif.gz_B Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	1.902E-03	0.967	75	26	279	317	9	223	243	291	0.801	0.885
LOKIASV2_3899_ESMFold_N-A	3zxt-assembly2.cif.gz_D	3zxt-assembly2.cif.gz_D Dimeric structure of DAPK-1 catalytic domain in complex with AMPPCP- Mg	1.869E-02	0.967	75	26	289	317	3	179	245	276	0.833	0.722
LOKIASV2_3899_ESMFold_N-A	5uor-assembly2.cif.gz_B	5uor-assembly2.cif.gz_B Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure	1.322E-03	0.967	75	29	279	317	1	242	262	311	0.792	0.924
LOKIASV2_3899_ESMFold_N-A	6e2o-assembly1.cif.gz_A	6e2o-assembly1.cif.gz_A ASK1 kinase domain complex with inhibitor	4.598E-03	0.967	75	29	279	317	1	244	264	318	0.792	0.924
LOKIASV2_3899_ESMFold_N-A	2j90-assembly1.cif.gz_B	2j90-assembly1.cif.gz_B Crystal structure of human ZIP kinase in complex with a tetracyclic pyridone inhibitor (Pyridone 6)	4.290E-02	0.967	75	29	289	317	1	240	264	315	0.823	0.909
LOKIASV2_3899_ESMFold_N-A	5a6n-assembly1.cif.gz_A	5a6n-assembly1.cif.gz_A Crystal structure of human death associated protein kinase 3 (DAPK3) in complex with compound 2	8.576E-03	0.967	75	26	289	317	2	203	271	285	0.833	0.745
LOKIASV2_3899_ESMFold_N-A	4eor-assembly2.cif.gz_C	4eor-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 WT - human cyclin A3 complex with the inhibitor NU6102	2.184E-02	0.967	75	27	307	317	2	258	271	339	0.886	0.948
LOKIASV2_3899_ESMFold_N-A	5kkr-assembly1.cif.gz_B	5kkr-assembly1.cif.gz_B KSR2:MEK1 Complex Bound to the Small Molecule APS-2-79	1.234E-02	0.967	75	28	302	317	15	270	272	338	0.868	0.941
LOKIASV2_3899_ESMFold_N-A	4wnp-assembly3.cif.gz_C	4wnp-assembly3.cif.gz_C Structure of ULK1 bound to a potent inhibitor	1.299E-02	0.967	75	30	279	317	7	252	272	323	0.789	0.904
LOKIASV2_3899_ESMFold_N-A	5auw-assembly1.cif.gz_A	5auw-assembly1.cif.gz_A Crystal structure of DAPK1 in complex with quercetin.	3.485E-02	0.967	75	26	289	317	8	253	274	321	0.833	0.898
LOKIASV2_3899_ESMFold_N-A	3ion-assembly1.cif.gz_A	3ion-assembly1.cif.gz_A PDK1 in complex with Compound 8h	1.518E-02	0.967	75	30	289	317	8	232	274	302	0.820	0.821
LOKIASV2_3899_ESMFold_N-A	5lvp-assembly4.cif.gz_D	5lvp-assembly4.cif.gz_D Human PDK1 Kinase Domain in Complex with an HM-Peptide Bound to the PIF-Pocket	8.142E-03	0.967	75	30	289	317	9	235	277	308	0.820	0.819
LOKIASV2_3899_ESMFold_N-A	3orx-assembly2.cif.gz_B	3orx-assembly2.cif.gz_B PDK1 mutant bound to allosteric disulfide fragment inhibitor 1F8	1.969E-02	0.967	75	30	289	317	6	239	281	318	0.820	0.833
LOKIASV2_3899_ESMFold_N-A	6thw-assembly2.cif.gz_B	6thw-assembly2.cif.gz_B IRAK4 in complex with inhibitor	1.171E-02	0.967	75	7	310	317	1	280	281	371	0.959	0.996
LOKIASV2_3899_ESMFold_N-A	8dks-assembly1.cif.gz_A	8dks-assembly1.cif.gz_A IRAK4 IN COMPLEX WITH COMPOUND #3	1.171E-02	0.967	75	25	311	317	21	282	283	350	0.905	0.926
LOKIASV2_3899_ESMFold_N-A	7qhg-assembly1.cif.gz_A	7qhg-assembly1.cif.gz_A LIM domain kinase 2 (LIMK2) in complex with TH-470	7.730E-03	0.967	75	29	289	317	2	231	283	313	0.823	0.813
LOKIASV2_3899_ESMFold_N-A	6o8u-assembly4.cif.gz_D	6o8u-assembly4.cif.gz_D Crystal structure of IRAK4 in complex with compound 23	1.369E-02	0.967	75	5	289	317	1	212	290	310	0.899	0.731
LOKIASV2_3899_ESMFold_N-A	4d2t-assembly3.cif.gz_B	4d2t-assembly3.cif.gz_B Structure of MELK in complex with inhibitors	5.374E-03	0.967	75	12	292	317	1	192	323	302	0.886	0.594
LOKIASV2_3899_ESMFold_N-A	6qy8-assembly4.cif.gz_D	6qy8-assembly4.cif.gz_D Human CSNK2A2 bound to ERB-041	1.171E-02	0.967	75	27	300	317	30	265	323	318	0.864	0.731
LOKIASV2_3899_ESMFold_N-A	6l23-assembly1.cif.gz_A	6l23-assembly1.cif.gz_A Crystal structure of CK2a1 V116I with hematein	1.685E-02	0.967	75	21	300	317	20	272	334	333	0.883	0.757
LOKIASV2_3899_ESMFold_N-A	4zhx-assembly1.cif.gz_A	4zhx-assembly1.cif.gz_A Novel binding site for allosteric activation of AMPK	2.832E-02	0.967	75	28	240	317	6	155	409	225	0.672	0.367
LOKIASV2_3899_ESMFold_N-A	6qat-assembly1.cif.gz_B-2	6qat-assembly1.cif.gz_B-2 Crystal structure of ULK2 in complexed with hesperadin	3.671E-02	0.961	74	33	279	317	17	223	245	284	0.779	0.845
LOKIASV2_3899_ESMFold_N-A	6xih-assembly2.cif.gz_B	6xih-assembly2.cif.gz_B Structure-guided optimization of a novel class of ASK1 inhibitors with increased sp3 character and an exquisite selectivity profile	1.685E-02	0.961	74	31	279	317	2	226	246	305	0.785	0.915
LOKIASV2_3899_ESMFold_N-A	4ztq-assembly1.cif.gz_A	4ztq-assembly1.cif.gz_A Human Aurora A catalytic domain bound to FK932	1.685E-02	0.961	74	30	310	317	7	245	247	324	0.886	0.968
LOKIASV2_3899_ESMFold_N-A	4l7s-assembly1.cif.gz_A	4l7s-assembly1.cif.gz_A Kinase domain mutant of human Itk in complex with an aminobenzothiazole inhibitor	1.969E-02	0.961	74	32	308	317	12	243	250	315	0.874	0.928
LOKIASV2_3899_ESMFold_N-A	5one-assembly1.cif.gz_A	5one-assembly1.cif.gz_A Crystal structure of Aurora-A in complex with FMF-03-145-1 (compound 2)	8.576E-03	0.961	74	28	289	317	10	230	257	305	0.826	0.860
LOKIASV2_3899_ESMFold_N-A	6xih-assembly1.cif.gz_A	6xih-assembly1.cif.gz_A Structure-guided optimization of a novel class of ASK1 inhibitors with increased sp3 character and an exquisite selectivity profile	1.234E-02	0.961	74	31	279	317	2	237	258	314	0.785	0.915
LOKIASV2_3899_ESMFold_N-A	4p2k-assembly1.cif.gz_A	4p2k-assembly1.cif.gz_A Structure of Ephrin type-A receptor 2	5.102E-03	0.961	74	25	313	317	11	257	259	325	0.912	0.954
LOKIASV2_3899_ESMFold_N-A	3dog-assembly1.cif.gz_C	3dog-assembly1.cif.gz_C Structure of Thr 160 phosphorylated CDK2/cyclin A in complex with the inhibitor N-&-N1	2.423E-02	0.961	74	27	308	317	2	253	268	336	0.890	0.940
LOKIASV2_3899_ESMFold_N-A	7jv0-assembly1.cif.gz_A	7jv0-assembly1.cif.gz_A Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor PD0325901	5.660E-03	0.961	74	28	301	317	11	273	276	340	0.864	0.953
LOKIASV2_3899_ESMFold_N-A	7eec-assembly1.cif.gz_A	7eec-assembly1.cif.gz_A Crystal structure of EphA7 mutant G656R	2.832E-02	0.961	74	26	317	317	23	272	277	334	0.921	0.903
LOKIASV2_3899_ESMFold_N-A	3kn6-assembly1.cif.gz_A	3kn6-assembly1.cif.gz_A Crystal structure of the C-terminal kinase domain of MSK1	5.660E-03	0.961	74	25	279	317	4	221	282	294	0.804	0.773
LOKIASV2_3899_ESMFold_N-A	5k76-assembly2.cif.gz_B	5k76-assembly2.cif.gz_B IRAK4 in complex with Compound 28	1.112E-02	0.961	74	34	289	317	28	205	283	276	0.808	0.629
LOKIASV2_3899_ESMFold_N-A	3kfa-assembly1.cif.gz_A	3kfa-assembly1.cif.gz_A Structural analysis of DFG-in and DFG-out dual Src-Abl inhibitors sharing a common vinyl purine template	1.442E-02	0.961	74	30	307	317	15	283	284	350	0.877	0.947
LOKIASV2_3899_ESMFold_N-A	3we4-assembly1.cif.gz_A	3we4-assembly1.cif.gz_A Crystal structure of S6K1 kinase domain in complex with a pyrimidine derivative PF-4708671 2-{[4-(5-ethylpyrimidin-4-yl)piperazin-1-yl]methyl}-5-(trifluoromethyl)-1H-benzimidazole	1.056E-02	0.961	74	30	279	317	7	241	287	312	0.789	0.819
LOKIASV2_3899_ESMFold_N-A	1ung-assembly1.cif.gz_A	1ung-assembly1.cif.gz_A Structural mechanism for the inhibition of CDK5-p25 by roscovitine, aloisine and indirubin.	2.074E-02	0.961	74	30	283	317	4	213	288	295	0.801	0.729
LOKIASV2_3899_ESMFold_N-A	2nru-assembly3.cif.gz_C	2nru-assembly3.cif.gz_C Crystal structure of IRAK-4	1.518E-02	0.961	74	17	303	317	7	294	295	370	0.905	0.976
LOKIASV2_3899_ESMFold_N-A	4mao-assembly1.cif.gz_A	4mao-assembly1.cif.gz_A RSK2 T493M C-Terminal Kinase Domain in Complex with RMM58	2.074E-02	0.961	74	27	312	317	5	297	298	379	0.902	0.983
LOKIASV2_3899_ESMFold_N-A	4nus-assembly1.cif.gz_A	4nus-assembly1.cif.gz_A Rsk2 N-terminal kinase in complex with LJH685	1.599E-02	0.961	74	29	289	317	15	251	301	317	0.823	0.787
LOKIASV2_3899_ESMFold_N-A	4d2v-assembly2.cif.gz_D	4d2v-assembly2.cif.gz_D Structure of MELK in complex with inhibitors	4.598E-03	0.961	74	20	317	317	2	251	318	349	0.940	0.786
LOKIASV2_3899_ESMFold_N-A	4ekk-assembly1.cif.gz_A	4ekk-assembly1.cif.gz_A Akt1 with AMP-PNP	5.374E-03	0.961	74	28	302	317	5	276	319	346	0.868	0.853
LOKIASV2_3899_ESMFold_N-A	3bv2-assembly1.cif.gz_A	3bv2-assembly1.cif.gz_A Morpholino pyrrolotriazine P38 Alpha map kinase inhibitor compound 30	1.774E-02	0.961	74	30	281	317	20	223	337	287	0.795	0.605
LOKIASV2_3899_ESMFold_N-A	3ptg-assembly1.cif.gz_A	3ptg-assembly1.cif.gz_A Design and Synthesis of a Novel, Orally Efficacious Tri-substituted Thiophene Based JNK Inhibitor	1.969E-02	0.961	74	28	275	317	17	216	340	275	0.782	0.588
LOKIASV2_3899_ESMFold_N-A	7o7i-assembly1.cif.gz_A	7o7i-assembly1.cif.gz_A Crystal structure of the human HIPK3 kinase domain	1.369E-02	0.961	74	28	283	317	10	230	367	302	0.808	0.602
LOKIASV2_3899_ESMFold_N-A	6c9j-assembly1.cif.gz_A	6c9j-assembly1.cif.gz_A AMP-activated protein kinase bound to pharmacological activator R734	2.983E-02	0.961	74	28	240	317	6	155	386	223	0.672	0.389
LOKIASV2_3899_ESMFold_N-A	6b2e-assembly1.cif.gz_A	6b2e-assembly1.cif.gz_A Structure of full length human AMPK (a2b2g1) in complex with a small molecule activator SC4.	1.112E-02	0.961	74	28	279	317	6	241	443	310	0.795	0.533
LOKIASV2_3899_ESMFold_N-A	7k7l-assembly1.cif.gz_A	7k7l-assembly1.cif.gz_A Structure of a hit for G Protein Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	1.685E-02	0.961	74	13	289	317	121	400	616	361	0.874	0.455
LOKIASV2_3899_ESMFold_N-A	6yid-assembly1.cif.gz_A	6yid-assembly1.cif.gz_A Crystal structure of ULK2 in complex with SBI-0206965	2.688E-02	0.956	73	28	280	317	6	237	259	311	0.798	0.896
LOKIASV2_3899_ESMFold_N-A	6e2n-assembly1.cif.gz_A	6e2n-assembly1.cif.gz_A ASK1 kinase domain complex with inhibitor	4.366E-03	0.956	73	29	279	317	1	244	264	317	0.792	0.924
LOKIASV2_3899_ESMFold_N-A	6bl8-assembly2.cif.gz_B	6bl8-assembly2.cif.gz_B Predicting the Conformational Variability of Abl Tyrosine Kinase Using Molecular Dynamics Simulations and Markov State Models	2.552E-02	0.956	73	30	297	317	10	262	268	334	0.845	0.944
LOKIASV2_3899_ESMFold_N-A	5hu9-assembly1.cif.gz_A	5hu9-assembly1.cif.gz_A Crystal structure of ABL1 in complex with CHMFL-074	1.969E-02	0.956	73	32	291	317	18	245	270	310	0.820	0.844
LOKIASV2_3899_ESMFold_N-A	5nka-assembly1.cif.gz_A	5nka-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2g	5.102E-03	0.956	73	29	315	317	10	254	271	328	0.905	0.904
LOKIASV2_3899_ESMFold_N-A	6iuo-assembly1.cif.gz_A	6iuo-assembly1.cif.gz_A Crystal structure of FGFR4 kinase domain in complex with a covalent inhibitor	1.369E-02	0.956	73	28	308	317	22	273	275	335	0.886	0.916
LOKIASV2_3899_ESMFold_N-A	5lvp-assembly2.cif.gz_B	5lvp-assembly2.cif.gz_B Human PDK1 Kinase Domain in Complex with an HM-Peptide Bound to the PIF-Pocket	1.599E-02	0.956	73	25	289	317	6	235	277	315	0.836	0.830
LOKIASV2_3899_ESMFold_N-A	1h1w-assembly1.cif.gz_A	1h1w-assembly1.cif.gz_A High resolution crystal structure of the human PDK1 catalytic domain	1.599E-02	0.956	73	30	289	317	12	243	285	309	0.820	0.814
LOKIASV2_3899_ESMFold_N-A	5k7g-assembly4.cif.gz_D	5k7g-assembly4.cif.gz_D IRAK4 in complex with AZ3862	1.056E-02	0.956	73	37	310	317	32	284	285	339	0.864	0.888
LOKIASV2_3899_ESMFold_N-A	2nry-assembly2.cif.gz_B	2nry-assembly2.cif.gz_B Crystal structure of IRAK-4	1.518E-02	0.956	73	7	310	317	1	286	287	376	0.959	0.997
LOKIASV2_3899_ESMFold_N-A	3lq5-assembly1.cif.gz_A	3lq5-assembly1.cif.gz_A Structure of CDK9/CyclinT in complex with S-CR8	4.290E-02	0.956	73	30	284	317	14	225	308	292	0.804	0.688
LOKIASV2_3899_ESMFold_N-A	5mag-assembly1.cif.gz_A	5mag-assembly1.cif.gz_A Crystal structure of MELK in complex with an inhibitor	1.112E-02	0.956	73	20	292	317	2	181	314	285	0.861	0.573
LOKIASV2_3899_ESMFold_N-A	2xh5-assembly1.cif.gz_A	2xh5-assembly1.cif.gz_A Structure of 4-(4-tert-Butylbenzyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4- yl)piperidin-4-amine bound to PKB	1.171E-02	0.956	73	32	302	317	10	275	317	339	0.855	0.839
LOKIASV2_3899_ESMFold_N-A	6qy8-assembly1.cif.gz_A	6qy8-assembly1.cif.gz_A Human CSNK2A2 bound to ERB-041	1.442E-02	0.956	73	27	300	317	30	265	321	319	0.864	0.735
LOKIASV2_3899_ESMFold_N-A	6qx9-assembly1.cif.gz_K	6qx9-assembly1.cif.gz_K Structure of a human fully-assembled precatalytic spliceosome (pre-B complex).	2.341E-03	0.956	73	38	290	317	22	208	322	273	0.798	0.581
LOKIASV2_3899_ESMFold_N-A	3d0e-assembly1.cif.gz_A	3d0e-assembly1.cif.gz_A Crystal structure of human Akt2 in complex with GSK690693	1.234E-02	0.956	73	28	302	317	5	275	324	344	0.868	0.836
LOKIASV2_3899_ESMFold_N-A	6r6e-assembly1.cif.gz_A	6r6e-assembly1.cif.gz_A Crystal structure of di-phosphorylated human CLK1 in complex with 5-(6,7-dichloro-1-methyl-1H-indol-3-yl)pyrimidin-4-amine	6.847E-02	0.956	73	27	139	317	6	122	327	126	0.356	0.358
LOKIASV2_3899_ESMFold_N-A	6fyv-assembly1.cif.gz_A	6fyv-assembly1.cif.gz_A X-RAY STRUCTURE OF CLK4-KD(146-480)/CX-4945 AT 2.46A	1.212E-01	0.956	73	29	141	317	11	131	329	127	0.356	0.368
LOKIASV2_3899_ESMFold_N-A	4r3c-assembly1.cif.gz_A	4r3c-assembly1.cif.gz_A Crystal structure of p38 alpha MAP kinase in complex with a novel isoform selective drug candidate	6.967E-03	0.956	73	30	283	317	21	221	336	284	0.801	0.598
LOKIASV2_3899_ESMFold_N-A	4nif-assembly1.cif.gz_E	4nif-assembly1.cif.gz_E Heterodimeric structure of ERK2 and RSK1	1.599E-02	0.956	73	28	283	317	14	230	348	295	0.808	0.624
LOKIASV2_3899_ESMFold_N-A	6ynb-assembly1.cif.gz_A	6ynb-assembly1.cif.gz_A Crystal structure of cAMP-dependent Protein Kinase (PKA) in complex with short-chain Fasudil-derivative N-(2-aminoethyl)isoquinoline-5-sulfonamide (soaked)	8.142E-03	0.956	73	14	292	317	19	270	348	330	0.880	0.724
LOKIASV2_3899_ESMFold_N-A	5t5t-assembly1.cif.gz_A	5t5t-assembly1.cif.gz_A AMPK bound to allosteric activator	1.518E-02	0.956	73	28	282	317	6	255	369	324	0.804	0.678
LOKIASV2_3899_ESMFold_N-A	3og7-assembly1.cif.gz_A	3og7-assembly1.cif.gz_A B-Raf Kinase V600E oncogenic mutant in complex with PLX4032	2.832E-02	0.949	72	28	303	317	7	244	247	318	0.871	0.964
LOKIASV2_3899_ESMFold_N-A	6e2o-assembly1.cif.gz_B	6e2o-assembly1.cif.gz_B ASK1 kinase domain complex with inhibitor	5.962E-03	0.949	72	31	279	317	12	230	250	293	0.785	0.876
LOKIASV2_3899_ESMFold_N-A	5jrs-assembly2.cif.gz_A	5jrs-assembly2.cif.gz_A CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH 4-[2-FLUORO-3-(4-OXO -3,4-DIHYDROQUINAZOLIN-3-YL)PHENYL]-7-(2-HYDROXYPROPAN-2-Y L)-9H-CARBAZOLE-1-CARBOXAMIDE	1.518E-02	0.949	72	26	308	317	4	254	258	329	0.893	0.973
LOKIASV2_3899_ESMFold_N-A	4rlp-assembly1.cif.gz_A	4rlp-assembly1.cif.gz_A Human p70s6k1 with ruthenium-based inhibitor FL772	1.969E-02	0.949	72	30	292	317	7	234	261	316	0.830	0.874
LOKIASV2_3899_ESMFold_N-A	7cc2-assembly2.cif.gz_B	7cc2-assembly2.cif.gz_B Strategic design of catalytic lysine-targeting reversible covalent BCR-ABL Inhibitors	2.184E-02	0.949	72	30	298	317	11	264	266	335	0.849	0.955
LOKIASV2_3899_ESMFold_N-A	3ma6-assembly1.cif.gz_A	3ma6-assembly1.cif.gz_A Crystal structure of kinase domain of TgCDPK1 in presence of 3BrB-PP1	1.234E-02	0.949	72	27	307	317	3	257	267	336	0.886	0.955
LOKIASV2_3899_ESMFold_N-A	1fpu-assembly2.cif.gz_B	1fpu-assembly2.cif.gz_B CRYSTAL STRUCTURE OF ABL KINASE DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITOR	2.074E-02	0.949	72	32	311	317	18	269	270	333	0.883	0.933
LOKIASV2_3899_ESMFold_N-A	5o26-assembly1.cif.gz_A	5o26-assembly1.cif.gz_A Crystal structure of WNK3 kinase domain in a diphosphorylated state and in complex with AMP-PNP/Mg2+	1.369E-02	0.949	72	34	285	317	18	244	273	305	0.795	0.832
LOKIASV2_3899_ESMFold_N-A	5wax-assembly2.cif.gz_B	5wax-assembly2.cif.gz_B Crystal Structure of Sugarcane SAPK10 (serine/threonine-protein kinase 10)	2.983E-02	0.949	72	32	142	317	10	116	274	118	0.350	0.391
LOKIASV2_3899_ESMFold_N-A	4l00-assembly3.cif.gz_A	4l00-assembly3.cif.gz_A Crystal structure of the apo Jak1 pseudokinase domain	2.736E-03	0.949	72	33	313	317	24	275	277	328	0.886	0.910
LOKIASV2_3899_ESMFold_N-A	3ik3-assembly1.cif.gz_A	3ik3-assembly1.cif.gz_A AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance	2.074E-02	0.949	72	32	312	317	15	266	280	333	0.886	0.900
LOKIASV2_3899_ESMFold_N-A	2pzr-assembly1.cif.gz_A	2pzr-assembly1.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K641R Mutation Responsible for Pfeiffer Syndrome	1.056E-02	0.949	72	32	309	317	14	278	280	343	0.877	0.946
LOKIASV2_3899_ESMFold_N-A	6f3i-assembly2.cif.gz_B	6f3i-assembly2.cif.gz_B IRAK4 IN COMPLEX WITH inhibitor	9.033E-03	0.949	72	7	310	317	1	280	281	374	0.959	0.996
LOKIASV2_3899_ESMFold_N-A	2qoh-assembly2.cif.gz_B	2qoh-assembly2.cif.gz_B Crystal Structure of Abl kinase bound with PPY-A	1.171E-02	0.949	72	32	307	317	15	280	281	345	0.871	0.947
LOKIASV2_3899_ESMFold_N-A	5okt-assembly1.cif.gz_A	5okt-assembly1.cif.gz_A Crystal structure of human Casein Kinase I delta in complex with IWP-2	1.171E-02	0.949	72	28	314	317	4	269	286	349	0.905	0.930
LOKIASV2_3899_ESMFold_N-A	5say-assembly2.cif.gz_B	5say-assembly2.cif.gz_B DDR1, N-[2-[3-(2-aminopyrimidin-5-yl)oxyphenyl]ethyl]-3-(trifluoromethoxy)benzamide, 2.190A, P1211, Rfree=27.7%	1.518E-02	0.949	72	25	278	317	5	234	288	313	0.801	0.799
LOKIASV2_3899_ESMFold_N-A	8g66-assembly1.cif.gz_C	8g66-assembly1.cif.gz_C Structure with SJ3149	3.935E-03	0.949	72	29	317	317	7	277	289	352	0.912	0.938
LOKIASV2_3899_ESMFold_N-A	5hvk-assembly1.cif.gz_A	5hvk-assembly1.cif.gz_A Crystal structure of LIMK1 mutant D460N in complex with full-length cofilin-1	1.969E-02	0.949	72	25	289	317	13	206	298	285	0.836	0.651
LOKIASV2_3899_ESMFold_N-A	6bfn-assembly1.cif.gz_A	6bfn-assembly1.cif.gz_A Crystal structure of human IRAK1	6.967E-03	0.949	72	11	289	317	8	204	301	299	0.880	0.654
LOKIASV2_3899_ESMFold_N-A	4nif-assembly1.cif.gz_D	4nif-assembly1.cif.gz_D Heterodimeric structure of ERK2 and RSK1	7.730E-03	0.949	72	27	303	317	3	263	313	344	0.874	0.834
LOKIASV2_3899_ESMFold_N-A	6cnh-assembly1.cif.gz_A	6cnh-assembly1.cif.gz_A Human PRPF4B in complex with Rebastinib	4.598E-03	0.949	72	29	283	317	23	226	321	279	0.804	0.636
LOKIASV2_3899_ESMFold_N-A	6yqk-assembly1.cif.gz_A	6yqk-assembly1.cif.gz_A Crystal structure of cAMP-dependent Protein Kinase (PKA) in complex with a methylisoquinoline Fasudil-derivative (soaked)	9.033E-03	0.949	72	14	292	317	19	270	346	332	0.880	0.728
LOKIASV2_3899_ESMFold_N-A	6yty-assembly1.cif.gz_A	6yty-assembly1.cif.gz_A CLK3 A319V mutant bound with benzothiazole Tg003 (Cpd 2)	7.596E-02	0.949	72	29	152	317	29	161	353	139	0.391	0.377
LOKIASV2_3899_ESMFold_N-A	6fad-assembly3.cif.gz_C	6fad-assembly3.cif.gz_C SR protein kinase 1 (SRPK1) in complex with the RGG-box of HSV1 ICP27	3.671E-02	0.949	72	29	145	317	25	154	359	141	0.369	0.362
LOKIASV2_3899_ESMFold_N-A	3tku-assembly1.cif.gz_B	3tku-assembly1.cif.gz_B MRCK beta in complex with fasudil	2.881E-03	0.949	72	14	285	317	52	298	395	325	0.858	0.625
LOKIASV2_3899_ESMFold_N-A	7mp8-assembly1.cif.gz_A-2	7mp8-assembly1.cif.gz_A-2 Crystal structure of the cytosolic domain of Tribolium castaneum PINK1 in the non-phosphorylated state	2.423E-02	0.949	72	14	236	317	22	211	399	255	0.703	0.476
LOKIASV2_3899_ESMFold_N-A	5t6i-assembly1.cif.gz_A	5t6i-assembly1.cif.gz_A CRYSTAL STRUCTURE OF TGCDPK1 FROM TOXOPLASMA GONDII COMPLEXED WITH 5GB	9.033E-03	0.949	72	27	311	317	5	266	427	342	0.899	0.614
LOKIASV2_3899_ESMFold_N-A	4ieb-assembly1.cif.gz_A	4ieb-assembly1.cif.gz_A Crystal Structure of a Gly128Met mutant of the toxoplasma CDPK, TGME49_101440	1.969E-02	0.949	72	27	307	317	17	268	472	329	0.886	0.534
LOKIASV2_3899_ESMFold_N-A	8jpd-assembly1.cif.gz_G	8jpd-assembly1.cif.gz_G Focused refinement structure of GRK2 in NTSR1-GRK2-Galpha(q) complexes	5.962E-03	0.949	72	28	290	317	188	462	658	346	0.830	0.418
LOKIASV2_3899_ESMFold_N-A	6tu9-assembly2.cif.gz_B	6tu9-assembly2.cif.gz_B The ROR1 Pseudokinase Domain Bound To Ponatinib	1.685E-02	0.941	71	8	313	317	1	258	259	354	0.965	0.996
LOKIASV2_3899_ESMFold_N-A	7dt2-assembly1.cif.gz_A	7dt2-assembly1.cif.gz_A Strategic design of catalytic lysine-targeting reversible covalent BCR-ABL Inhibitors	2.184E-02	0.941	71	32	312	317	10	264	265	338	0.886	0.962
LOKIASV2_3899_ESMFold_N-A	2g2i-assembly2.cif.gz_B	2g2i-assembly2.cif.gz_B A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain	2.300E-02	0.941	71	30	297	317	11	263	265	334	0.845	0.955
LOKIASV2_3899_ESMFold_N-A	2x9f-assembly1.cif.gz_A	2x9f-assembly1.cif.gz_A ephB4 kinase domain inhibitor complex	1.171E-02	0.941	71	26	312	317	4	257	265	339	0.905	0.958
LOKIASV2_3899_ESMFold_N-A	3dk3-assembly1.cif.gz_A	3dk3-assembly1.cif.gz_A Crystal structure of mutant ABL kinase domain in complex with small molecule fragment	1.774E-02	0.941	71	32	298	317	10	263	266	341	0.842	0.955
LOKIASV2_3899_ESMFold_N-A	7b8w-assembly2.cif.gz_B	7b8w-assembly2.cif.gz_B Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470	1.369E-02	0.941	71	33	305	317	14	273	275	337	0.861	0.945
LOKIASV2_3899_ESMFold_N-A	8fjz-assembly2.cif.gz_F-2	8fjz-assembly2.cif.gz_F-2 Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(3R,5S)-3-Amino-5-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	2.423E-02	0.941	71	26	289	317	5	192	276	278	0.833	0.681
LOKIASV2_3899_ESMFold_N-A	5x1s-assembly1.cif.gz_A	5x1s-assembly1.cif.gz_A PpkA-294 with Amppcp	1.056E-02	0.941	71	28	289	317	11	221	281	292	0.826	0.751
LOKIASV2_3899_ESMFold_N-A	1oky-assembly1.cif.gz_A	1oky-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with staurosporine	6.967E-03	0.941	71	30	289	317	11	240	282	306	0.820	0.816
LOKIASV2_3899_ESMFold_N-A	4eoi-assembly1.cif.gz_A	4eoi-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 K89D, Q131E - human cyclin A3 complex with the inhibitor RO3306	1.869E-02	0.941	71	27	283	317	2	214	295	301	0.811	0.722
LOKIASV2_3899_ESMFold_N-A	4uv0-assembly1.cif.gz_A	4uv0-assembly1.cif.gz_A Structure of a semisynthetic phosphorylated DAPK	9.514E-03	0.941	71	26	317	317	7	271	300	350	0.921	0.883
LOKIASV2_3899_ESMFold_N-A	6b3e-assembly2.cif.gz_C	6b3e-assembly2.cif.gz_C Crystal structure of human CDK12/CyclinK in complex with an inhibitor	1.599E-02	0.941	71	28	283	317	7	222	308	302	0.808	0.701
LOKIASV2_3899_ESMFold_N-A	4d2t-assembly1.cif.gz_A	4d2t-assembly1.cif.gz_A Structure of MELK in complex with inhibitors	9.514E-03	0.941	71	22	292	317	2	185	316	287	0.855	0.582
LOKIASV2_3899_ESMFold_N-A	4iir-assembly1.cif.gz_A	4iir-assembly1.cif.gz_A Crystal Structure of AMPPNP-bound Human PRPF4B kinase domain	4.145E-03	0.941	71	28	283	317	18	234	326	292	0.808	0.666
LOKIASV2_3899_ESMFold_N-A	7pvu-assembly1.cif.gz_A	7pvu-assembly1.cif.gz_A Crystal structure of p38alpha C162S in complex with CAS2094511-69-8, P 1 21 1	1.518E-02	0.941	71	28	283	317	18	221	337	283	0.808	0.605
LOKIASV2_3899_ESMFold_N-A	6xdf-assembly3.cif.gz_B	6xdf-assembly3.cif.gz_B Crystal structure of IRE1a in complex with G-4100	2.423E-02	0.941	71	28	300	317	6	249	400	324	0.861	0.610
LOKIASV2_3899_ESMFold_N-A	7mp9-assembly1.cif.gz_A-2	7mp9-assembly1.cif.gz_A-2 Crystal structure of the cytosolic domain of Tribolium castaneum PINK1 phosphorylated at Ser205 in complex with ADP analog	2.832E-02	0.941	71	14	236	317	22	211	414	256	0.703	0.459
LOKIASV2_3899_ESMFold_N-A	4rer-assembly1.cif.gz_A	4rer-assembly1.cif.gz_A Crystal structure of the phosphorylated human alpha1 beta2 gamma1 holo-AMPK complex bound to AMP and cyclodextrin	7.338E-03	0.941	71	33	289	317	1	237	459	321	0.811	0.516
LOKIASV2_3899_ESMFold_N-A	3qgw-assembly1.cif.gz_A	3qgw-assembly1.cif.gz_A Crystal Structure of ITK kinase bound to an inhibitor	5.014E-02	0.933	70	28	308	317	4	239	244	318	0.886	0.967
LOKIASV2_3899_ESMFold_N-A	6e2n-assembly1.cif.gz_B	6e2n-assembly1.cif.gz_B ASK1 kinase domain complex with inhibitor	8.576E-03	0.933	70	29	292	317	1	230	250	307	0.833	0.920
LOKIASV2_3899_ESMFold_N-A	7n9g-assembly1.cif.gz_A	7n9g-assembly1.cif.gz_A Crystal structure of the Abl 1b Kinase domain in complex with Dasatinib and Imatinib	2.552E-02	0.933	70	32	296	317	10	249	250	325	0.836	0.960
LOKIASV2_3899_ESMFold_N-A	3is5-assembly1.cif.gz_C	3is5-assembly1.cif.gz_C Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	3.485E-02	0.933	70	30	292	317	11	197	259	280	0.830	0.722
LOKIASV2_3899_ESMFold_N-A	4xey-assembly1.cif.gz_A	4xey-assembly1.cif.gz_A Crystal structure of an SH2-kinase domain construct of c-Abl tyrosine kinase	4.290E-02	0.933	70	30	298	317	12	265	269	337	0.849	0.944
LOKIASV2_3899_ESMFold_N-A	4uya-assembly1.cif.gz_A	4uya-assembly1.cif.gz_A Structure of MLK4 kinase domain with ATPgammaS	3.197E-03	0.933	70	29	306	317	9	272	274	330	0.877	0.964
LOKIASV2_3899_ESMFold_N-A	2g2f-assembly1.cif.gz_A	2g2f-assembly1.cif.gz_A A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain	2.983E-02	0.933	70	30	312	317	11	268	275	343	0.893	0.938
LOKIASV2_3899_ESMFold_N-A	8fko-assembly3.cif.gz_D	8fko-assembly3.cif.gz_D Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(2S,5R)-5-Amino-2-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	2.552E-02	0.933	70	24	289	317	9	195	279	283	0.839	0.670
LOKIASV2_3899_ESMFold_N-A	3sc1-assembly1.cif.gz_A	3sc1-assembly1.cif.gz_A Novel Isoquinolone PDK1 Inhibitors Discovered through Fragment-Based Lead Discovery	1.869E-02	0.933	70	30	289	317	10	237	279	307	0.820	0.817
LOKIASV2_3899_ESMFold_N-A	3hrc-assembly1.cif.gz_A	3hrc-assembly1.cif.gz_A Crystal structure of a mutant of human PDK1 Kinase domain in complex with ATP	2.184E-02	0.933	70	30	289	317	7	238	280	315	0.820	0.829
LOKIASV2_3899_ESMFold_N-A	5i9u-assembly1.cif.gz_A	5i9u-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase	3.485E-02	0.933	70	29	315	317	14	263	281	335	0.905	0.890
LOKIASV2_3899_ESMFold_N-A	5w85-assembly1.cif.gz_A	5w85-assembly1.cif.gz_A CRYSTAL STRUCTURE OF IRAK-4 WITH A 4,6-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 9)	1.685E-02	0.933	70	34	310	317	28	280	281	344	0.874	0.900
LOKIASV2_3899_ESMFold_N-A	5x18-assembly2.cif.gz_B	5x18-assembly2.cif.gz_B Crystal structure of Casein kinase I homolog 1	1.299E-02	0.933	70	30	317	317	8	284	294	362	0.909	0.942
LOKIASV2_3899_ESMFold_N-A	2bdw-assembly1.cif.gz_B	2bdw-assembly1.cif.gz_B Crystal Structure of the Auto-Inhibited Kinase Domain of Calcium/Calmodulin Activated Kinase II	2.832E-02	0.933	70	27	289	317	2	243	309	319	0.830	0.783
LOKIASV2_3899_ESMFold_N-A	1ukh-assembly1.cif.gz_A	1ukh-assembly1.cif.gz_A Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125	8.576E-03	0.933	70	28	278	317	16	211	321	272	0.792	0.611
LOKIASV2_3899_ESMFold_N-A	3u87-assembly1.cif.gz_A	3u87-assembly1.cif.gz_A Structure of a chimeric construct of human CK2alpha and human CK2alpha' in complex with a non-hydrolysable ATP-analogue	2.423E-02	0.933	70	27	300	317	35	272	329	318	0.864	0.723
LOKIASV2_3899_ESMFold_N-A	6xx7-assembly1.cif.gz_A	6xx7-assembly1.cif.gz_A Arabidopsis thaliana Casein Kinase 2 (CK2) alpha-1 crystal in complex with ANP	1.969E-02	0.933	70	3	300	317	20	268	329	344	0.940	0.757
LOKIASV2_3899_ESMFold_N-A	6yqi-assembly1.cif.gz_A	6yqi-assembly1.cif.gz_A Crystal structure of cAMP-dependent Protein Kinase (PKA) in complex with long-chain Fasudil-derivative N-[2-(propylamino)ethyl]isoquinoline-5-sulfonamide (soaked)	1.234E-02	0.933	70	14	292	317	19	269	347	329	0.880	0.723
LOKIASV2_3899_ESMFold_N-A	3cd3-assembly1.cif.gz_A	3cd3-assembly1.cif.gz_A Crystal structure of phosphorylated human feline sarcoma viral oncogene homologue (v-FES) in complex with staurosporine and a consensus peptide	1.171E-02	0.933	70	16	305	317	62	352	353	375	0.915	0.824
LOKIASV2_3899_ESMFold_N-A	6fad-assembly4.cif.gz_D	6fad-assembly4.cif.gz_D SR protein kinase 1 (SRPK1) in complex with the RGG-box of HSV1 ICP27	3.309E-02	0.933	70	29	278	317	25	269	356	325	0.789	0.688
LOKIASV2_3899_ESMFold_N-A	7kpx-assembly1.cif.gz_A	7kpx-assembly1.cif.gz_A Structure of the yeast CKM	7.338E-03	0.933	70	7	278	317	2	255	357	328	0.858	0.711
LOKIASV2_3899_ESMFold_N-A	6c9f-assembly1.cif.gz_A	6c9f-assembly1.cif.gz_A AMP-activated protein kinase bound to pharmacological activator R734	7.338E-03	0.933	70	34	279	317	8	241	373	307	0.776	0.627
LOKIASV2_3899_ESMFold_N-A	8q61-assembly1.cif.gz_A	8q61-assembly1.cif.gz_A Co-crystal structure of human AKT2 with compound 3	5.374E-03	0.933	70	11	303	317	87	370	384	360	0.924	0.740
LOKIASV2_3899_ESMFold_N-A	6c9h-assembly1.cif.gz_A	6c9h-assembly1.cif.gz_A non-phosphorylated AMP-activated protein kinase bound to pharmacological activator R734	1.112E-02	0.933	70	28	315	317	6	313	435	384	0.909	0.708
LOKIASV2_3899_ESMFold_N-A	5tkd-assembly3.cif.gz_A-2	5tkd-assembly3.cif.gz_A-2 CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH 6-[(3,5-DIMETHYLPHE NYL)AMINO]-8- (METHYLAMINO)IMIDAZO[1,2-B]PYRIDAZINE-3-CARBO XAMIDE	5.660E-03	0.923	69	32	278	317	9	212	248	285	0.779	0.823
LOKIASV2_3899_ESMFold_N-A	6c2t-assembly1.cif.gz_A-2	6c2t-assembly1.cif.gz_A-2 Aurora A ligand complex	3.671E-02	0.923	69	30	310	317	6	251	253	331	0.886	0.972
LOKIASV2_3899_ESMFold_N-A	3vw6-assembly1.cif.gz_A	3vw6-assembly1.cif.gz_A Crystal structure of human apoptosis signal-regulating kinase 1 (ASK1) with imidazopyridine inhibitor	9.033E-03	0.923	69	29	279	317	2	235	255	309	0.792	0.918
LOKIASV2_3899_ESMFold_N-A	4aoj-assembly1.cif.gz_A	4aoj-assembly1.cif.gz_A Human TrkA in complex with the inhibitor AZ-23	1.369E-02	0.923	69	30	311	317	11	257	260	323	0.890	0.950
LOKIASV2_3899_ESMFold_N-A	6oyw-assembly1.cif.gz_C	6oyw-assembly1.cif.gz_C ASK1 kinase domain in complex with Compound 11	7.338E-03	0.923	69	31	289	317	12	240	260	305	0.817	0.881
LOKIASV2_3899_ESMFold_N-A	3hmi-assembly1.cif.gz_A	3hmi-assembly1.cif.gz_A The crystal structure of human ABL2 in complex with 5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE	3.867E-02	0.923	69	32	298	317	10	267	268	342	0.842	0.963
LOKIASV2_3899_ESMFold_N-A	2vwi-assembly1.cif.gz_C	2vwi-assembly1.cif.gz_C Structure of the OSR1 kinase, a hypertension drug target	1.002E-02	0.923	69	26	289	317	7	207	270	290	0.833	0.744
LOKIASV2_3899_ESMFold_N-A	1uu9-assembly1.cif.gz_A	1uu9-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with BIM-3	1.518E-02	0.923	69	30	289	317	11	237	277	306	0.820	0.819
LOKIASV2_3899_ESMFold_N-A	2o8y-assembly1.cif.gz_A	2o8y-assembly1.cif.gz_A Apo IRAK4 Kinase Domain	2.300E-02	0.923	69	34	311	317	27	279	280	346	0.877	0.904
LOKIASV2_3899_ESMFold_N-A	5ho7-assembly1.cif.gz_A	5ho7-assembly1.cif.gz_A DISCOVERY OF NOVEL 7-AZAINDOLES AS PDK1 INHIBITORS	2.688E-02	0.923	69	30	289	317	12	239	281	302	0.820	0.811
LOKIASV2_3899_ESMFold_N-A	3orx-assembly4.cif.gz_D	3orx-assembly4.cif.gz_D PDK1 mutant bound to allosteric disulfide fragment inhibitor 1F8	2.184E-02	0.923	69	30	289	317	7	241	283	319	0.820	0.830
LOKIASV2_3899_ESMFold_N-A	5mrd-assembly1.cif.gz_A	5mrd-assembly1.cif.gz_A Human PDK1-PKCiota Kinase Chimera in Complex with Allosteric Compound PS267 Bound to the PIF-Pocket	1.774E-02	0.923	69	30	303	317	7	241	284	317	0.864	0.827
LOKIASV2_3899_ESMFold_N-A	2iw6-assembly1.cif.gz_A	2iw6-assembly1.cif.gz_A STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR	3.485E-02	0.923	69	27	283	317	2	215	293	299	0.811	0.730
LOKIASV2_3899_ESMFold_N-A	1zmu-assembly1.cif.gz_A	1zmu-assembly1.cif.gz_A Catalytic and ubiqutin-associated domains of MARK2/PAR-1: Wild type	1.171E-02	0.923	69	30	292	317	3	214	293	300	0.830	0.724
LOKIASV2_3899_ESMFold_N-A	7ukz-assembly3.cif.gz_C	7ukz-assembly3.cif.gz_C CDK11 in complex with small molecule inhibitor OTS964	1.171E-02	0.923	69	28	280	317	1	211	294	300	0.798	0.718
LOKIASV2_3899_ESMFold_N-A	3ocb-assembly2.cif.gz_B	3ocb-assembly2.cif.gz_B Akt1 kinase domain with pyrrolopyrimidine inhibitor	1.969E-02	0.923	69	28	285	317	5	251	320	321	0.814	0.772
LOKIASV2_3899_ESMFold_N-A	5r9t-assembly1.cif.gz_A	5r9t-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13477a in complex with MAP kinase p38-alpha	2.832E-02	0.923	69	28	235	317	18	163	346	222	0.656	0.422
LOKIASV2_3899_ESMFold_N-A	5r9x-assembly1.cif.gz_A	5r9x-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13611a in complex with MAP kinase p38-alpha	1.685E-02	0.923	69	28	283	317	18	231	346	293	0.808	0.618
LOKIASV2_3899_ESMFold_N-A	3v3v-assembly1.cif.gz_A	3v3v-assembly1.cif.gz_A Structural and functional analysis of quercetagetin, a natural JNK1 inhibitor	3.671E-02	0.923	69	28	283	317	18	231	351	291	0.808	0.610
LOKIASV2_3899_ESMFold_N-A	4aw2-assembly1.cif.gz_A-2	4aw2-assembly1.cif.gz_A-2 Crystal structure of CDC42 binding protein kinase alpha (MRCK alpha)	8.576E-03	0.923	69	4	280	317	40	294	398	338	0.874	0.641
LOKIASV2_3899_ESMFold_N-A	4rew-assembly1.cif.gz_A	4rew-assembly1.cif.gz_A Crystal structure of the non-phosphorylated human alpha1 beta2 gamma1 holo-AMPK complex	1.518E-02	0.923	69	33	240	317	1	155	411	231	0.656	0.377
LOKIASV2_3899_ESMFold_N-A	4yga-assembly2.cif.gz_C	4yga-assembly2.cif.gz_C CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	1.112E-02	0.923	69	27	307	317	4	255	449	336	0.886	0.561
LOKIASV2_3899_ESMFold_N-A	7dts-assembly1.cif.gz_a	7dts-assembly1.cif.gz_a Crystal structure of RNase L in complex with AC40357	1.599E-02	0.923	69	28	304	317	333	547	672	300	0.874	0.320
LOKIASV2_3899_ESMFold_N-A	3pj1-assembly1.cif.gz_A	3pj1-assembly1.cif.gz_A Crystal structure of BTK kinase domain complexed with 3-(2,6-Dichloro-phenyl)-7-[4-(2-diethylamino-ethoxy)-phenylamino]-1-methyl-3,4-dihydro-1H-pyrimido[4,5-d]pyrimidin-2-one	2.300E-02	0.912	68	32	312	317	12	238	241	313	0.886	0.942
LOKIASV2_3899_ESMFold_N-A	6nze-assembly1.cif.gz_A	6nze-assembly1.cif.gz_A CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_5 AKA 4-[(2-CARBAMOYLPHEN YL)AMINO]-6-[(5-FLUOROPYRIDIN-2-YL)AMINO]-N-METHYLPYRIDINE -3-CARBOXAMIDE	1.518E-02	0.912	68	32	296	317	9	218	250	300	0.836	0.840
LOKIASV2_3899_ESMFold_N-A	2yn8-assembly1.cif.gz_A	2yn8-assembly1.cif.gz_A ephB4 kinase domain inhibitor complex	1.869E-02	0.912	68	26	317	317	4	246	253	330	0.921	0.960
LOKIASV2_3899_ESMFold_N-A	2yza-assembly1.cif.gz_A	2yza-assembly1.cif.gz_A Crystal structure of kinase domain of Human 5'-AMP-activated protein kinase alpha-2 subunit mutant (T172D)	4.073E-02	0.912	68	30	279	317	7	229	258	300	0.789	0.864
LOKIASV2_3899_ESMFold_N-A	6cz3-assembly1.cif.gz_A	6cz3-assembly1.cif.gz_A Structure of the PTK6 kinase domain bound to a type I inhibitor (3-fluoro-4-{[6-methyl-3-(1H-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]amino}phenyl)(morpholin-4-yl)methanone	3.671E-02	0.912	68	26	145	317	2	127	262	139	0.379	0.481
LOKIASV2_3899_ESMFold_N-A	2e2b-assembly2.cif.gz_B	2e2b-assembly2.cif.gz_B Crystal structure of the c-Abl kinase domain in complex with INNO-406	3.671E-02	0.912	68	32	296	317	18	262	262	331	0.836	0.935
LOKIASV2_3899_ESMFold_N-A	6hex-assembly1.cif.gz_A	6hex-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATMM006	4.760E-02	0.912	68	30	315	317	9	248	268	324	0.902	0.896
LOKIASV2_3899_ESMFold_N-A	6qav-assembly1.cif.gz_B	6qav-assembly1.cif.gz_B Crystal structure of ULK2 in complexed with MRT68921	1.518E-02	0.912	68	29	291	317	1	197	269	285	0.830	0.732
LOKIASV2_3899_ESMFold_N-A	7w7y-assembly1.cif.gz_A	7w7y-assembly1.cif.gz_A The crystal structure of human abl1 kinase domain in complex with ABL2-A5	4.073E-02	0.912	68	38	312	317	23	268	269	329	0.868	0.914
LOKIASV2_3899_ESMFold_N-A	6cje-assembly1.cif.gz_A	6cje-assembly1.cif.gz_A Crystal Structure of Mnk2-D228G in complex with Inhibitor	1.869E-02	0.912	68	29	179	317	14	194	272	189	0.476	0.665
LOKIASV2_3899_ESMFold_N-A	3udb-assembly2.cif.gz_B	3udb-assembly2.cif.gz_B Crystal structure of SnRK2.6	2.074E-02	0.912	68	26	150	317	6	128	278	138	0.394	0.442
LOKIASV2_3899_ESMFold_N-A	3f5g-assembly1.cif.gz_A	3f5g-assembly1.cif.gz_A Crystal structure of death associated protein kinase in complex with ADP and Mg2+	6.847E-02	0.912	68	26	289	317	8	254	279	322	0.833	0.885
LOKIASV2_3899_ESMFold_N-A	3gu6-assembly1.cif.gz_A	3gu6-assembly1.cif.gz_A Crystal structure of DAPKQ23V-ADP	5.014E-02	0.912	68	26	289	317	8	209	280	287	0.833	0.721
LOKIASV2_3899_ESMFold_N-A	4aw1-assembly1.cif.gz_A	4aw1-assembly1.cif.gz_A Human PDK1 Kinase Domain in Complex with Allosteric Compound PS210 Bound to the PIF-Pocket	2.300E-02	0.912	68	30	292	317	14	242	284	312	0.830	0.806
LOKIASV2_3899_ESMFold_N-A	6ege-assembly1.cif.gz_D	6ege-assembly1.cif.gz_D Crystal structure of the unphosphorylated IRAK4 kinase domain Bound to a type I inhibitor	2.074E-02	0.912	68	34	307	317	30	281	284	343	0.864	0.887
LOKIASV2_3899_ESMFold_N-A	8fjz-assembly2.cif.gz_B	8fjz-assembly2.cif.gz_B Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(3R,5S)-3-Amino-5-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	3.142E-02	0.912	68	26	289	317	9	200	284	279	0.833	0.676
LOKIASV2_3899_ESMFold_N-A	5okt-assembly3.cif.gz_C	5okt-assembly3.cif.gz_C Crystal structure of human Casein Kinase I delta in complex with IWP-2	1.969E-02	0.912	68	28	314	317	4	268	285	352	0.905	0.930
LOKIASV2_3899_ESMFold_N-A	2ivu-assembly1.cif.gz_A-2	2ivu-assembly1.cif.gz_A-2 Crystal structure of phosphorylated RET tyrosine kinase domain complexed with the inhibitor ZD6474	2.184E-02	0.912	68	30	305	317	24	288	289	346	0.871	0.917
LOKIASV2_3899_ESMFold_N-A	5o1s-assembly1.cif.gz_A	5o1s-assembly1.cif.gz_A Dimethyl fumarate is an allosteric covalent inhibitor of the p90 ribosomal S6 kinases	1.869E-02	0.912	68	32	279	317	8	238	290	312	0.782	0.797
LOKIASV2_3899_ESMFold_N-A	2i0e-assembly2.cif.gz_B	2i0e-assembly2.cif.gz_B Structure of catalytic domain of human protein kinase C beta II complexed with a bisindolylmaleimide inhibitor	2.074E-02	0.912	68	30	280	317	4	216	302	293	0.792	0.705
LOKIASV2_3899_ESMFold_N-A	3e88-assembly2.cif.gz_B	3e88-assembly2.cif.gz_B Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors	2.074E-02	0.912	68	28	302	317	5	275	321	344	0.868	0.844
LOKIASV2_3899_ESMFold_N-A	2pvl-assembly1.cif.gz_A	2pvl-assembly1.cif.gz_A Structure-Based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase CK2	2.983E-02	0.912	68	28	300	317	32	268	328	318	0.861	0.723
LOKIASV2_3899_ESMFold_N-A	2eu9-assembly1.cif.gz_A	2eu9-assembly1.cif.gz_A Crystal Structure of CLK3	1.037E-01	0.912	68	29	139	317	20	134	345	124	0.350	0.333
LOKIASV2_3899_ESMFold_N-A	5x3f-assembly1.cif.gz_B	5x3f-assembly1.cif.gz_B Crystal structure of the YgjG-Protein A-Zpa963-PKA catalytic domain	1.056E-02	0.912	68	15	286	317	50	285	349	319	0.858	0.676
LOKIASV2_3899_ESMFold_N-A	8bzp-assembly1.cif.gz_A	8bzp-assembly1.cif.gz_A JNK3 (Mitogen-activated protein kinase 10) in Complex with Compound 23 bearing a C(sp3)F2Br moiety	1.234E-02	0.912	68	28	289	317	17	290	350	351	0.826	0.783
LOKIASV2_3899_ESMFold_N-A	7m74-assembly1.cif.gz_A	7m74-assembly1.cif.gz_A ATP-bound AMP-activated protein kinase	6.967E-03	0.912	68	30	292	317	6	197	380	282	0.830	0.505
LOKIASV2_3899_ESMFold_N-A	7v3v-assembly1.cif.gz_H	7v3v-assembly1.cif.gz_H Cryo-EM structure of MCM double hexamer bound with DDK in State I	3.142E-02	0.912	68	14	241	317	6	178	381	249	0.719	0.454
LOKIASV2_3899_ESMFold_N-A	6hhj-assembly1.cif.gz_A	6hhj-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 24b	7.338E-03	0.912	68	14	279	317	93	350	410	330	0.839	0.629
LOKIASV2_3899_ESMFold_N-A	3cik-assembly1.cif.gz_A	3cik-assembly1.cif.gz_A Human GRK2 in Complex with Gbetagamma subunits	4.290E-02	0.912	68	27	307	317	160	419	619	341	0.886	0.420
LOKIASV2_3899_ESMFold_N-A	3kl8-assembly4.cif.gz_E	3kl8-assembly4.cif.gz_E CaMKIINtide Inhibitor Complex	6.500E-02	0.900	67	27	289	317	3	233	256	313	0.830	0.902
LOKIASV2_3899_ESMFold_N-A	6npe-assembly1.cif.gz_B	6npe-assembly1.cif.gz_B C-abl Kinase domain with the activator(cmpd6), 2-cyano-N-(4-(3,4-dichlorophenyl)thiazol-2-yl)acetamide	2.983E-02	0.900	67	32	307	317	10	255	256	334	0.871	0.961
LOKIASV2_3899_ESMFold_N-A	2hyy-assembly3.cif.gz_C	2hyy-assembly3.cif.gz_C Human Abl kinase domain in complex with imatinib (STI571, Glivec)	3.485E-02	0.900	67	32	311	317	10	262	262	338	0.883	0.966
LOKIASV2_3899_ESMFold_N-A	3dk7-assembly2.cif.gz_B	3dk7-assembly2.cif.gz_B Crystal structure of mutant ABL kinase domain in complex with small molecule fragment	4.760E-02	0.900	67	32	311	317	10	262	269	340	0.883	0.941
LOKIASV2_3899_ESMFold_N-A	7dua-assembly1.cif.gz_B	7dua-assembly1.cif.gz_B Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with 4-amino-7-(1-methylcyclopropyl)-N-(5-methyl-1H-pyrazol-3-yl)pyrrolo[2,3-d]pyrimidine-5-carboxamide	2.688E-02	0.900	67	15	307	317	2	267	274	354	0.924	0.971
LOKIASV2_3899_ESMFold_N-A	4rt7-assembly1.cif.gz_A-2	4rt7-assembly1.cif.gz_A-2 Crystal Structure of FLT3 with a small molecule inhibitor	4.290E-02	0.900	67	27	308	317	9	272	274	346	0.890	0.964
LOKIASV2_3899_ESMFold_N-A	7eed-assembly1.cif.gz_A	7eed-assembly1.cif.gz_A Crystal structure of EphA7 mutant D751H	2.688E-02	0.900	67	26	317	317	23	273	278	332	0.921	0.903
LOKIASV2_3899_ESMFold_N-A	3eh9-assembly1.cif.gz_A	3eh9-assembly1.cif.gz_A Crystal structure of death associated protein kinase complexed with ADP	5.281E-02	0.900	67	26	289	317	8	207	278	292	0.833	0.719
LOKIASV2_3899_ESMFold_N-A	8wsw-assembly4.cif.gz_D	8wsw-assembly4.cif.gz_D The Crystal Structure of LIMK2a from Biortus	2.074E-02	0.900	67	29	291	317	1	190	281	286	0.830	0.676
LOKIASV2_3899_ESMFold_N-A	3oy3-assembly2.cif.gz_B	3oy3-assembly2.cif.gz_B Crystal structure of ABL T315I mutant kinase domain bound with a DFG-out inhibitor AP24589	2.983E-02	0.900	67	32	307	317	15	283	284	349	0.871	0.947
LOKIASV2_3899_ESMFold_N-A	8pyi-assembly7.cif.gz_GGG	8pyi-assembly7.cif.gz_GGG Human IGF1R with inhibitor 6	1.774E-02	0.900	67	30	290	317	13	245	284	319	0.823	0.820
LOKIASV2_3899_ESMFold_N-A	7siu-assembly1.cif.gz_B	7siu-assembly1.cif.gz_B Crystal structure of HPK1 (MAP4K1) complex with inhibitor A-745	8.001E-02	0.900	67	30	142	317	7	120	284	126	0.356	0.401
LOKIASV2_3899_ESMFold_N-A	4bkj-assembly1.cif.gz_A	4bkj-assembly1.cif.gz_A Crystal structure of the human DDR1 kinase domain in complex with imatinib	1.002E-02	0.900	67	17	307	317	34	270	295	336	0.918	0.803
LOKIASV2_3899_ESMFold_N-A	3zdu-assembly1.cif.gz_A-2	3zdu-assembly1.cif.gz_A-2 Crystal structure of the human CDKL3 kinase domain	2.300E-02	0.900	67	30	278	317	4	200	297	282	0.785	0.663
LOKIASV2_3899_ESMFold_N-A	4d2t-assembly2.cif.gz_C	4d2t-assembly2.cif.gz_C Structure of MELK in complex with inhibitors	2.074E-02	0.900	67	13	292	317	1	182	313	293	0.883	0.581
LOKIASV2_3899_ESMFold_N-A	3qkl-assembly1.cif.gz_A	3qkl-assembly1.cif.gz_A Spirochromane Akt Inhibitors	1.869E-02	0.900	67	28	302	317	5	276	318	346	0.868	0.855
LOKIASV2_3899_ESMFold_N-A	5etf-assembly1.cif.gz_A	5etf-assembly1.cif.gz_A Structure of dead kinase MAPK14 with bound the KIM domain of MKK6	1.774E-02	0.900	67	30	283	317	21	222	338	287	0.801	0.598
LOKIASV2_3899_ESMFold_N-A	4kin-assembly3.cif.gz_C	4kin-assembly3.cif.gz_C Crystal structure of mitogen-activated protein kinase 14 (P38-H5) complex with 5-(2-CHLOROPHENYL)-N-(5-(CYCLOPROPYLCARBAMOYL)-2-METHYLPHENYL)-2-THIOPHENECARBOXAMIDE	1.685E-02	0.900	67	28	281	317	19	223	338	294	0.801	0.607
LOKIASV2_3899_ESMFold_N-A	5czo-assembly2.cif.gz_B	5czo-assembly2.cif.gz_B Structure of S. cerevisiae Hrr25:Mam1 complex, form 2	1.869E-02	0.900	67	8	315	317	1	332	374	421	0.972	0.888
LOKIASV2_3899_ESMFold_N-A	5t6a-assembly1.cif.gz_A	5t6a-assembly1.cif.gz_A Crystal Structure of TgCDPK1 from toxoplasma gondii complexed with 5GA	1.442E-02	0.900	67	27	312	317	4	337	431	409	0.902	0.775
LOKIASV2_3899_ESMFold_N-A	6b1u-assembly2.cif.gz_C	6b1u-assembly2.cif.gz_C Structure of full-length human AMPK (a2b1g1) in complex with a small molecule activator SC4	2.184E-02	0.900	67	33	240	317	1	155	460	228	0.656	0.337
LOKIASV2_3899_ESMFold_N-A	4wbo-assembly1.cif.gz_A	4wbo-assembly1.cif.gz_A Bovine G Protein Coupled Receptor Kinase 1 in Complex with Amlexanox	1.234E-02	0.900	67	12	279	317	138	401	497	344	0.845	0.531
LOKIASV2_3899_ESMFold_N-A	4kio-assembly4.cif.gz_D	4kio-assembly4.cif.gz_D Kinase domain mutant of human Itk in complex with a covalently-binding inhibitor	5.281E-02	0.887	66	27	303	317	6	240	242	322	0.874	0.971
LOKIASV2_3899_ESMFold_N-A	4pp9-assembly1.cif.gz_A	4pp9-assembly1.cif.gz_A ITK kinase domain with compound 1 (N-[1-(3-CYANOBENZYL)-1H-PYRAZOL-4-YL]-2H-INDAZOLE-3-CARBOXAMIDE)	1.442E-02	0.887	66	30	317	317	8	246	246	320	0.909	0.972
LOKIASV2_3899_ESMFold_N-A	4b8l-assembly1.cif.gz_A	4b8l-assembly1.cif.gz_A Aurora B kinase P353G mutant	7.730E-03	0.887	66	27	303	317	4	244	249	327	0.874	0.968
LOKIASV2_3899_ESMFold_N-A	4bf2-assembly2.cif.gz_B	4bf2-assembly2.cif.gz_B Crystal Structures of Ask1-inhibitor Complexes	6.280E-03	0.887	66	31	279	317	2	231	252	314	0.785	0.913
LOKIASV2_3899_ESMFold_N-A	4bhn-assembly1.cif.gz_A	4bhn-assembly1.cif.gz_A Crystal Structures of Ask1-inhibitor Complexes	3.367E-03	0.887	66	29	279	317	1	235	256	311	0.792	0.918
LOKIASV2_3899_ESMFold_N-A	3kl8-assembly1.cif.gz_A	3kl8-assembly1.cif.gz_A CaMKIINtide Inhibitor Complex	6.847E-02	0.887	66	38	289	317	1	233	256	308	0.795	0.910
LOKIASV2_3899_ESMFold_N-A	3kl8-assembly5.cif.gz_G	3kl8-assembly5.cif.gz_G CaMKIINtide Inhibitor Complex	5.859E-02	0.887	66	27	289	317	4	236	259	313	0.830	0.900
LOKIASV2_3899_ESMFold_N-A	2hz4-assembly2.cif.gz_B	2hz4-assembly2.cif.gz_B Abl kinase domain unligated and in complex with tetrahydrostaurosporine	4.760E-02	0.887	66	32	314	317	10	260	261	344	0.893	0.962
LOKIASV2_3899_ESMFold_N-A	5h2u-assembly4.cif.gz_D	5h2u-assembly4.cif.gz_D Crystal structure of PTK6 Kinase Domain complexed with Dasatinib	4.290E-02	0.887	66	30	312	317	7	258	263	333	0.893	0.958
LOKIASV2_3899_ESMFold_N-A	2vwi-assembly1.cif.gz_B	2vwi-assembly1.cif.gz_B Structure of the OSR1 kinase, a hypertension drug target	3.142E-02	0.887	66	30	289	317	9	244	264	315	0.820	0.894
LOKIASV2_3899_ESMFold_N-A	6yid-assembly1.cif.gz_B	6yid-assembly1.cif.gz_B Crystal structure of ULK2 in complex with SBI-0206965	4.760E-02	0.887	66	34	279	317	18	243	264	303	0.776	0.856
LOKIASV2_3899_ESMFold_N-A	3oxz-assembly1.cif.gz_A	3oxz-assembly1.cif.gz_A Crystal structure of ABL kinase domain bound with a DFG-out inhibitor AP24534	3.671E-02	0.887	66	30	307	317	15	267	268	339	0.877	0.944
LOKIASV2_3899_ESMFold_N-A	1mry-assembly1.cif.gz_A	1mry-assembly1.cif.gz_A crystal structure of an inactive akt2 kinase domain	1.518E-02	0.887	66	28	302	317	5	250	270	334	0.868	0.911
LOKIASV2_3899_ESMFold_N-A	2pe0-assembly1.cif.gz_A	2pe0-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) 5-Hydroxy-3-[1-(1H-pyrrol-2-yl)-eth-(Z)-ylidene]-1,3-dihydro-indol-2-one COMPLEX	3.309E-02	0.887	66	30	289	317	9	234	276	307	0.820	0.819
LOKIASV2_3899_ESMFold_N-A	3dgk-assembly1.cif.gz_A	3dgk-assembly1.cif.gz_A Crystal structure of a glycine-rich loop mutant of the death associated protein kinase catalytic domain	6.500E-02	0.887	66	26	289	317	8	255	278	323	0.833	0.892
LOKIASV2_3899_ESMFold_N-A	5fm3-assembly1.cif.gz_A	5fm3-assembly1.cif.gz_A Crystal structure of hyper-phosphorylated RET kinase domain with (proximal) juxtamembrane segment	3.485E-02	0.887	66	30	307	317	18	274	280	340	0.877	0.918
LOKIASV2_3899_ESMFold_N-A	2wnt-assembly1.cif.gz_A	2wnt-assembly1.cif.gz_A Crystal Structure of the Human Ribosomal protein S6 kinase	2.423E-02	0.887	66	30	279	317	3	229	281	310	0.789	0.808
LOKIASV2_3899_ESMFold_N-A	5nk6-assembly1.cif.gz_A	5nk6-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2d	1.599E-02	0.887	66	32	315	317	9	264	284	341	0.896	0.901
LOKIASV2_3899_ESMFold_N-A	6tsz-assembly1.cif.gz_U	6tsz-assembly1.cif.gz_U The ULK4 Pseudokinase Domain Bound To ATPgammaS	4.145E-03	0.887	66	26	291	317	4	216	287	296	0.839	0.742
LOKIASV2_3899_ESMFold_N-A	3o0g-assembly1.cif.gz_A	3o0g-assembly1.cif.gz_A Crystal Structure of Cdk5:p25 in complex with an ATP analogue	6.171E-02	0.887	66	29	283	317	5	217	289	302	0.804	0.737
LOKIASV2_3899_ESMFold_N-A	4tw9-assembly1.cif.gz_B	4tw9-assembly1.cif.gz_B Difluoro-dioxolo-benzoimidazol-benzamides as potent inhibitors of CK1delta and epsilon with nanomolar inhibitory activity on cancer cell proliferation	1.599E-02	0.887	66	28	314	317	7	271	289	348	0.905	0.917
LOKIASV2_3899_ESMFold_N-A	6gro-assembly1.cif.gz_A	6gro-assembly1.cif.gz_A Human CSNK1G3 bound to SB-223133	8.142E-03	0.887	66	28	315	317	5	277	293	357	0.909	0.932
LOKIASV2_3899_ESMFold_N-A	7jv7-assembly1.cif.gz_A	7jv7-assembly1.cif.gz_A Crystal Structure of the yeast RNA Pol II CTD kinase CTDK-1 complex	2.423E-02	0.887	66	28	283	317	7	219	304	292	0.808	0.701
LOKIASV2_3899_ESMFold_N-A	4bky-assembly1.cif.gz_A	4bky-assembly1.cif.gz_A Crystal structure of unphosphorylated Maternal Embryonic Leucine zipper Kinase (MELK) in complex with pyrrolopyrazole inhibitor	2.184E-02	0.887	66	20	292	317	2	221	311	314	0.861	0.707
LOKIASV2_3899_ESMFold_N-A	6npz-assembly1.cif.gz_A	6npz-assembly1.cif.gz_A Crystal structure of Akt1 (aa 123-480) kinase with a bisubstrate	2.552E-02	0.887	66	30	302	317	10	278	322	344	0.861	0.835
LOKIASV2_3899_ESMFold_N-A	4d2w-assembly1.cif.gz_D	4d2w-assembly1.cif.gz_D Structure of MELK in complex with inhibitors	1.685E-02	0.887	66	20	279	317	4	237	326	315	0.820	0.718
LOKIASV2_3899_ESMFold_N-A	7axv-assembly1.cif.gz_A	7axv-assembly1.cif.gz_A Crystal structure of the cAMP-dependent protein kinase A cocrystallized with 5-isoquinolinesulfonic acid and PKI (5-24)	1.685E-02	0.887	66	14	279	317	19	270	346	326	0.839	0.728
LOKIASV2_3899_ESMFold_N-A	3beg-assembly1.cif.gz_A	3beg-assembly1.cif.gz_A Crystal structure of SR protein kinase 1 complexed to its substrate ASF/SF2	1.417E-01	0.887	66	30	142	317	12	137	348	129	0.356	0.362
LOKIASV2_3899_ESMFold_N-A	1opl-assembly2.cif.gz_B	1opl-assembly2.cif.gz_B Structural basis for the auto-inhibition of c-Abl tyrosine kinase	1.277E-01	0.887	66	32	141	317	108	221	365	124	0.347	0.312
LOKIASV2_3899_ESMFold_N-A	6w39-assembly1.cif.gz_A	6w39-assembly1.cif.gz_A Structure of unphosphorylated IRE1 in complex with G-1749	1.369E-02	0.887	66	28	289	317	5	227	374	310	0.826	0.596
LOKIASV2_3899_ESMFold_N-A	6w3k-assembly1.cif.gz_A-2	6w3k-assembly1.cif.gz_A-2 Structure of unphosphorylated human IRE1 bound to G-9807	4.290E-02	0.887	66	34	307	317	15	262	398	330	0.864	0.623
LOKIASV2_3899_ESMFold_N-A	4cfe-assembly1.cif.gz_C	4cfe-assembly1.cif.gz_C Structure of full length human AMPK in complex with a small molecule activator, a benzimidazole derivative (991)	9.350E-02	0.887	66	28	141	317	5	122	404	125	0.360	0.292
LOKIASV2_3899_ESMFold_N-A	6xdb-assembly1.cif.gz_A	6xdb-assembly1.cif.gz_A Crystal structure of IRE1a in complex with G-6904	3.671E-02	0.887	66	34	307	317	16	267	404	333	0.864	0.624
LOKIASV2_3899_ESMFold_N-A	3soa-assembly1.cif.gz_A	3soa-assembly1.cif.gz_A Full-length human CaMKII	9.350E-02	0.887	66	25	141	317	2	119	436	128	0.369	0.271
LOKIASV2_3899_ESMFold_N-A	4yga-assembly1.cif.gz_A	4yga-assembly1.cif.gz_A CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	1.774E-02	0.887	66	27	307	317	4	263	448	336	0.886	0.580
LOKIASV2_3899_ESMFold_N-A	2bcj-assembly1.cif.gz_A	2bcj-assembly1.cif.gz_A Crystal Structure of G Protein-Coupled Receptor Kinase 2 in Complex with Galpha-q and Gbetagamma Subunits	4.519E-02	0.887	66	27	317	317	161	440	624	365	0.918	0.449
LOKIASV2_3899_ESMFold_N-A	6m11-assembly1.cif.gz_a	6m11-assembly1.cif.gz_a Crystal structure of Rnase L in complex with Sunitinib	3.485E-02	0.887	66	28	302	317	342	550	681	292	0.868	0.307
LOKIASV2_3899_ESMFold_N-A	3cs9-assembly2.cif.gz_B	3cs9-assembly2.cif.gz_B Human ABL kinase in complex with nilotinib	4.519E-02	0.872	65	32	315	317	10	245	247	325	0.896	0.955
LOKIASV2_3899_ESMFold_N-A	5v24-assembly1.cif.gz_A	5v24-assembly1.cif.gz_A Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead optimization strategy	1.112E-02	0.872	65	31	280	317	2	229	249	301	0.789	0.916
LOKIASV2_3899_ESMFold_N-A	3is5-assembly1.cif.gz_B	3is5-assembly1.cif.gz_B Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	3.309E-02	0.872	65	27	292	317	8	197	260	284	0.839	0.731
LOKIASV2_3899_ESMFold_N-A	3dk7-assembly1.cif.gz_A	3dk7-assembly1.cif.gz_A Crystal structure of mutant ABL kinase domain in complex with small molecule fragment	2.983E-02	0.872	65	32	315	317	10	262	266	334	0.896	0.951
LOKIASV2_3899_ESMFold_N-A	8h7f-assembly1.cif.gz_A	8h7f-assembly1.cif.gz_A The crystal structure of human abl1 kinase domain in complex with abl1-B-EBA	5.281E-02	0.872	65	32	298	317	11	266	267	340	0.842	0.959
LOKIASV2_3899_ESMFold_N-A	5o49-assembly2.cif.gz_B	5o49-assembly2.cif.gz_B Human FGF in complex with a covalent inhibitor	2.300E-02	0.872	65	28	309	317	17	281	286	341	0.890	0.927
LOKIASV2_3899_ESMFold_N-A	3uyt-assembly6.cif.gz_B-3	3uyt-assembly6.cif.gz_B-3 crystal structure of ck1d with PF670462 from P1 crystal form	2.688E-02	0.872	65	28	312	317	3	274	286	357	0.899	0.951
LOKIASV2_3899_ESMFold_N-A	4twc-assembly2.cif.gz_B	4twc-assembly2.cif.gz_B 2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4- carboxamide derivatives as potent inhibitors of CK1d/e	1.969E-02	0.872	65	28	312	317	7	278	292	355	0.899	0.932
LOKIASV2_3899_ESMFold_N-A	1zmv-assembly1.cif.gz_A	1zmv-assembly1.cif.gz_A Catalytic and ubiqutin-associated domains of MARK2/PAR-1: K82R mutant	1.969E-02	0.872	65	28	292	317	1	214	293	298	0.836	0.730
LOKIASV2_3899_ESMFold_N-A	1oi9-assembly1.cif.gz_A	1oi9-assembly1.cif.gz_A Structure of human Thr160-phospho CDK2/cyclin A complexed with a 6-cyclohexylmethyloxy-2-anilino-purine inhibitor	1.037E-01	0.872	65	27	280	317	2	216	296	296	0.801	0.726
LOKIASV2_3899_ESMFold_N-A	1z9x-assembly1.cif.gz_A	1z9x-assembly1.cif.gz_A Human DRP-1 kinase, W305S S308A D40 mutant, crystal form with 3 monomers in the asymmetric unit	4.290E-02	0.872	65	30	317	317	12	278	303	351	0.909	0.881
LOKIASV2_3899_ESMFold_N-A	5ywm-assembly1.cif.gz_X	5ywm-assembly1.cif.gz_X Crystal structure of CK2a2 form-1	4.073E-02	0.872	65	8	288	317	1	249	313	327	0.886	0.796
LOKIASV2_3899_ESMFold_N-A	3ocb-assembly1.cif.gz_A	3ocb-assembly1.cif.gz_A Akt1 kinase domain with pyrrolopyrimidine inhibitor	2.688E-02	0.872	65	28	292	317	5	240	316	313	0.836	0.747
LOKIASV2_3899_ESMFold_N-A	5yf9-assembly2.cif.gz_B	5yf9-assembly2.cif.gz_B Crystal structure of CK2a2 form-2	2.983E-02	0.872	65	21	292	317	17	254	319	320	0.858	0.746
LOKIASV2_3899_ESMFold_N-A	4d2v-assembly1.cif.gz_B	4d2v-assembly1.cif.gz_B Structure of MELK in complex with inhibitors	4.598E-03	0.872	65	21	317	317	3	250	322	340	0.937	0.770
LOKIASV2_3899_ESMFold_N-A	6isj-assembly1.cif.gz_A	6isj-assembly1.cif.gz_A Crystal structure of CX-4945 bound CK2 alpha from C. neoformans	4.073E-02	0.872	65	4	289	317	20	297	324	373	0.902	0.858
LOKIASV2_3899_ESMFold_N-A	6khf-assembly1.cif.gz_A	6khf-assembly1.cif.gz_A Crystal structure of CLK3 in complex with CX-4945	3.309E-02	0.872	65	30	284	317	15	234	327	292	0.804	0.673
LOKIASV2_3899_ESMFold_N-A	3new-assembly1.cif.gz_A	3new-assembly1.cif.gz_A p38-alpha complexed with Compound 10	1.234E-02	0.872	65	28	283	317	18	219	334	290	0.808	0.605
LOKIASV2_3899_ESMFold_N-A	8ssn-assembly1.cif.gz_A	8ssn-assembly1.cif.gz_A Abl kinase in complex with SKI and asciminib	1.969E-02	0.872	65	23	297	317	166	411	420	334	0.868	0.586
LOKIASV2_3899_ESMFold_N-A	3is5-assembly1.cif.gz_D	3is5-assembly1.cif.gz_D Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	5.014E-02	0.855	64	6	292	317	1	189	236	304	0.905	0.801
LOKIASV2_3899_ESMFold_N-A	3vw6-assembly1.cif.gz_B	3vw6-assembly1.cif.gz_B Crystal structure of human apoptosis signal-regulating kinase 1 (ASK1) with imidazopyridine inhibitor	1.002E-02	0.855	64	31	316	317	2	213	253	314	0.902	0.838
LOKIASV2_3899_ESMFold_N-A	3kl8-assembly2.cif.gz_I	3kl8-assembly2.cif.gz_I CaMKIINtide Inhibitor Complex	7.596E-02	0.855	64	27	289	317	4	233	254	313	0.830	0.906
LOKIASV2_3899_ESMFold_N-A	6nzr-assembly1.cif.gz_B	6nzr-assembly1.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_12 AKA 4-[(2-methanesulfonylphenyl)amino]-N-(H3)methyl-6-[(pyridin-2- yl)amino]pyridazine-3-carboxamide	7.730E-03	0.855	64	31	279	317	12	257	259	296	0.785	0.950
LOKIASV2_3899_ESMFold_N-A	3zxt-assembly2.cif.gz_C	3zxt-assembly2.cif.gz_C Dimeric structure of DAPK-1 catalytic domain in complex with AMPPCP- Mg	3.142E-02	0.855	64	30	289	317	9	239	259	301	0.820	0.892
LOKIASV2_3899_ESMFold_N-A	1ung-assembly2.cif.gz_B	1ung-assembly2.cif.gz_B Structural mechanism for the inhibition of CDK5-p25 by roscovitine, aloisine and indirubin.	8.427E-02	0.855	64	31	283	317	2	200	268	284	0.798	0.743
LOKIASV2_3899_ESMFold_N-A	5vo1-assembly1.cif.gz_A	5vo1-assembly1.cif.gz_A DLK in complex with compound 10 (5-(1-isopropyl-5-(3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl)-1H-pyrazol-3-yl)-3-(trifluoromethyl)pyridin-2-amine)	3.547E-03	0.855	64	31	292	317	11	193	269	288	0.826	0.680
LOKIASV2_3899_ESMFold_N-A	7vdq-assembly2.cif.gz_B	7vdq-assembly2.cif.gz_B The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 7	3.867E-02	0.855	64	33	283	317	1	206	277	288	0.792	0.744
LOKIASV2_3899_ESMFold_N-A	7qra-assembly4.cif.gz_D	7qra-assembly4.cif.gz_D Crystal structure of CK1 delta in complex with VN725	2.983E-02	0.855	64	28	314	317	5	263	280	342	0.905	0.925
LOKIASV2_3899_ESMFold_N-A	6n8g-assembly3.cif.gz_C	6n8g-assembly3.cif.gz_C IRAK4 bound to benzoxazole compound	4.760E-02	0.855	64	7	310	317	1	287	289	378	0.959	0.993
LOKIASV2_3899_ESMFold_N-A	4oh4-assembly2.cif.gz_B	4oh4-assembly2.cif.gz_B Crystal structure of BRI1 in complex with BKI1	4.760E-02	0.855	64	11	315	317	15	289	293	365	0.962	0.939
LOKIASV2_3899_ESMFold_N-A	6w4p-assembly1.cif.gz_H	6w4p-assembly1.cif.gz_H CaMKII alpha-30 Cryo-EM reconstruction - Class B	1.345E-01	0.855	64	25	141	317	2	119	293	126	0.369	0.403
LOKIASV2_3899_ESMFold_N-A	6wjg-assembly1.cif.gz_B	6wjg-assembly1.cif.gz_B PKA RIIbeta holoenzyme with DnaJB1-PKAc fusion in fibrolamellar hepatoceullar carcinoma	3.309E-02	0.855	64	28	292	317	1	191	310	289	0.836	0.616
LOKIASV2_3899_ESMFold_N-A	4dli-assembly1.cif.gz_A	4dli-assembly1.cif.gz_A Human p38 MAP kinase in complex with RL87	1.442E-02	0.855	64	28	281	317	18	217	334	289	0.801	0.599
LOKIASV2_3899_ESMFold_N-A	2rg6-assembly1.cif.gz_A	2rg6-assembly1.cif.gz_A Phenylalanine pyrrolotriazine p38 alpha map kinase inhibitor compound 11J	1.774E-02	0.855	64	28	283	317	19	220	335	288	0.808	0.603
LOKIASV2_3899_ESMFold_N-A	6q8p-assembly1.cif.gz_A	6q8p-assembly1.cif.gz_A Structure of CLK1 with bound N-methyl-10-nitropyrido[3,4-g]quinazolin-2-amine	1.037E-01	0.855	64	27	142	317	13	136	336	132	0.366	0.369
LOKIASV2_3899_ESMFold_N-A	3oz6-assembly1.cif.gz_A	3oz6-assembly1.cif.gz_A Crystal structure of MapK from Cryptosporidium Parvum, cgd2_1960	3.867E-02	0.855	64	25	313	317	3	280	343	359	0.912	0.810
LOKIASV2_3899_ESMFold_N-A	5r9c-assembly1.cif.gz_A	5r9c-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N14074a in complex with MAP kinase p38-alpha	2.300E-02	0.855	64	28	283	317	18	232	347	293	0.808	0.620
LOKIASV2_3899_ESMFold_N-A	7w5c-assembly1.cif.gz_A	7w5c-assembly1.cif.gz_A Crystal structure of Mitogen Activated Protein Kinase 4 (MPK4) from Arabidopsis thaliana	2.832E-02	0.855	64	30	307	317	27	263	355	327	0.877	0.668
LOKIASV2_3899_ESMFold_N-A	4z7h-assembly1.cif.gz_A	4z7h-assembly1.cif.gz_A Crystal structure of human IRE1 cytoplasmic kinase-RNase region - complex with imidazopyridine compound 3	6.171E-02	0.855	64	33	289	317	14	242	385	310	0.811	0.595
LOKIASV2_3899_ESMFold_N-A	3c4x-assembly1.cif.gz_B	3c4x-assembly1.cif.gz_B Crystal Structure of G protein coupled receptor kinase 1 bound to ATP and magnesium chloride at 2.9A	1.171E-02	0.855	64	8	286	317	93	391	475	374	0.880	0.629
LOKIASV2_3899_ESMFold_N-A	4wbo-assembly2.cif.gz_B	4wbo-assembly2.cif.gz_B Bovine G Protein Coupled Receptor Kinase 1 in Complex with Amlexanox	2.832E-02	0.855	64	12	276	317	136	377	495	325	0.836	0.489
LOKIASV2_3899_ESMFold_N-A	6oyw-assembly2.cif.gz_D-3	6oyw-assembly2.cif.gz_D-3 ASK1 kinase domain in complex with Compound 11	1.112E-02	0.837	63	31	279	317	2	240	260	310	0.785	0.919
LOKIASV2_3899_ESMFold_N-A	3dk6-assembly1.cif.gz_A	3dk6-assembly1.cif.gz_A Crystal structure of mutant ABL kinase domain in complex with small molecule fragment	5.281E-02	0.837	63	32	298	317	10	260	263	342	0.842	0.954
LOKIASV2_3899_ESMFold_N-A	2wma-assembly2.cif.gz_C	2wma-assembly2.cif.gz_C Structural and thermodynamic consequences of cyclization of peptide ligands for the recruitment site of cyclin A	8.427E-02	0.837	63	27	289	317	2	237	266	320	0.830	0.887
LOKIASV2_3899_ESMFold_N-A	5a6n-assembly1.cif.gz_B	5a6n-assembly1.cif.gz_B Crystal structure of human death associated protein kinase 3 (DAPK3) in complex with compound 2	3.142E-02	0.837	63	26	289	317	3	245	267	316	0.833	0.910
LOKIASV2_3899_ESMFold_N-A	6q7f-assembly1.cif.gz_A	6q7f-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATDL18	1.774E-02	0.837	63	30	315	317	9	247	267	316	0.902	0.895
LOKIASV2_3899_ESMFold_N-A	6het-assembly1.cif.gz_A	6het-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative AT055	1.774E-02	0.837	63	25	315	317	6	248	268	321	0.918	0.907
LOKIASV2_3899_ESMFold_N-A	4r6v-assembly1.cif.gz_A	4r6v-assembly1.cif.gz_A Crystal Structure of FGF Receptor (FGFR) 4 Kinase Harboring the V550L Gate-Keeper Mutation in Complex with FIIN-3, an Irreversible Tyrosine Kinase Inhibitor Capable of Overcoming FGFR kinase Gate-Keeper Mutations	2.184E-02	0.837	63	28	308	317	23	271	273	327	0.886	0.912
LOKIASV2_3899_ESMFold_N-A	3ztx-assembly2.cif.gz_B	3ztx-assembly2.cif.gz_B Aurora kinase selective inhibitors identified using a Taxol-induced checkpoint sensitivity screen.	2.552E-02	0.837	63	30	303	317	16	264	273	328	0.864	0.912
LOKIASV2_3899_ESMFold_N-A	4fzd-assembly1.cif.gz_B	4fzd-assembly1.cif.gz_B Crystal structure of MST4-MO25 complex with WSF motif	3.142E-02	0.837	63	37	305	317	19	271	275	339	0.849	0.920
LOKIASV2_3899_ESMFold_N-A	6rfj-assembly2.cif.gz_B	6rfj-assembly2.cif.gz_B IRAK4 IN COMPLEX WITH inhibitor	5.281E-02	0.837	63	7	310	317	1	278	279	367	0.959	0.996
LOKIASV2_3899_ESMFold_N-A	4ct1-assembly1.cif.gz_A	4ct1-assembly1.cif.gz_A Human PDK1-PKCzeta Kinase Chimera in Complex with Allosteric Compound PS315 Bound to the PIF-Pocket	3.142E-02	0.837	63	30	303	317	7	241	284	315	0.864	0.827
LOKIASV2_3899_ESMFold_N-A	7nzy-assembly4.cif.gz_D	7nzy-assembly4.cif.gz_D Crystal structure of human Casein Kinase I delta in complex with CGS-15943	2.832E-02	0.837	63	28	314	317	5	268	285	347	0.905	0.926
LOKIASV2_3899_ESMFold_N-A	4ytf-assembly1.cif.gz_A	4ytf-assembly1.cif.gz_A Discovery of VX-509 (Decernotinib): A Potent and Selective Janus kinase (JAK) 3 Inhibitor for the Treatment of Autoimmune Diseases	1.037E-01	0.837	63	30	312	317	8	284	285	363	0.893	0.972
LOKIASV2_3899_ESMFold_N-A	6p69-assembly2.cif.gz_B	6p69-assembly2.cif.gz_B Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to compound 11.	3.142E-02	0.837	63	28	309	317	16	284	286	346	0.890	0.941
LOKIASV2_3899_ESMFold_N-A	4hok-assembly13.cif.gz_E	4hok-assembly13.cif.gz_E crystal structure of apo ck1e	1.969E-02	0.837	63	28	312	317	7	278	291	352	0.899	0.935
LOKIASV2_3899_ESMFold_N-A	2izr-assembly1.cif.gz_A	2izr-assembly1.cif.gz_A Structure of casein kinase gamma 3 in complex with inhibitor	1.112E-02	0.837	63	28	315	317	6	277	298	357	0.909	0.913
LOKIASV2_3899_ESMFold_N-A	7enc-assembly1.cif.gz_8	7enc-assembly1.cif.gz_8 TFIID-based PIC-Mediator holo-complex in fully-assembled state (hPIC-MED)	5.014E-02	0.837	63	31	283	317	2	215	299	295	0.798	0.716
LOKIASV2_3899_ESMFold_N-A	4ump-assembly2.cif.gz_C	4ump-assembly2.cif.gz_C Structure of MELK in complex with inhibitors	4.290E-02	0.837	63	20	292	317	4	221	311	311	0.861	0.701
LOKIASV2_3899_ESMFold_N-A	6l20-assembly1.cif.gz_A	6l20-assembly1.cif.gz_A Crystal structure of CK2a2 with hematein	6.847E-02	0.837	63	26	288	317	21	240	313	305	0.830	0.703
LOKIASV2_3899_ESMFold_N-A	4ump-assembly1.cif.gz_D	4ump-assembly1.cif.gz_D Structure of MELK in complex with inhibitors	2.074E-02	0.837	63	20	292	317	3	194	321	294	0.861	0.598
LOKIASV2_3899_ESMFold_N-A	6buu-assembly1.cif.gz_A	6buu-assembly1.cif.gz_A Crystal structure of AKT1 (aa 144-480) with a bisubstrate	4.290E-02	0.837	63	28	285	317	5	251	323	321	0.814	0.765
LOKIASV2_3899_ESMFold_N-A	2r9s-assembly2.cif.gz_B	2r9s-assembly2.cif.gz_B c-Jun N-terminal Kinase 3 with 3,5-Disubstituted Quinoline inhibitor	4.760E-02	0.837	63	31	283	317	21	214	325	279	0.798	0.597
LOKIASV2_3899_ESMFold_N-A	6xx8-assembly1.cif.gz_A	6xx8-assembly1.cif.gz_A Arabidopsis thaliana Casein Kinase 2 (CK2) alpha-1 crystal form II	6.171E-02	0.837	63	28	300	317	24	260	326	318	0.861	0.727
LOKIASV2_3899_ESMFold_N-A	3oht-assembly1.cif.gz_B	3oht-assembly1.cif.gz_B Crystal Structure of Salmo Salar p38alpha	2.074E-02	0.837	63	28	281	317	19	217	331	279	0.801	0.601
LOKIASV2_3899_ESMFold_N-A	3iw4-assembly1.cif.gz_A	3iw4-assembly1.cif.gz_A Crystal structure of PKC alpha in complex with NVP-AEB071	5.281E-02	0.837	63	30	292	317	9	242	332	323	0.830	0.705
LOKIASV2_3899_ESMFold_N-A	3o8u-assembly1.cif.gz_A	3o8u-assembly1.cif.gz_A Conformational plasticity of p38 MAP kinase DFG motif mutants in response to inhibitor binding	8.142E-03	0.837	63	28	283	317	18	217	332	287	0.808	0.602
LOKIASV2_3899_ESMFold_N-A	5ts8-assembly1.cif.gz_A	5ts8-assembly1.cif.gz_A Z. MAYS CK2 KINASE ALPHA SUBUNIT IN COMPLEX WITH THE ATP-COMPETITIVE INHIBITOR 5,6-DIBROMOBENZOTRIAZOLE	3.142E-02	0.837	63	28	300	317	31	267	332	322	0.861	0.714
LOKIASV2_3899_ESMFold_N-A	5r92-assembly1.cif.gz_A	5r92-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL063 in complex with MAP kinase p38-alpha	2.184E-02	0.837	63	28	283	317	19	230	345	294	0.808	0.614
LOKIASV2_3899_ESMFold_N-A	8efj-assembly1.cif.gz_A	8efj-assembly1.cif.gz_A A structural study of selectivity mechanisms for JNK3 and p38 alpha with indazole scaffold probing compounds	2.983E-02	0.837	63	28	283	317	18	225	348	295	0.808	0.598
LOKIASV2_3899_ESMFold_N-A	6e4t-assembly1.cif.gz_A	6e4t-assembly1.cif.gz_A Structure of AMPK bound to activator	3.142E-02	0.837	63	34	284	317	8	219	362	299	0.792	0.586
LOKIASV2_3899_ESMFold_N-A	6w3a-assembly1.cif.gz_A	6w3a-assembly1.cif.gz_A Structure of unphosphorylated IRE1 in complex with G-7658	8.427E-02	0.837	63	33	142	317	14	111	363	115	0.347	0.270
LOKIASV2_3899_ESMFold_N-A	2f2u-assembly2.cif.gz_B-3	2f2u-assembly2.cif.gz_B-3 crystal structure of the Rho-kinase kinase domain	1.685E-02	0.837	63	4	317	317	37	290	383	347	0.991	0.663
LOKIASV2_3899_ESMFold_N-A	4z7h-assembly2.cif.gz_B	4z7h-assembly2.cif.gz_B Crystal structure of human IRE1 cytoplasmic kinase-RNase region - complex with imidazopyridine compound 3	6.171E-02	0.837	63	33	292	317	14	238	388	306	0.820	0.580
LOKIASV2_3899_ESMFold_N-A	6s9w-assembly1.cif.gz_A	6s9w-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 16a	1.599E-02	0.837	63	14	279	317	95	351	411	331	0.839	0.625
LOKIASV2_3899_ESMFold_N-A	5iso-assembly1.cif.gz_A	5iso-assembly1.cif.gz_A STRUCTURE OF FULL LENGTH HUMAN AMPK (NON-PHOSPHORYLATED AT T-LOOP) IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR, A BENZIMIDAZOLE DERIVATIVE (991)	2.300E-02	0.837	63	33	240	317	1	155	453	223	0.656	0.342
LOKIASV2_3899_ESMFold_N-A	6nyh-assembly2.cif.gz_B	6nyh-assembly2.cif.gz_B Structure of human RIPK1 kinase domain in complex with GNE684	3.485E-02	0.817	62	34	291	317	7	175	246	273	0.814	0.687
LOKIASV2_3899_ESMFold_N-A	8s9f-assembly1.cif.gz_A	8s9f-assembly1.cif.gz_A Crystal structure of the kinase domain of Bruton's Tyrosine Kinase bound to dasatinib	5.859E-02	0.817	62	32	312	317	11	251	254	318	0.886	0.949
LOKIASV2_3899_ESMFold_N-A	3udb-assembly5.cif.gz_E	3udb-assembly5.cif.gz_E Crystal structure of SnRK2.6	4.519E-02	0.817	62	26	152	317	5	131	255	140	0.401	0.498
LOKIASV2_3899_ESMFold_N-A	3h9f-assembly1.cif.gz_A	3h9f-assembly1.cif.gz_A Crystal Structure of Human Dual Specificity Protein Kinase (TTK) in complex with a pyrimido-diazepin ligand	1.774E-02	0.817	62	29	279	317	15	241	263	304	0.792	0.863
LOKIASV2_3899_ESMFold_N-A	8bof-assembly1.cif.gz_A	8bof-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 12	2.184E-02	0.817	62	27	277	317	6	198	266	270	0.792	0.726
LOKIASV2_3899_ESMFold_N-A	8bzi-assembly1.cif.gz_A	8bzi-assembly1.cif.gz_A Human MST3 (STK24) kinase in complex with inhibitor MR39	5.562E-02	0.817	62	25	312	317	7	264	267	347	0.909	0.966
LOKIASV2_3899_ESMFold_N-A	6fnh-assembly3.cif.gz_C	6fnh-assembly3.cif.gz_C Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with a pyrazolo[3,4-d]pyrimidine fragment of NVP-BHG712	2.074E-02	0.817	62	25	315	317	11	256	270	327	0.918	0.911
LOKIASV2_3899_ESMFold_N-A	2hiw-assembly2.cif.gz_B	2hiw-assembly2.cif.gz_B Crystal Structure of Inactive Conformation Abl Kinase Catalytic Domain Complexed with Type II Inhibitor	6.500E-02	0.817	62	32	311	317	17	273	274	337	0.883	0.938
LOKIASV2_3899_ESMFold_N-A	4tpt-assembly1.cif.gz_B	4tpt-assembly1.cif.gz_B Crystal Structure of the Human LIMK2 Kinase Domain In Complex With a Non-ATP Competitive Inhibitor	1.969E-02	0.817	62	31	309	317	15	252	277	325	0.880	0.859
LOKIASV2_3899_ESMFold_N-A	6f1w-assembly1.cif.gz_A	6f1w-assembly1.cif.gz_A Crystal structure of human Casein Kinase I delta in complex with compound 31a	3.485E-02	0.817	62	28	317	317	5	278	285	360	0.915	0.961
LOKIASV2_3899_ESMFold_N-A	3mvh-assembly1.cif.gz_A	3mvh-assembly1.cif.gz_A Crystal structure of Akt-1-inhibitor complexes	4.760E-02	0.817	62	28	292	317	4	239	312	315	0.836	0.756
LOKIASV2_3899_ESMFold_N-A	4d2v-assembly1.cif.gz_C	4d2v-assembly1.cif.gz_C Structure of MELK in complex with inhibitors	5.660E-03	0.817	62	26	317	317	3	244	316	339	0.921	0.766
LOKIASV2_3899_ESMFold_N-A	6khd-assembly1.cif.gz_A	6khd-assembly1.cif.gz_A Crystal structure of CLK1 in complex with CX-4945	2.552E-02	0.817	62	27	283	317	10	234	322	310	0.811	0.699
LOKIASV2_3899_ESMFold_N-A	6yu1-assembly1.cif.gz_a	6yu1-assembly1.cif.gz_a CLK3 bound with beta-carboline KH-CARB13 (Cpd 3)	6.500E-02	0.817	62	29	283	317	21	247	340	301	0.804	0.668
LOKIASV2_3899_ESMFold_N-A	5r8y-assembly1.cif.gz_A	5r8y-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N08078b in complex with MAP kinase p38-alpha	3.142E-02	0.817	62	28	283	317	19	231	346	292	0.808	0.616
LOKIASV2_3899_ESMFold_N-A	1pmv-assembly1.cif.gz_A	1pmv-assembly1.cif.gz_A The structure of JNK3 in complex with a dihydroanthrapyrazole inhibitor	6.847E-02	0.817	62	30	278	317	20	225	347	286	0.785	0.594
LOKIASV2_3899_ESMFold_N-A	7dd1-assembly1.cif.gz_A	7dd1-assembly1.cif.gz_A Crystal structure of SRPK1 in complex with a peptide inhibitor	1.369E-02	0.817	62	29	283	317	13	267	351	321	0.804	0.726
LOKIASV2_3899_ESMFold_N-A	4xhg-assembly1.cif.gz_A	4xhg-assembly1.cif.gz_A Structure of C. glabrata Hrr25 bound to ADP (formate condition)	3.309E-02	0.817	62	28	314	317	11	276	357	355	0.905	0.745
LOKIASV2_3899_ESMFold_N-A	6xdf-assembly2.cif.gz_A	6xdf-assembly2.cif.gz_A Crystal structure of IRE1a in complex with G-4100	8.877E-02	0.817	62	34	300	317	17	249	402	314	0.842	0.580
LOKIASV2_3899_ESMFold_N-A	4wbo-assembly3.cif.gz_C	4wbo-assembly3.cif.gz_C Bovine G Protein Coupled Receptor Kinase 1 in Complex with Amlexanox	2.184E-02	0.817	62	12	279	317	135	398	481	344	0.845	0.549
LOKIASV2_3899_ESMFold_N-A	6m13-assembly1.cif.gz_b	6m13-assembly1.cif.gz_b Crystal structure of Rnase L in complex with Toceranib	2.983E-02	0.817	62	37	302	317	351	551	688	291	0.839	0.292
LOKIASV2_3899_ESMFold_N-A	6cpg-assembly1.cif.gz_A	6cpg-assembly1.cif.gz_A Structure of dephosphorylated Aurora A (122-403) in complex with inhibiting monobody and AT9283 in an inactive conformation	3.867E-02	0.795	61	30	310	317	7	248	249	327	0.886	0.972
LOKIASV2_3899_ESMFold_N-A	3kl8-assembly3.cif.gz_C	3kl8-assembly3.cif.gz_C CaMKIINtide Inhibitor Complex	1.093E-01	0.795	61	27	290	317	3	234	256	314	0.833	0.906
LOKIASV2_3899_ESMFold_N-A	2hzi-assembly2.cif.gz_B	2hzi-assembly2.cif.gz_B Abl kinase domain in complex with PD180970	5.859E-02	0.795	61	32	315	317	10	262	264	336	0.896	0.958
LOKIASV2_3899_ESMFold_N-A	8bk0-assembly1.cif.gz_A	8bk0-assembly1.cif.gz_A Crystal structure of human Ephrin type-A receptor 2 (EPHA2) Kinase domain in complex with LDN-211904	2.983E-02	0.795	61	25	315	317	6	255	266	332	0.918	0.940
LOKIASV2_3899_ESMFold_N-A	5vja-assembly1.cif.gz_B	5vja-assembly1.cif.gz_B Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	3.309E-02	0.795	61	27	289	317	4	244	266	314	0.830	0.906
LOKIASV2_3899_ESMFold_N-A	3ue4-assembly2.cif.gz_B	3ue4-assembly2.cif.gz_B Structural and spectroscopic analysis of the kinase inhibitor bosutinib binding to the Abl tyrosine kinase domain	8.427E-02	0.795	61	30	312	317	10	265	268	337	0.893	0.955
LOKIASV2_3899_ESMFold_N-A	4zog-assembly2.cif.gz_B	4zog-assembly2.cif.gz_B VX-680/MK-0457 binds to human ABL1 also in inactive DFG conformations.	5.859E-02	0.795	61	30	298	317	9	264	268	331	0.849	0.955
LOKIASV2_3899_ESMFold_N-A	5auu-assembly1.cif.gz_A	5auu-assembly1.cif.gz_A Crystal structure of DAPK1 in complex with luteolin.	1.151E-01	0.795	61	26	289	317	8	253	274	321	0.833	0.898
LOKIASV2_3899_ESMFold_N-A	2oib-assembly2.cif.gz_B	2oib-assembly2.cif.gz_B Crystal structure of IRAK4 kinase domain apo form	3.867E-02	0.795	61	34	311	317	26	279	280	342	0.877	0.907
LOKIASV2_3899_ESMFold_N-A	1xjd-assembly1.cif.gz_A	1xjd-assembly1.cif.gz_A Crystal Structure of PKC-theta complexed with Staurosporine at 2A resolution	5.562E-02	0.795	61	28	279	317	7	238	282	312	0.795	0.823
LOKIASV2_3899_ESMFold_N-A	8fjz-assembly3.cif.gz_E-2	8fjz-assembly3.cif.gz_E-2 Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(3R,5S)-3-Amino-5-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	5.562E-02	0.795	61	26	289	317	8	199	283	281	0.833	0.678
LOKIASV2_3899_ESMFold_N-A	5lvl-assembly1.cif.gz_A	5lvl-assembly1.cif.gz_A Human PDK1 Kinase Domain in Complex with Compound PS653 Bound to the ATP-Binding Site	2.983E-02	0.795	61	30	289	317	9	202	286	283	0.820	0.678
LOKIASV2_3899_ESMFold_N-A	6qhr-assembly1.cif.gz_A	6qhr-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidine 1m	3.309E-02	0.795	61	28	279	317	18	221	286	283	0.795	0.713
LOKIASV2_3899_ESMFold_N-A	2vz6-assembly1.cif.gz_A	2vz6-assembly1.cif.gz_A Structure of human calcium calmodulin dependent protein kinase type II alpha (CAMK2A) in complex with Indirubin E804	1.869E-02	0.795	61	32	289	317	7	244	291	312	0.814	0.818
LOKIASV2_3899_ESMFold_N-A	4btj-assembly2.cif.gz_B	4btj-assembly2.cif.gz_B TTBK1 in complex with ATP	2.552E-02	0.795	61	27	306	317	11	279	293	350	0.883	0.918
LOKIASV2_3899_ESMFold_N-A	6gue-assembly1.cif.gz_A	6gue-assembly1.cif.gz_A CDK2/CyclinA in complex with AZD5438	9.350E-02	0.795	61	27	283	317	2	213	294	298	0.811	0.721
LOKIASV2_3899_ESMFold_N-A	2hak-assembly5.cif.gz_E	2hak-assembly5.cif.gz_E Catalytic and ubiqutin-associated domains of MARK1/PAR-1	5.562E-02	0.795	61	30	289	317	7	239	318	320	0.820	0.733
LOKIASV2_3899_ESMFold_N-A	2r7i-assembly1.cif.gz_A	2r7i-assembly1.cif.gz_A Crystal structure of catalytic subunit of protein kinase CK2	6.847E-02	0.795	61	27	283	317	35	239	322	290	0.811	0.637
LOKIASV2_3899_ESMFold_N-A	3s4q-assembly1.cif.gz_A	3s4q-assembly1.cif.gz_A P38 alpha kinase complexed with a pyrazolo-triazine based inhibitor	1.969E-02	0.795	61	28	283	317	1	211	326	294	0.808	0.647
LOKIASV2_3899_ESMFold_N-A	3qkm-assembly1.cif.gz_A	3qkm-assembly1.cif.gz_A Spirocyclic sulfonamides as AKT inhibitors	5.859E-02	0.795	61	28	279	317	5	241	330	309	0.795	0.718
LOKIASV2_3899_ESMFold_N-A	7zkx-assembly1.cif.gz_A	7zkx-assembly1.cif.gz_A SRPK2 IN COMPLEX WITH INHIBITOR	2.423E-02	0.795	61	29	283	317	11	256	339	318	0.804	0.726
LOKIASV2_3899_ESMFold_N-A	7mt9-assembly1.cif.gz_G	7mt9-assembly1.cif.gz_G Rhodopsin kinase (GRK1) in complex with rhodopsin	4.760E-02	0.795	61	14	279	317	7	266	346	334	0.839	0.751
LOKIASV2_3899_ESMFold_N-A	5mxx-assembly1.cif.gz_A	5mxx-assembly1.cif.gz_A Crystal structure of human SR protein kinase 1 (SRPK1) in complex with compound 1	1.212E-01	0.795	61	29	143	317	24	151	361	140	0.363	0.355
LOKIASV2_3899_ESMFold_N-A	7jhh-assembly1.cif.gz_A	7jhh-assembly1.cif.gz_A Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Fab and nanobody	1.442E-02	0.795	61	30	292	317	6	197	379	286	0.830	0.507
LOKIASV2_3899_ESMFold_N-A	6b1u-assembly1.cif.gz_A	6b1u-assembly1.cif.gz_A Structure of full-length human AMPK (a2b1g1) in complex with a small molecule activator SC4	2.074E-02	0.795	61	28	279	317	7	242	442	310	0.795	0.534
LOKIASV2_3899_ESMFold_N-A	3c50-assembly1.cif.gz_A	3c50-assembly1.cif.gz_A Crystal Structure of G protein coupled receptor kinase 1 bound to ADP and magnesium chloride at 2.6A	1.869E-02	0.795	61	9	289	317	107	399	499	376	0.886	0.587
LOKIASV2_3899_ESMFold_N-A	7elw-assembly1.cif.gz_b	7elw-assembly1.cif.gz_b Crystal structure of RNase L in complex with Myricetin	1.969E-02	0.795	61	28	301	317	332	543	676	300	0.864	0.314
LOKIASV2_3899_ESMFold_N-A	1snu-assembly2.cif.gz_B	1snu-assembly2.cif.gz_B CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN	3.309E-02	0.772	60	32	303	317	6	240	241	319	0.858	0.975
LOKIASV2_3899_ESMFold_N-A	4af3-assembly1.cif.gz_A	4af3-assembly1.cif.gz_A Human Aurora B Kinase in complex with INCENP and VX-680	5.014E-02	0.772	60	38	286	317	20	203	253	268	0.785	0.727
LOKIASV2_3899_ESMFold_N-A	3qri-assembly3.cif.gz_B-2	3qri-assembly3.cif.gz_B-2 The crystal structure of human abl1 kinase domain in complex with DCC-2036	1.037E-01	0.772	60	32	296	317	11	261	262	336	0.836	0.958
LOKIASV2_3899_ESMFold_N-A	6npv-assembly1.cif.gz_A	6npv-assembly1.cif.gz_A C-abl Kinase domain with the activator(cmpd51), N-(1-(3,4-dichlorophenyl)-4-(2-hydroxyethyl)-4,5-dihydro-1H-pyrazol-3-yl)isonicotinamide	8.427E-02	0.772	60	32	298	317	11	263	264	340	0.842	0.958
LOKIASV2_3899_ESMFold_N-A	5l6o-assembly1.cif.gz_A	5l6o-assembly1.cif.gz_A EphB3 kinase domain covalently bound to an irreversible inhibitor (compound 3)	8.427E-02	0.772	60	29	315	317	1	259	267	340	0.905	0.970
LOKIASV2_3899_ESMFold_N-A	5o2b-assembly1.cif.gz_A	5o2b-assembly1.cif.gz_A Crystal structure of WNK3 kinase domain in a diphosphorylated state and in a complex with the inhibitor PP-121	2.074E-02	0.772	60	34	289	317	22	196	269	269	0.808	0.651
LOKIASV2_3899_ESMFold_N-A	4nka-assembly1.cif.gz_A	4nka-assembly1.cif.gz_A Crystal structure of human fibroblast growth factor receptor 1 kinase domain in complex with pyrazolaminopyrimidine 2	2.074E-02	0.772	60	28	309	317	13	274	279	339	0.890	0.939
LOKIASV2_3899_ESMFold_N-A	4a07-assembly1.cif.gz_A	4a07-assembly1.cif.gz_A Human PDK1 Kinase Domain in Complex with Allosteric Activator PS171 Bound to the PIF-Pocket	5.014E-02	0.772	60	30	292	317	7	240	283	322	0.830	0.827
LOKIASV2_3899_ESMFold_N-A	5j5t-assembly1.cif.gz_A-2	5j5t-assembly1.cif.gz_A-2 GLK co-crystal structure with aminopyrrolopyrimidine inhibitor	1.093E-01	0.772	60	30	289	317	5	193	298	280	0.820	0.634
LOKIASV2_3899_ESMFold_N-A	5g6v-assembly1.cif.gz_A	5g6v-assembly1.cif.gz_A Crystal structure of the PCTAIRE1 kinase in complex with inhibitor	3.309E-02	0.772	60	31	283	317	1	210	308	290	0.798	0.682
LOKIASV2_3899_ESMFold_N-A	4imy-assembly1.cif.gz_A	4imy-assembly1.cif.gz_A The AFF4 scaffold binds human P-TEFb adjacent to HIV Tat	1.345E-01	0.772	60	27	283	317	9	228	315	300	0.811	0.698
LOKIASV2_3899_ESMFold_N-A	4ae6-assembly2.cif.gz_B	4ae6-assembly2.cif.gz_B Structure and Function of the Human Sperm-Specific Isoform of Protein Kinase A (PKA) Catalytic Subunit Calpha 2	2.832E-02	0.772	60	15	292	317	2	257	323	333	0.877	0.793
LOKIASV2_3899_ESMFold_N-A	4ump-assembly2.cif.gz_B	4ump-assembly2.cif.gz_B Structure of MELK in complex with inhibitors	3.867E-02	0.772	60	21	317	317	4	252	324	345	0.937	0.769
LOKIASV2_3899_ESMFold_N-A	3pze-assembly1.cif.gz_A	3pze-assembly1.cif.gz_A JNK1 in complex with inhibitor	7.596E-02	0.772	60	28	283	317	18	224	347	286	0.808	0.597
LOKIASV2_3899_ESMFold_N-A	5lw1-assembly3.cif.gz_H	5lw1-assembly3.cif.gz_H Crystal structure of DARPin-DARPin rigid fusion, variant DD_232_11_D12 in complex JNK1a1 and JIP1 peptide	1.277E-01	0.772	60	28	141	317	17	136	355	127	0.360	0.338
LOKIASV2_3899_ESMFold_N-A	6z55-assembly2.cif.gz_B	6z55-assembly2.cif.gz_B Crystal structure of CLK3 in complex with macrocycle ODS2004070	4.760E-02	0.772	60	29	283	317	28	261	357	308	0.804	0.655
LOKIASV2_3899_ESMFold_N-A	6w3c-assembly2.cif.gz_B	6w3c-assembly2.cif.gz_B Structure of phosphorylated apo IRE1	9.848E-02	0.772	60	29	152	317	1	133	404	144	0.391	0.329
LOKIASV2_3899_ESMFold_N-A	3q5i-assembly1.cif.gz_A	3q5i-assembly1.cif.gz_A Crystal Structure of PBANKA_031420	6.171E-02	0.772	60	7	310	317	19	281	470	359	0.959	0.560
LOKIASV2_3899_ESMFold_N-A	3uqc-assembly1.cif.gz_C	3uqc-assembly1.cif.gz_C Structure of the Intracellular Kinase Homology Domain of Rv3910 at 2.2 A resolution	3.671E-02	0.747	59	40	303	317	31	247	250	300	0.833	0.868
LOKIASV2_3899_ESMFold_N-A	3dk6-assembly2.cif.gz_B	3dk6-assembly2.cif.gz_B Crystal structure of mutant ABL kinase domain in complex with small molecule fragment	1.345E-01	0.747	59	32	298	317	9	254	260	333	0.842	0.946
LOKIASV2_3899_ESMFold_N-A	5tx5-assembly1.cif.gz_B	5tx5-assembly1.cif.gz_B Rip1 Kinase ( flag 1-294, C34A, C127A, C233A, C240A) with GSK772	3.309E-02	0.747	59	34	291	317	9	192	263	285	0.814	0.700
LOKIASV2_3899_ESMFold_N-A	2g2f-assembly2.cif.gz_B	2g2f-assembly2.cif.gz_B A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain	7.596E-02	0.747	59	27	298	317	6	261	264	335	0.858	0.970
LOKIASV2_3899_ESMFold_N-A	5vja-assembly1.cif.gz_A	5vja-assembly1.cif.gz_A Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	3.671E-02	0.747	59	27	289	317	4	245	266	315	0.830	0.910
LOKIASV2_3899_ESMFold_N-A	6vrf-assembly2.cif.gz_B	6vrf-assembly2.cif.gz_B ADP bound TTBK2 kinase domain	2.931E-01	0.747	59	29	152	317	12	134	287	137	0.391	0.429
LOKIASV2_3899_ESMFold_N-A	7jxy-assembly2.cif.gz_B	7jxy-assembly2.cif.gz_B Structure of TTBK1 kinase domain in complex with Compound 18	2.184E-02	0.747	59	27	313	317	12	235	288	317	0.905	0.778
LOKIASV2_3899_ESMFold_N-A	4twc-assembly1.cif.gz_A	4twc-assembly1.cif.gz_A 2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4- carboxamide derivatives as potent inhibitors of CK1d/e	3.142E-02	0.747	59	28	314	317	6	275	293	351	0.905	0.922
LOKIASV2_3899_ESMFold_N-A	2iw9-assembly2.cif.gz_A	2iw9-assembly2.cif.gz_A STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR	1.037E-01	0.747	59	27	283	317	2	214	294	299	0.811	0.724
LOKIASV2_3899_ESMFold_N-A	2cci-assembly2.cif.gz_C	2cci-assembly2.cif.gz_C Crystal structure of phospho-CDK2 Cyclin A in complex with a peptide containing both the substrate and recruitment sites of CDC6	1.655E-01	0.747	59	27	280	317	2	217	297	296	0.801	0.727
LOKIASV2_3899_ESMFold_N-A	4eom-assembly1.cif.gz_A	4eom-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 H84S, Q85M, Q131E - human cyclin A3 complex with ATP	1.037E-01	0.747	59	29	283	317	7	217	297	296	0.804	0.710
LOKIASV2_3899_ESMFold_N-A	4d2p-assembly2.cif.gz_D	4d2p-assembly2.cif.gz_D Structure of MELK in complex with inhibitors	1.442E-02	0.747	59	20	279	317	4	237	317	313	0.820	0.738
LOKIASV2_3899_ESMFold_N-A	3txo-assembly1.cif.gz_A	3txo-assembly1.cif.gz_A PKC eta kinase in complex with a naphthyridine	5.014E-02	0.747	59	28	292	317	1	186	318	287	0.836	0.585
LOKIASV2_3899_ESMFold_N-A	6khd-assembly2.cif.gz_B	6khd-assembly2.cif.gz_B Crystal structure of CLK1 in complex with CX-4945	7.212E-02	0.747	59	27	284	317	10	243	332	317	0.814	0.705
LOKIASV2_3899_ESMFold_N-A	6so1-assembly1.cif.gz_A	6so1-assembly1.cif.gz_A Fragment N13569a in complex with MAP kinase p38-alpha	3.485E-02	0.747	59	28	283	317	18	228	343	299	0.808	0.615
LOKIASV2_3899_ESMFold_N-A	6w39-assembly1.cif.gz_B	6w39-assembly1.cif.gz_B Structure of unphosphorylated IRE1 in complex with G-1749	3.671E-02	0.747	59	28	289	317	5	226	374	310	0.826	0.594
LOKIASV2_3899_ESMFold_N-A	3upx-assembly1.cif.gz_A	3upx-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with inhibitor UW1300	3.671E-02	0.747	59	27	308	317	5	339	445	413	0.890	0.753
LOKIASV2_3899_ESMFold_N-A	2acx-assembly1.cif.gz_B	2acx-assembly1.cif.gz_B Crystal Structure of G protein coupled receptor kinase 6 bound to AMPPNP	3.142E-02	0.747	59	29	311	317	167	430	492	345	0.893	0.537
LOKIASV2_3899_ESMFold_N-A	4oav-assembly1.cif.gz_D	4oav-assembly1.cif.gz_D Complete human RNase L in complex with 2-5A (5'-ppp heptamer), AMPPCP and RNA substrate.	9.848E-02	0.747	59	28	302	317	334	539	674	289	0.868	0.306
LOKIASV2_3899_ESMFold_N-A	3w10-assembly1.cif.gz_A	3w10-assembly1.cif.gz_A Aurora kinase A complexed to pyrazole aminoquinoline I	5.562E-02	0.720	58	28	289	317	6	197	263	279	0.826	0.730
LOKIASV2_3899_ESMFold_N-A	2y4p-assembly1.cif.gz_C	2y4p-assembly1.cif.gz_C Dimeric structure of DAPK-1 catalytic domain	1.151E-01	0.720	58	26	279	317	8	244	264	308	0.801	0.898
LOKIASV2_3899_ESMFold_N-A	3bqr-assembly1.cif.gz_A-2	3bqr-assembly1.cif.gz_A-2 Crystal structure of human death associated protein kinase 3 (DAPK3) in complex with an imidazo-pyridazine ligand	1.935E-01	0.720	58	26	289	317	3	247	275	321	0.833	0.891
LOKIASV2_3899_ESMFold_N-A	3wf6-assembly1.cif.gz_A	3wf6-assembly1.cif.gz_A Crystal structure of S6K1 kinase domain in complex with a pyrazolopyrimidine derivative 4-[4-(1H-indol-3-yl)-3,6-dihydropyridin-1(2H)-yl]-1H-pyrazolo[3,4-d]pyrimidine	1.037E-01	0.720	58	30	279	317	7	232	278	310	0.789	0.813
LOKIASV2_3899_ESMFold_N-A	6vpj-assembly1.cif.gz_A-2	6vpj-assembly1.cif.gz_A-2 TPX2 residues 7-20 fused to Aurora A residues 116-389 C247V + C319V double mutant dephosphorylated, and in complex with AMP-PNP	2.552E-02	0.720	58	1	310	317	1	276	279	374	0.978	0.989
LOKIASV2_3899_ESMFold_N-A	7ovm-assembly1.cif.gz_A	7ovm-assembly1.cif.gz_A Protein kinase MKK7 in complex with cyclobutyl-substituted indazole	5.859E-02	0.720	58	28	277	317	17	214	282	273	0.789	0.702
LOKIASV2_3899_ESMFold_N-A	7r9t-assembly1.cif.gz_B	7r9t-assembly1.cif.gz_B Crystal structure of HPK1 in complex with compound 17	7.212E-02	0.720	58	24	289	317	10	199	285	287	0.839	0.667
LOKIASV2_3899_ESMFold_N-A	6tia-assembly2.cif.gz_B	6tia-assembly2.cif.gz_B IRAK4 IN COMPLEX WITH inhibitor	6.847E-02	0.720	58	40	311	317	37	286	287	330	0.858	0.871
LOKIASV2_3899_ESMFold_N-A	6cqd-assembly1.cif.gz_A	6cqd-assembly1.cif.gz_A Crystal structure of HPK1 in complex with ATP analogue (AMPPNP)	4.290E-02	0.720	58	28	289	317	14	203	289	294	0.826	0.657
LOKIASV2_3899_ESMFold_N-A	6fex-assembly1.cif.gz_A	6fex-assembly1.cif.gz_A DDR1, 2-[4-bromo-2-oxo-1'-(1H-pyrazolo[4,3-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide, 1.291A, P212121, Rfree=17.4%	8.001E-02	0.720	58	30	278	317	9	238	289	314	0.785	0.796
LOKIASV2_3899_ESMFold_N-A	5twy-assembly2.cif.gz_B	5twy-assembly2.cif.gz_B Structure of Maternal Embryonic Leucine Zipper Kinase	4.073E-02	0.720	58	9	317	317	1	235	306	353	0.975	0.768
LOKIASV2_3899_ESMFold_N-A	4ra5-assembly1.cif.gz_B	4ra5-assembly1.cif.gz_B Human Protein Kinase C THETA IN COMPLEX WITH LIGAND COMPOUND 11a (6-[(1,3-Dimethyl-azetidin-3-yl)-methyl-amino]-4(R)-methyl-7-phenyl-2,10-dihydro-9-oxa-1,2,4a-triaza-phenanthren-3-one)	1.151E-01	0.720	58	27	292	317	3	239	312	316	0.839	0.760
LOKIASV2_3899_ESMFold_N-A	6ise-assembly2.cif.gz_A	6ise-assembly2.cif.gz_A Crystal structure of AMPPNP bound CK2 alpha from C. neoformans	1.345E-01	0.720	58	4	276	317	21	268	327	340	0.861	0.758
LOKIASV2_3899_ESMFold_N-A	3qkk-assembly1.cif.gz_A	3qkk-assembly1.cif.gz_A Spirochromane Akt Inhibitors	6.500E-02	0.720	58	28	302	317	5	276	327	346	0.868	0.832
LOKIASV2_3899_ESMFold_N-A	4xhl-assembly1.cif.gz_A	4xhl-assembly1.cif.gz_A Structure of S. cerevisiae Hrr25 1-394 (K38R mutant)	3.309E-02	0.720	58	28	315	317	3	304	330	388	0.909	0.915
LOKIASV2_3899_ESMFold_N-A	6q2a-assembly13.cif.gz_M	6q2a-assembly13.cif.gz_M Trypanosoma brucei CLK1 kinase domain in complex with a covalent aminobenzimidazole inhibitor AB1	6.500E-02	0.720	58	28	315	317	1	328	339	402	0.909	0.968
LOKIASV2_3899_ESMFold_N-A	2x7g-assembly1.cif.gz_A	2x7g-assembly1.cif.gz_A Structure of human serine-arginine-rich protein-specific kinase 2 (SRPK2) bound to purvalanol B	3.608E-01	0.720	58	29	143	317	11	138	344	131	0.363	0.372
LOKIASV2_3899_ESMFold_N-A	5myv-assembly3.cif.gz_C	5myv-assembly3.cif.gz_C Crystal structure of SRPK2 in complex with compound 1	3.252E-01	0.720	58	29	143	317	13	140	348	133	0.363	0.368
LOKIASV2_3899_ESMFold_N-A	6fyk-assembly2.cif.gz_B	6fyk-assembly2.cif.gz_B X-Ray structure of CLK2-KD(136-496)/Indazole1 at 2.39A	8.427E-02	0.720	58	29	289	317	26	238	349	301	0.823	0.610
LOKIASV2_3899_ESMFold_N-A	4qfg-assembly1.cif.gz_A	4qfg-assembly1.cif.gz_A Structure of AMPK in complex with STAUROSPORINE inhibitor and in the absence of a synthetic activator	5.859E-02	0.720	58	28	279	317	6	241	366	309	0.795	0.645
LOKIASV2_3899_ESMFold_N-A	4z7g-assembly1.cif.gz_A	4z7g-assembly1.cif.gz_A Crystal structure of human IRE1 cytoplasmic kinase-RNase region - apo	7.212E-02	0.720	58	33	292	317	14	225	366	295	0.820	0.579
LOKIASV2_3899_ESMFold_N-A	5cyz-assembly1.cif.gz_A	5cyz-assembly1.cif.gz_A Structure of S. cerevisiae Hrr25:Mam1 complex, form 1	2.983E-02	0.720	58	8	314	317	1	278	369	373	0.968	0.753
LOKIASV2_3899_ESMFold_N-A	5w80-assembly1.cif.gz_A	5w80-assembly1.cif.gz_A Toxoplasma Gondii CDPK1 in complex with inhibitor GXJ-237	4.519E-02	0.720	58	27	315	317	5	287	453	360	0.912	0.625
LOKIASV2_3899_ESMFold_N-A	4wbo-assembly4.cif.gz_D	4wbo-assembly4.cif.gz_D Bovine G Protein Coupled Receptor Kinase 1 in Complex with Amlexanox	5.281E-02	0.720	58	12	276	317	131	372	491	325	0.836	0.493
LOKIASV2_3899_ESMFold_N-A	4pni-assembly1.cif.gz_A-2	4pni-assembly1.cif.gz_A-2 Bovine G protein-coupled receptor kinase 1 in complex with GSK2163632A	3.309E-02	0.720	58	12	289	317	136	399	492	346	0.877	0.537
LOKIASV2_3899_ESMFold_N-A	4l9i-assembly1.cif.gz_B	4l9i-assembly1.cif.gz_B Bovine G Protein Coupled Receptor Kinase 1 in Complex with Paroxetine	4.290E-02	0.720	58	12	275	317	135	372	493	321	0.833	0.483
LOKIASV2_3899_ESMFold_N-A	3pvw-assembly1.cif.gz_A	3pvw-assembly1.cif.gz_A Bovine GRK2 in complex with Gbetagamma subunits and a selective kinase inhibitor (CMPD103A)	3.142E-02	0.720	58	4	292	317	151	400	613	346	0.912	0.408
LOKIASV2_3899_ESMFold_N-A	8em8-assembly1.cif.gz_A	8em8-assembly1.cif.gz_A Co-crystal structure of the cGMP-dependent protein kinase PKG from Plasmodium falciparum in complex with RY-1-165	1.774E-02	0.720	58	11	279	317	482	736	779	326	0.849	0.327
LOKIASV2_3899_ESMFold_N-A	3hyh-assembly3.cif.gz_B	3hyh-assembly3.cif.gz_B Crystal structure of the protein kinase domain of yeast AMP-activated protein kinase Snf1	5.014E-02	0.692	57	31	279	317	11	205	233	282	0.785	0.837
LOKIASV2_3899_ESMFold_N-A	2hyy-assembly1.cif.gz_A	2hyy-assembly1.cif.gz_A Human Abl kinase domain in complex with imatinib (STI571, Glivec)	8.001E-02	0.692	57	32	295	317	8	261	263	330	0.833	0.966
LOKIASV2_3899_ESMFold_N-A	3rny-assembly3.cif.gz_B	3rny-assembly3.cif.gz_B Crystal structure of human RSK1 C-terminal kinase domain	8.001E-02	0.692	57	46	303	317	13	241	271	317	0.814	0.845
LOKIASV2_3899_ESMFold_N-A	6qg4-assembly1.cif.gz_A	6qg4-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidine inhibitor 1h	4.519E-02	0.692	57	32	277	317	18	205	272	270	0.776	0.691
LOKIASV2_3899_ESMFold_N-A	5l6p-assembly1.cif.gz_A	5l6p-assembly1.cif.gz_A EphB3 kinase domain covalently bound to an irreversible inhibitor (compound 6)	1.037E-01	0.692	57	30	315	317	16	266	274	337	0.902	0.916
LOKIASV2_3899_ESMFold_N-A	4ct2-assembly1.cif.gz_A	4ct2-assembly1.cif.gz_A Human PDK1-PKCzeta Kinase Chimera	8.001E-02	0.692	57	30	289	317	7	194	278	281	0.820	0.676
LOKIASV2_3899_ESMFold_N-A	7qr9-assembly4.cif.gz_D	7qr9-assembly4.cif.gz_D Crystal structure of CK1 delta in complex with PK-09-82	3.485E-02	0.692	57	28	314	317	5	266	283	342	0.905	0.926
LOKIASV2_3899_ESMFold_N-A	6rcg-assembly1.cif.gz_A	6rcg-assembly1.cif.gz_A Crystal structure of Casein kinase 1 delta (CK1 delta) complexed with SR3029 inhibitor	5.859E-02	0.692	57	28	314	317	9	279	295	354	0.905	0.919
LOKIASV2_3899_ESMFold_N-A	3uc4-assembly1.cif.gz_A	3uc4-assembly1.cif.gz_A The crystal structure of Snf1-related kinase 2.6	3.367E-03	0.692	57	26	274	317	6	264	295	296	0.785	0.878
LOKIASV2_3899_ESMFold_N-A	7egb-assembly1.cif.gz_8	7egb-assembly1.cif.gz_8 TFIID-based holo PIC on SCP promoter	1.744E-01	0.692	57	28	283	317	1	213	298	294	0.808	0.715
LOKIASV2_3899_ESMFold_N-A	2yaa-assembly1.cif.gz_B	2yaa-assembly1.cif.gz_B Crystal structure of the autoinhibited form of mouse DAPK2 in complex with ATP	3.142E-02	0.692	57	26	317	317	7	277	299	355	0.921	0.906
LOKIASV2_3899_ESMFold_N-A	1fot-assembly1.cif.gz_A	1fot-assembly1.cif.gz_A STRUCTURE OF THE UNLIGANDED CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT FROM SACCHAROMYCES CEREVISIAE	2.074E-02	0.692	57	30	300	317	6	236	300	313	0.855	0.770
LOKIASV2_3899_ESMFold_N-A	2r7i-assembly3.cif.gz_C	2r7i-assembly3.cif.gz_C Crystal structure of catalytic subunit of protein kinase CK2	8.877E-02	0.692	57	21	283	317	20	238	321	303	0.830	0.682
LOKIASV2_3899_ESMFold_N-A	1cm8-assembly2.cif.gz_B	1cm8-assembly2.cif.gz_B PHOSPHORYLATED MAP KINASE P38-GAMMA	5.859E-02	0.692	57	29	305	317	1	250	329	333	0.874	0.760
LOKIASV2_3899_ESMFold_N-A	2i0e-assembly1.cif.gz_A	2i0e-assembly1.cif.gz_A Structure of catalytic domain of human protein kinase C beta II complexed with a bisindolylmaleimide inhibitor	4.073E-02	0.692	57	30	307	317	4	271	329	344	0.877	0.815
LOKIASV2_3899_ESMFold_N-A	3mgy-assembly1.cif.gz_A	3mgy-assembly1.cif.gz_A Mutagenesis of p38 MAP Kinase eshtablishes key roles of Phe169 in function and structural dynamics and reveals a novel DFG-out state	3.867E-02	0.692	57	29	283	317	1	214	329	297	0.804	0.650
LOKIASV2_3899_ESMFold_N-A	4loq-assembly3.cif.gz_C	4loq-assembly3.cif.gz_C Structural basis of autoactivation of p38 alpha induced by TAB1 (Tetragonal crystal form with bound sulphate)	3.485E-02	0.692	57	28	291	317	19	216	337	283	0.833	0.588
LOKIASV2_3899_ESMFold_N-A	4lop-assembly3.cif.gz_C	4lop-assembly3.cif.gz_C Structural basis of autoactivation of p38 alpha induced by TAB1 (Tetragonal crystal form)	2.184E-02	0.692	57	30	283	317	22	235	341	300	0.801	0.628
LOKIASV2_3899_ESMFold_N-A	6c9g-assembly1.cif.gz_A	6c9g-assembly1.cif.gz_A AMP-activated protein kinase bound to pharmacological activator R739	3.485E-02	0.692	57	33	279	317	1	241	386	309	0.779	0.624
LOKIASV2_3899_ESMFold_N-A	6w3e-assembly1.cif.gz_B	6w3e-assembly1.cif.gz_B Structure of phosphorylated IRE1 in complex with G-0701	1.417E-01	0.692	57	28	289	317	5	239	389	316	0.826	0.604
LOKIASV2_3899_ESMFold_N-A	5iso-assembly2.cif.gz_C	5iso-assembly2.cif.gz_C STRUCTURE OF FULL LENGTH HUMAN AMPK (NON-PHOSPHORYLATED AT T-LOOP) IN COMPLEX WITH A SMALL MOLECULE ACTIVATOR, A BENZIMIDAZOLE DERIVATIVE (991)	6.500E-02	0.692	57	33	240	317	1	155	429	223	0.656	0.361
LOKIASV2_3899_ESMFold_N-A	4uw0-assembly1.cif.gz_A	4uw0-assembly1.cif.gz_A Low resolution structure of WbdD with C-terminal bundle ordered to residue 505	9.350E-02	0.692	57	29	313	317	216	495	501	355	0.899	0.559
LOKIASV2_3899_ESMFold_N-A	1u4d-assembly2.cif.gz_B	1u4d-assembly2.cif.gz_B Structure of the ACK1 Kinase Domain bound to Debromohymenialdisine	2.381E-01	0.663	56	30	241	317	10	149	262	223	0.669	0.534
LOKIASV2_3899_ESMFold_N-A	6yg3-assembly1.cif.gz_A	6yg3-assembly1.cif.gz_A Crystal structure of MKK7 (MAP2K7) covalently bound with CPT1-70-1	4.519E-02	0.663	56	28	316	317	16	265	265	327	0.912	0.943
LOKIASV2_3899_ESMFold_N-A	3fme-assembly1.cif.gz_A	3fme-assembly1.cif.gz_A Crystal Structure of Human Mitogen-Activated Protein Kinase Kinase 6 (MEK6) Activated Mutant (S207D, T211D)	6.171E-02	0.663	56	29	285	317	9	229	268	303	0.811	0.825
LOKIASV2_3899_ESMFold_N-A	3dk3-assembly2.cif.gz_B	3dk3-assembly2.cif.gz_B Crystal structure of mutant ABL kinase domain in complex with small molecule fragment	1.093E-01	0.663	56	32	311	317	10	262	269	339	0.883	0.941
LOKIASV2_3899_ESMFold_N-A	7t1t-assembly1.cif.gz_A	7t1t-assembly1.cif.gz_A JAK2 JH2 IN COMPLEX WITH JAK292	3.485E-02	0.663	56	32	314	317	10	274	274	340	0.893	0.967
LOKIASV2_3899_ESMFold_N-A	7nzy-assembly3.cif.gz_C	7nzy-assembly3.cif.gz_C Crystal structure of human Casein Kinase I delta in complex with CGS-15943	6.500E-02	0.663	56	28	314	317	5	266	283	347	0.905	0.926
LOKIASV2_3899_ESMFold_N-A	2x2m-assembly1.cif.gz_A	2x2m-assembly1.cif.gz_A Crystal Structure of phosphorylated RET tyrosine kinase domain with inhibitor	1.212E-01	0.663	56	18	306	317	2	286	287	367	0.912	0.993
LOKIASV2_3899_ESMFold_N-A	6bp0-assembly2.cif.gz_B	6bp0-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase 1 bound to (R)-2-phenylaminopteridinone inhibitor	6.500E-02	0.663	56	40	305	317	23	254	304	315	0.839	0.763
LOKIASV2_3899_ESMFold_N-A	3juh-assembly2.cif.gz_B	3juh-assembly2.cif.gz_B Crystal structure of a mutant of human protein kinase CK2alpha with altered cosubstrate specificity	1.492E-01	0.663	56	30	288	317	38	257	334	302	0.817	0.659
LOKIASV2_3899_ESMFold_N-A	5awm-assembly1.cif.gz_A	5awm-assembly1.cif.gz_A The Crystal Structure of JNK from Drosophila melanogaster Reveals an Evolutionarily Conserved Topology with that of Mammalian JNK Proteins.	6.171E-02	0.663	56	29	235	317	1	158	345	233	0.653	0.458
LOKIASV2_3899_ESMFold_N-A	6w3e-assembly1.cif.gz_A	6w3e-assembly1.cif.gz_A Structure of phosphorylated IRE1 in complex with G-0701	8.427E-02	0.663	56	33	289	317	14	221	366	292	0.811	0.568
LOKIASV2_3899_ESMFold_N-A	3lj0-assembly1.cif.gz_A	3lj0-assembly1.cif.gz_A IRE1 complexed with ADP and Quercetin	2.146E-01	0.663	56	28	152	317	7	124	407	133	0.394	0.290
LOKIASV2_3899_ESMFold_N-A	5w9e-assembly1.cif.gz_A	5w9e-assembly1.cif.gz_A Toxoplasma Gondii CDPK1 in complex with inhibitor GXJ-186	6.500E-02	0.663	56	27	315	317	5	286	451	360	0.912	0.625
LOKIASV2_3899_ESMFold_N-A	3t8o-assembly1.cif.gz_A	3t8o-assembly1.cif.gz_A Rhodopsin kinase (GRK1) L166K mutant at 2.5A resolution	4.519E-02	0.663	56	1	283	317	94	376	493	365	0.893	0.574
LOKIASV2_3899_ESMFold_N-A	3zzw-assembly1.cif.gz_B	3zzw-assembly1.cif.gz_B Crystal structure of the kinase domain of ROR2	2.261E-01	0.632	55	32	142	317	8	123	265	129	0.350	0.438
LOKIASV2_3899_ESMFold_N-A	3com-assembly1.cif.gz_A	3com-assembly1.cif.gz_A Crystal structure of Mst1 kinase	1.655E-01	0.632	55	31	303	317	1	265	266	346	0.861	0.996
LOKIASV2_3899_ESMFold_N-A	6cpy-assembly1.cif.gz_A	6cpy-assembly1.cif.gz_A Structure of apo GRMZM2G135359 pseudokinase	2.184E-02	0.632	55	7	290	317	3	274	277	340	0.896	0.982
LOKIASV2_3899_ESMFold_N-A	3alo-assembly1.cif.gz_A	3alo-assembly1.cif.gz_A Crystal structure of human non-phosphorylated MKK4 kinase domain ternary complex with AMP-PNP and p38 peptide	2.074E-02	0.632	55	30	292	317	8	200	289	277	0.830	0.668
LOKIASV2_3899_ESMFold_N-A	7qra-assembly2.cif.gz_B	7qra-assembly2.cif.gz_B Crystal structure of CK1 delta in complex with VN725	5.014E-02	0.632	55	28	314	317	5	272	289	348	0.905	0.927
LOKIASV2_3899_ESMFold_N-A	7qr9-assembly2.cif.gz_B	7qr9-assembly2.cif.gz_B Crystal structure of CK1 delta in complex with PK-09-82	5.281E-02	0.632	55	28	314	317	6	274	291	349	0.905	0.924
LOKIASV2_3899_ESMFold_N-A	4u6r-assembly1.cif.gz_A	4u6r-assembly1.cif.gz_A Crystal structure of human IRE1 cytoplasmic domains in complex with a sulfonamide inhibitor.	1.492E-01	0.632	55	34	292	317	16	252	403	318	0.817	0.588
LOKIASV2_3899_ESMFold_N-A	4qox-assembly1.cif.gz_A	4qox-assembly1.cif.gz_A Crystal Structure of CDPK4 from Plasmodium Falciparum, PF3D7_0717500	7.212E-02	0.632	55	34	307	317	25	275	462	335	0.864	0.543
LOKIASV2_3899_ESMFold_N-A	6m12-assembly1.cif.gz_b	6m12-assembly1.cif.gz_b Crystal Structure of Rnase L in complex with SU11652	6.847E-02	0.632	55	37	317	317	350	557	684	300	0.886	0.304
LOKIASV2_3899_ESMFold_N-A	5ezr-assembly1.cif.gz_A	5ezr-assembly1.cif.gz_A Crystal Structure of PVX_084705 bound to compound	6.500E-02	0.632	55	11	292	317	498	710	803	314	0.890	0.265
LOKIASV2_3899_ESMFold_N-A	5f0a-assembly1.cif.gz_A	5f0a-assembly1.cif.gz_A CRYSTAL STRUCTURE OF PVX_084705 WITH BOUND 1-tert-butyl-3-(3-chlorophenoxy)-1H-pyrazolo[3,4-d]pyrimidin-4-amine INHIBITOR	3.485E-02	0.632	55	11	285	317	503	765	811	342	0.868	0.324
LOKIASV2_3899_ESMFold_N-A	1snx-assembly2.cif.gz_B	1snx-assembly2.cif.gz_B CRYSTAL STRUCTURE OF APO INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN	1.151E-01	0.601	54	32	317	317	10	245	245	325	0.902	0.963
LOKIASV2_3899_ESMFold_N-A	7kx6-assembly2.cif.gz_B	7kx6-assembly2.cif.gz_B Crystal structure of DCLK1-KD in complex with XMD8-85	6.847E-02	0.601	54	25	285	317	4	233	254	310	0.823	0.906
LOKIASV2_3899_ESMFold_N-A	5vd9-assembly1.cif.gz_A	5vd9-assembly1.cif.gz_A Crystal structure of human WEE1 kinase domain in complex with RAC-IV-097, a MK1775 analogue	1.093E-01	0.601	54	27	279	317	5	240	261	311	0.798	0.904
LOKIASV2_3899_ESMFold_N-A	7b32-assembly1.cif.gz_A	7b32-assembly1.cif.gz_A MST3 in complex with MRIA7	1.655E-01	0.601	54	25	312	317	7	262	264	347	0.909	0.970
LOKIASV2_3899_ESMFold_N-A	5nk8-assembly1.cif.gz_A	5nk8-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2f	9.848E-02	0.601	54	32	273	317	9	200	266	281	0.763	0.722
LOKIASV2_3899_ESMFold_N-A	7b36-assembly2.cif.gz_C	7b36-assembly2.cif.gz_C MST4 in complex with compound G-5555	3.485E-02	0.601	54	24	282	317	4	261	267	304	0.817	0.966
LOKIASV2_3899_ESMFold_N-A	2jam-assembly1.cif.gz_A	2jam-assembly1.cif.gz_A Crystal structure of human calmodulin-dependent protein kinase I G	1.837E-01	0.601	54	30	141	317	6	112	279	122	0.353	0.384
LOKIASV2_3899_ESMFold_N-A	6cqh-assembly2.cif.gz_B	6cqh-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase bound to a N-propynyl-N-ethyl-dihydropteridine inhibitor	8.877E-02	0.601	54	30	305	317	16	266	316	332	0.871	0.794
LOKIASV2_3899_ESMFold_N-A	3l8x-assembly1.cif.gz_A	3l8x-assembly1.cif.gz_A P38 alpha kinase complexed with a pyrazolo-pyrimidine based inhibitor	6.847E-02	0.601	54	28	281	317	1	211	326	299	0.801	0.647
LOKIASV2_3899_ESMFold_N-A	8fp1-assembly1.cif.gz_A	8fp1-assembly1.cif.gz_A PKCeta kinase domain in complex with compound 2	6.500E-02	0.601	54	40	299	317	21	247	328	308	0.820	0.692
LOKIASV2_3899_ESMFold_N-A	6z4z-assembly2.cif.gz_B	6z4z-assembly2.cif.gz_B Crystal structure of CLK1 in complex with macrocycle ODS2004070	9.848E-02	0.601	54	27	284	317	13	248	339	319	0.814	0.696
LOKIASV2_3899_ESMFold_N-A	4qp1-assembly1.cif.gz_A	4qp1-assembly1.cif.gz_A Crystal structure of ERK2 in complex with N-cyclohexyl-9H-purin-6-amine	1.417E-01	0.601	54	1	283	317	2	230	342	326	0.893	0.670
LOKIASV2_3899_ESMFold_N-A	3fko-assembly1.cif.gz_A	3fko-assembly1.cif.gz_A P38 kinase crystal structure in complex with RO3668	9.350E-02	0.601	54	28	283	317	18	228	343	295	0.808	0.615
LOKIASV2_3899_ESMFold_N-A	5myv-assembly2.cif.gz_B	5myv-assembly2.cif.gz_B Crystal structure of SRPK2 in complex with compound 1	2.508E-01	0.601	54	29	143	317	13	140	349	139	0.363	0.367
LOKIASV2_3899_ESMFold_N-A	4fr4-assembly1.cif.gz_A	4fr4-assembly1.cif.gz_A Crystal structure of human serine/threonine-protein kinase 32A (YANK1)	5.562E-02	0.601	54	28	289	317	2	248	350	324	0.826	0.706
LOKIASV2_3899_ESMFold_N-A	4z7g-assembly2.cif.gz_B	4z7g-assembly2.cif.gz_B Crystal structure of human IRE1 cytoplasmic kinase-RNase region - apo	1.345E-01	0.601	54	33	307	317	14	242	377	311	0.868	0.607
LOKIASV2_3899_ESMFold_N-A	5dzc-assembly1.cif.gz_A-2	5dzc-assembly1.cif.gz_A-2 Crystal structure of the cGMP-dependent protein kinase PKG from Plasmodium Vivax - AMPPNP bound	4.519E-02	0.601	54	11	285	317	503	765	816	336	0.868	0.322
LOKIASV2_3899_ESMFold_N-A	4qd6-assembly2.cif.gz_B	4qd6-assembly2.cif.gz_B ITK kinase domain in complex with inhibitor compound	1.093E-01	0.569	53	26	303	317	5	240	243	324	0.877	0.971
LOKIASV2_3899_ESMFold_N-A	2pk9-assembly3.cif.gz_C	2pk9-assembly3.cif.gz_C Structure of the Pho85-Pho80 CDK-cyclin Complex of the Phosphate-responsive Signal Transduction Pathway	4.216E-01	0.569	53	42	240	317	10	123	266	199	0.628	0.429
LOKIASV2_3899_ESMFold_N-A	5uq3-assembly1.cif.gz_A	5uq3-assembly1.cif.gz_A Crystal structure of human Cdk2-Spy1-P27 ternary complex	2.038E-01	0.569	53	33	241	317	1	130	270	214	0.659	0.481
LOKIASV2_3899_ESMFold_N-A	7l26-assembly4.cif.gz_D	7l26-assembly4.cif.gz_D HPK1 IN COMPLEX WITH COMPOUND 38	1.212E-01	0.569	53	32	307	317	10	272	275	343	0.871	0.956
LOKIASV2_3899_ESMFold_N-A	5okt-assembly4.cif.gz_D	5okt-assembly4.cif.gz_D Crystal structure of human Casein Kinase I delta in complex with IWP-2	6.171E-02	0.569	53	32	314	317	7	265	282	342	0.893	0.918
LOKIASV2_3899_ESMFold_N-A	2q0b-assembly1.cif.gz_B	2q0b-assembly1.cif.gz_B Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic E565A Mutation Responsible for Pfeiffer Syndrome	5.859E-02	0.569	53	39	311	317	13	281	282	341	0.861	0.954
LOKIASV2_3899_ESMFold_N-A	1s9i-assembly1.cif.gz_B	1s9i-assembly1.cif.gz_B X-ray structure of the human mitogen-activated protein kinase kinase 2 (MEK2)in a complex with ligand and MgATP	7.596E-02	0.569	53	6	312	317	4	287	291	372	0.968	0.976
LOKIASV2_3899_ESMFold_N-A	5r9n-assembly1.cif.gz_A	5r9n-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment N13421a in complex with MAP kinase p38-alpha	1.277E-01	0.569	53	28	152	317	19	144	342	137	0.394	0.368
LOKIASV2_3899_ESMFold_N-A	1wbp-assembly1.cif.gz_A	1wbp-assembly1.cif.gz_A SRPK1 bound to 9mer docking motif peptide	8.877E-02	0.569	53	29	278	317	13	263	350	311	0.789	0.717
LOKIASV2_3899_ESMFold_N-A	3c50-assembly1.cif.gz_B	3c50-assembly1.cif.gz_B Crystal Structure of G protein coupled receptor kinase 1 bound to ADP and magnesium chloride at 2.6A	1.417E-01	0.569	53	16	284	317	139	377	496	321	0.849	0.482
LOKIASV2_3899_ESMFold_N-A	5ukk-assembly1.cif.gz_A	5ukk-assembly1.cif.gz_A Human GRK2 in complex with human G-beta-gamma subunits and CCG211998 (14ak)	3.867E-02	0.569	53	28	317	317	151	429	613	354	0.915	0.455
LOKIASV2_3899_ESMFold_N-A	4yc8-assembly1.cif.gz_A	4yc8-assembly1.cif.gz_A C-Helix-Out Binding of Dasatinib Analog to c-Abl Kinase	1.345E-01	0.537	52	32	315	317	10	256	259	330	0.896	0.954
LOKIASV2_3899_ESMFold_N-A	3otu-assembly1.cif.gz_A	3otu-assembly1.cif.gz_A PDK1 mutant bound to allosteric disulfide fragment activator JS30	6.847E-02	0.537	52	33	289	317	10	235	277	307	0.811	0.816
LOKIASV2_3899_ESMFold_N-A	4qp2-assembly2.cif.gz_B	4qp2-assembly2.cif.gz_B Crystal Structure of ERKs in complex with 5-chlorobenzo[d]oxazol-2-amine	1.572E-01	0.537	52	28	283	317	12	227	329	296	0.808	0.657
LOKIASV2_3899_ESMFold_N-A	6sfo-assembly1.cif.gz_A	6sfo-assembly1.cif.gz_A MAPK14 with bound inhibitor SR-318	5.859E-02	0.537	52	29	283	317	1	219	334	302	0.804	0.656
LOKIASV2_3899_ESMFold_N-A	4xey-assembly2.cif.gz_B	4xey-assembly2.cif.gz_B Crystal structure of an SH2-kinase domain construct of c-Abl tyrosine kinase	1.417E-01	0.537	52	12	307	317	70	331	359	364	0.934	0.730
LOKIASV2_3899_ESMFold_N-A	4ih8-assembly1.cif.gz_A	4ih8-assembly1.cif.gz_A Crystal structure of TgCDPK1 with inhibitor bound	1.492E-01	0.537	52	27	311	317	4	266	433	341	0.899	0.607
LOKIASV2_3899_ESMFold_N-A	3qrj-assembly3.cif.gz_A	3qrj-assembly3.cif.gz_A The crystal structure of human abl1 kinase domain T315I mutant in complex with DCC-2036	3.608E-01	0.505	51	32	279	317	9	214	258	295	0.782	0.798
LOKIASV2_3899_ESMFold_N-A	5oop-assembly1.cif.gz_A	5oop-assembly1.cif.gz_A Structure of CHK1 10-pt. mutant complex with AMP-PNP	2.146E-01	0.505	51	32	240	317	8	144	261	215	0.659	0.525
LOKIASV2_3899_ESMFold_N-A	8c0a-assembly2.cif.gz_B	8c0a-assembly2.cif.gz_B Crystal structure of JAK2 JH2-R683S	5.562E-02	0.505	51	32	312	317	10	272	273	336	0.886	0.963
LOKIASV2_3899_ESMFold_N-A	7ovj-assembly1.cif.gz_A	7ovj-assembly1.cif.gz_A Protein kinase MKK7 in complex with difluoro-phenethyltriazole-substituted pyrazolopyrimidine	1.151E-01	0.505	51	33	277	317	23	206	276	266	0.773	0.667
LOKIASV2_3899_ESMFold_N-A	6f26-assembly1.cif.gz_A	6f26-assembly1.cif.gz_A Crystal structure of human Casein Kinase I delta in complex with compound 31b	1.093E-01	0.505	51	28	314	317	5	264	280	349	0.905	0.929
LOKIASV2_3899_ESMFold_N-A	2ivv-assembly1.cif.gz_A-2	2ivv-assembly1.cif.gz_A-2 Crystal structure of phosphorylated RET tyrosine kinase domain complexed with the inhibitor PP1	5.859E-02	0.505	51	18	307	317	2	277	283	358	0.915	0.975
LOKIASV2_3899_ESMFold_N-A	7ovn-assembly1.cif.gz_A	7ovn-assembly1.cif.gz_A Protein kinase MKK7 in complex with tolyl-substituted indazole	1.345E-01	0.505	51	27	279	317	16	217	283	286	0.798	0.714
LOKIASV2_3899_ESMFold_N-A	6ib0-assembly1.cif.gz_A	6ib0-assembly1.cif.gz_A The structure of MKK7 in complex with the covalent 4-amino-pyrazolopyrimidine 3a	6.847E-02	0.505	51	33	316	317	24	290	290	350	0.896	0.921
LOKIASV2_3899_ESMFold_N-A	6u0k-assembly2.cif.gz_A	6u0k-assembly2.cif.gz_A TTBK2 kinase domain in complex with Compound 1	2.642E-01	0.505	51	27	317	317	11	282	290	359	0.918	0.938
LOKIASV2_3899_ESMFold_N-A	4lmn-assembly1.cif.gz_A	4lmn-assembly1.cif.gz_A Crystal Structure of MEK1 kinase bound to GDC0973	1.345E-01	0.505	51	33	317	317	12	292	292	359	0.899	0.962
LOKIASV2_3899_ESMFold_N-A	4aaa-assembly1.cif.gz_A	4aaa-assembly1.cif.gz_A Crystal structure of the human CDKL2 kinase domain	3.800E-01	0.505	51	32	237	317	9	154	295	219	0.650	0.495
LOKIASV2_3899_ESMFold_N-A	4fr4-assembly2.cif.gz_B	4fr4-assembly2.cif.gz_B Crystal structure of human serine/threonine-protein kinase 32A (YANK1)	1.345E-01	0.505	51	7	299	317	1	254	350	348	0.924	0.726
LOKIASV2_3899_ESMFold_N-A	7bmk-assembly1.cif.gz_B	7bmk-assembly1.cif.gz_B ATP-Competitive Partial Antagonists-'PAIR's-Rheostatically Modulate IRE1alpha's Kinase Helix-alphaC to Segregate its RNase-Mediated Biological Outputs	1.417E-01	0.505	51	33	291	317	1	198	392	294	0.817	0.505
LOKIASV2_3899_ESMFold_N-A	2rio-assembly1.cif.gz_A	2rio-assembly1.cif.gz_A Structure of the dual enzyme Ire1 reveals the basis for catalysis and regulation of non-conventional splicing	2.783E-01	0.505	51	30	152	317	9	125	396	134	0.388	0.295
LOKIASV2_3899_ESMFold_N-A	4m97-assembly1.cif.gz_A	4m97-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Neospora caninum	9.350E-02	0.505	51	26	303	317	5	269	465	345	0.877	0.570
LOKIASV2_3899_ESMFold_N-A	3qc9-assembly2.cif.gz_C	3qc9-assembly2.cif.gz_C Crystal structure of cross-linked bovine GRK1 T8C/N480C double mutant complexed with ADP and Mg	1.345E-01	0.505	51	12	275	317	130	367	482	325	0.833	0.494
LOKIASV2_3899_ESMFold_N-A	3c51-assembly1.cif.gz_A	3c51-assembly1.cif.gz_A Crystal structure of G protein coupled receptor kinase 1 bound to ADP and magnesium chloride at 3.55A	9.848E-02	0.505	51	7	289	317	105	395	487	377	0.893	0.598
LOKIASV2_3899_ESMFold_N-A	2yn8-assembly2.cif.gz_B	2yn8-assembly2.cif.gz_B ephB4 kinase domain inhibitor complex	2.832E-02	0.473	50	26	317	317	6	253	260	333	0.921	0.954
LOKIASV2_3899_ESMFold_N-A	3ujg-assembly1.cif.gz_A	3ujg-assembly1.cif.gz_A Crystal structure of SnRK2.6 in complex with HAB1	1.599E-02	0.473	50	29	303	317	1	287	290	333	0.868	0.990
LOKIASV2_3899_ESMFold_N-A	2jed-assembly2.cif.gz_B	2jed-assembly2.cif.gz_B The crystal structure of the kinase domain of the protein kinase C theta in complex with NVP-XAA228 at 2.32A resolution.	1.572E-01	0.473	50	30	292	317	6	239	322	320	0.830	0.727
LOKIASV2_3899_ESMFold_N-A	3lfb-assembly1.cif.gz_A	3lfb-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with RL98	8.877E-02	0.473	50	28	283	317	19	217	333	285	0.808	0.598
LOKIASV2_3899_ESMFold_N-A	7myj-assembly1.cif.gz_A	7myj-assembly1.cif.gz_A Structure of full length human AMPK (a2b1g1) in complex with a small molecule activator MSG011	1.151E-01	0.473	50	33	284	317	3	221	435	292	0.795	0.503
LOKIASV2_3899_ESMFold_N-A	3n51-assembly1.cif.gz_A	3n51-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with bumped kinase inhibitor RM-1-95	1.171E-02	0.473	50	27	308	317	4	344	448	376	0.890	0.761
LOKIASV2_3899_ESMFold_N-A	4l9i-assembly1.cif.gz_A	4l9i-assembly1.cif.gz_A Bovine G Protein Coupled Receptor Kinase 1 in Complex with Paroxetine	1.492E-01	0.473	50	31	289	317	162	399	504	321	0.817	0.472
LOKIASV2_3899_ESMFold_N-A	5vja-assembly1.cif.gz_D	5vja-assembly1.cif.gz_D Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)	1.492E-01	0.442	49	27	289	317	4	240	261	312	0.830	0.908
LOKIASV2_3899_ESMFold_N-A	7l26-assembly2.cif.gz_B	7l26-assembly2.cif.gz_B HPK1 IN COMPLEX WITH COMPOUND 38	1.212E-01	0.442	49	32	289	317	10	189	275	274	0.814	0.655
LOKIASV2_3899_ESMFold_N-A	7ovl-assembly1.cif.gz_A	7ovl-assembly1.cif.gz_A Protein kinase MKK7 in complex with methoxycyclohexyl-substituted indazole	1.037E-01	0.442	49	32	310	317	19	277	279	337	0.880	0.928
LOKIASV2_3899_ESMFold_N-A	6bru-assembly2.cif.gz_B	6bru-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase bound to a (S)-2-phenylaminopteridinone inhibitor	8.427E-02	0.442	49	40	305	317	23	251	301	312	0.839	0.761
LOKIASV2_3899_ESMFold_N-A	6bu6-assembly2.cif.gz_B	6bu6-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase bound to a bis-difluorophenol-aminopyridine inhibitor	1.277E-01	0.442	49	30	304	317	15	256	307	330	0.868	0.788
LOKIASV2_3899_ESMFold_N-A	4yr8-assembly3.cif.gz_C	4yr8-assembly3.cif.gz_C Crystal structure of JNK in complex with a regulator protein	3.485E-02	0.442	49	28	306	317	12	285	318	355	0.880	0.862
LOKIASV2_3899_ESMFold_N-A	4xhh-assembly1.cif.gz_A	4xhh-assembly1.cif.gz_A Structure of C. glabrata Hrr25, Apo state	1.345E-01	0.442	49	28	279	317	6	223	358	298	0.795	0.609
LOKIASV2_3899_ESMFold_N-A	3i7b-assembly1.cif.gz_A	3i7b-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with bumped kinase inhibitor NM-PP1	1.234E-02	0.442	49	26	312	317	2	347	459	381	0.905	0.754
LOKIASV2_3899_ESMFold_N-A	3qc9-assembly2.cif.gz_B	3qc9-assembly2.cif.gz_B Crystal structure of cross-linked bovine GRK1 T8C/N480C double mutant complexed with ADP and Mg	1.417E-01	0.442	49	13	279	317	117	398	481	358	0.842	0.586
LOKIASV2_3899_ESMFold_N-A	3qc9-assembly1.cif.gz_D	3qc9-assembly1.cif.gz_D Crystal structure of cross-linked bovine GRK1 T8C/N480C double mutant complexed with ADP and Mg	1.345E-01	0.442	49	13	279	317	117	398	486	359	0.842	0.580
LOKIASV2_3899_ESMFold_N-A	8boi-assembly1.cif.gz_A	8boi-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 9	1.572E-01	0.411	48	29	315	317	11	249	269	326	0.905	0.888
LOKIASV2_3899_ESMFold_N-A	6qft-assembly1.cif.gz_A	6qft-assembly1.cif.gz_A Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidin 1b	5.281E-02	0.411	48	28	277	317	16	210	276	273	0.789	0.707
LOKIASV2_3899_ESMFold_N-A	4fzf-assembly1.cif.gz_B	4fzf-assembly1.cif.gz_B Crystal structure of MST4-MO25 complex with DKI	2.783E-01	0.411	48	40	306	317	20	273	279	331	0.842	0.910
LOKIASV2_3899_ESMFold_N-A	7l26-assembly3.cif.gz_C	7l26-assembly3.cif.gz_C HPK1 IN COMPLEX WITH COMPOUND 38	2.508E-01	0.411	48	24	289	317	6	194	280	273	0.839	0.675
LOKIASV2_3899_ESMFold_N-A	5amn-assembly1.cif.gz_A-2	5amn-assembly1.cif.gz_A-2 The Discovery of 2-Substituted Phenol Quinazolines as Potent and Selective RET Kinase Inhibitors	8.001E-02	0.411	48	16	307	317	2	284	289	360	0.921	0.979
LOKIASV2_3899_ESMFold_N-A	5myv-assembly1.cif.gz_A	5myv-assembly1.cif.gz_A Crystal structure of SRPK2 in complex with compound 1	1.212E-01	0.411	48	29	289	317	13	280	352	331	0.823	0.761
LOKIASV2_3899_ESMFold_N-A	5toe-assembly1.cif.gz_A	5toe-assembly1.cif.gz_A Pim-1 kinase in complex with a 7-azaindole	3.800E-01	0.382	47	27	289	317	2	237	272	323	0.830	0.868
LOKIASV2_3899_ESMFold_N-A	5nk5-assembly1.cif.gz_A	5nk5-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 1m	1.572E-01	0.382	47	32	270	317	9	215	287	287	0.754	0.721
LOKIASV2_3899_ESMFold_N-A	5f9e-assembly2.cif.gz_B	5f9e-assembly2.cif.gz_B Structure of Protein Kinase C theta with compound 10: 2,2-dimethyl-7-(2-oxidanylidene-3~{H}-imidazo[4,5-b]pyridin-1-yl)-1-(phenylmethyl)-3~{H}-quinazolin-4-one	2.783E-01	0.382	47	30	292	317	6	239	294	315	0.830	0.796
LOKIASV2_3899_ESMFold_N-A	6dd4-assembly2.cif.gz_B	6dd4-assembly2.cif.gz_B Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropyl-dihydropteridine inhibitor	2.038E-01	0.382	47	34	305	317	20	259	309	324	0.858	0.777
LOKIASV2_3899_ESMFold_N-A	3c4w-assembly1.cif.gz_B	3c4w-assembly1.cif.gz_B Crystal Structure of G protein coupled receptor kinase 1 bound to ATP and magnesium chloride at 2.7A	2.146E-01	0.382	47	13	279	317	141	422	519	355	0.842	0.543
LOKIASV2_3899_ESMFold_N-A	6zwo-assembly1.cif.gz_B	6zwo-assembly1.cif.gz_B cryo-EM structure of human mTOR complex 2, focused on one half	2.300E-02	0.382	47	28	310	317	1248	1525	1592	334	0.893	0.175
LOKIASV2_3899_ESMFold_N-A	7nfe-assembly1.cif.gz_A	7nfe-assembly1.cif.gz_A Cryo-EM structure of NHEJ super-complex (monomer)	1.774E-02	0.382	47	31	311	317	3166	3452	3585	344	0.886	0.080
LOKIASV2_3899_ESMFold_N-A	3dy7-assembly1.cif.gz_A	3dy7-assembly1.cif.gz_A X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) in a complex with ligand and MgATP	6.171E-02	0.353	46	31	285	317	9	194	260	279	0.804	0.715
LOKIASV2_3899_ESMFold_N-A	8ex2-assembly1.cif.gz_A	8ex2-assembly1.cif.gz_A Crystal structure of JAK2 JH2 (pseudokinase domain) in complex with HTSA3	6.171E-02	0.353	46	28	279	317	13	270	273	303	0.795	0.945
LOKIASV2_3899_ESMFold_N-A	4q9z-assembly1.cif.gz_B	4q9z-assembly1.cif.gz_B Human Protein Kinase C Theta in Complex with Compound35 ((1R)-9-(AZETIDIN-3-YLAMINO)-1,8-DIMETHYL-3,5-DIHYDRO[1,2,4]TRIAZINO[3,4-C][1,4]BENZOXAZIN-2(1H)-ONE)	3.252E-01	0.353	46	27	289	317	4	241	309	327	0.830	0.770
LOKIASV2_3899_ESMFold_N-A	6ohd-assembly1.cif.gz_A	6ohd-assembly1.cif.gz_A P38 in complex with T-3220137	1.037E-01	0.353	46	28	283	317	1	215	330	300	0.808	0.652
LOKIASV2_3899_ESMFold_N-A	3c4w-assembly1.cif.gz_A	3c4w-assembly1.cif.gz_A Crystal Structure of G protein coupled receptor kinase 1 bound to ATP and magnesium chloride at 2.7A	3.087E-01	0.353	46	12	279	317	135	398	494	343	0.845	0.534
LOKIASV2_3899_ESMFold_N-A	4ppc-assembly3.cif.gz_A	4ppc-assembly3.cif.gz_A ITK kinase domain with compound 27 (N-{1-[(1R)-3-(DIMETHYLAMINO)-1-PHENYLPROPYL]-1H-PYRAZOL-4-YL}-6-(1H-PYRAZOL-4-YL)-1H-INDAZOLE-3-CARBOXAMIDE)	4.216E-01	0.326	45	32	303	317	8	230	233	318	0.858	0.957
LOKIASV2_3899_ESMFold_N-A	7l24-assembly4.cif.gz_D	7l24-assembly4.cif.gz_D HPK1 IN COMPLEX WITH COMPOUND 11	4.003E-01	0.326	45	32	292	317	10	190	274	277	0.823	0.661
LOKIASV2_3899_ESMFold_N-A	3e92-assembly1.cif.gz_A	3e92-assembly1.cif.gz_A Crystal Structure of P38 Kinase in Complex with A Biaryl Amide Inhibitor	1.837E-01	0.326	45	28	283	317	20	234	349	304	0.808	0.616
LOKIASV2_3899_ESMFold_N-A	5jms-assembly1.cif.gz_A	5jms-assembly1.cif.gz_A Crystal structure of TgCDPK1 bound to CGP060476	2.983E-02	0.326	45	27	308	317	5	339	447	367	0.890	0.749
LOKIASV2_3899_ESMFold_N-A	3c4z-assembly1.cif.gz_A-2	3c4z-assembly1.cif.gz_A-2 Crystal structure of G protein coupled receptor kinase 1 bound to ADP and magnesium chloride at 1.84A	5.562E-02	0.326	45	37	279	317	163	395	493	303	0.767	0.473
LOKIASV2_3899_ESMFold_N-A	5dyk-assembly1.cif.gz_A	5dyk-assembly1.cif.gz_A Crystal structure of the cGMP-dependent protein kinase PKG from Plasmodium falciparum - Apo form	1.093E-01	0.326	45	11	279	317	500	755	809	327	0.849	0.316
LOKIASV2_3899_ESMFold_N-A	6ib2-assembly1.cif.gz_A	6ib2-assembly1.cif.gz_A The structure of MKK7 in complex with the covalent 4-amino-pyrazolopyrimidine 4a	2.642E-01	0.301	44	32	275	317	19	198	265	264	0.770	0.679
LOKIASV2_3899_ESMFold_N-A	2hzn-assembly1.cif.gz_A	2hzn-assembly1.cif.gz_A Abl kinase domain in complex with NVP-AFG210	6.388E-01	0.301	44	1	140	317	1	125	272	157	0.442	0.460
LOKIASV2_3899_ESMFold_N-A	6ath-assembly1.cif.gz_A	6ath-assembly1.cif.gz_A Cdk2/cyclin A/p27-KID-deltaC	4.216E-01	0.301	44	50	283	317	13	197	278	270	0.738	0.665
LOKIASV2_3899_ESMFold_N-A	7be5-assembly1.cif.gz_A	7be5-assembly1.cif.gz_A Crystal structure of MAP kinase p38 alpha in complex with inhibitor SR276	1.093E-01	0.301	44	30	300	317	21	240	329	308	0.855	0.669
LOKIASV2_3899_ESMFold_N-A	3t3u-assembly1.cif.gz_A	3t3u-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with Bumped Kinase Inhibitor, RM-1-130	3.485E-02	0.301	44	27	308	317	4	344	452	377	0.890	0.754
LOKIASV2_3899_ESMFold_N-A	4ebw-assembly1.cif.gz_A	4ebw-assembly1.cif.gz_A Structure of Focal Adhesion Kinase catalytic domain in complex with novel allosteric inhibitor	9.678E-01	0.277	43	30	140	317	12	125	259	123	0.350	0.440
LOKIASV2_3899_ESMFold_N-A	3uc4-assembly2.cif.gz_B	3uc4-assembly2.cif.gz_B The crystal structure of Snf1-related kinase 2.6	5.014E-02	0.277	43	28	279	317	5	272	277	309	0.795	0.968
LOKIASV2_3899_ESMFold_N-A	7r9p-assembly1.cif.gz_A	7r9p-assembly1.cif.gz_A Crystal structure of HPK1 in complex with compound 14	4.678E-01	0.277	43	32	289	317	13	201	287	286	0.814	0.659
LOKIASV2_3899_ESMFold_N-A	3hv6-assembly1.cif.gz_A	3hv6-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with RL39	2.038E-01	0.277	43	28	283	317	19	216	331	289	0.808	0.598
LOKIASV2_3899_ESMFold_N-A	4pl5-assembly2.cif.gz_C	4pl5-assembly2.cif.gz_C Crystal structure of murine IRE1 in complex with OICR573 inhibitor	8.282E-01	0.277	43	28	145	317	6	123	386	131	0.372	0.306
LOKIASV2_3899_ESMFold_N-A	5w8r-assembly1.cif.gz_A	5w8r-assembly1.cif.gz_A Toxoplasma Gondii CDPK1 in complex with inhibitor 3CIB-PPI	3.671E-02	0.277	43	27	308	317	5	343	456	376	0.890	0.743
LOKIASV2_3899_ESMFold_N-A	3o0g-assembly2.cif.gz_B	3o0g-assembly2.cif.gz_B Crystal Structure of Cdk5:p25 in complex with an ATP analogue	7.087E-01	0.254	42	41	283	317	7	193	264	275	0.767	0.708
LOKIASV2_3899_ESMFold_N-A	4yzd-assembly3.cif.gz_C	4yzd-assembly3.cif.gz_C Crystal Structure of human phosphorylated IRE1alpha in complex with ADP-Mg	6.065E-01	0.254	42	28	300	317	5	230	379	313	0.861	0.596
LOKIASV2_3899_ESMFold_N-A	6zha-assembly1.cif.gz_A	6zha-assembly1.cif.gz_A Cryo-EM structure of DNA-PK monomer	4.760E-02	0.254	42	31	275	317	3276	3570	3707	332	0.773	0.080
LOKIASV2_3899_ESMFold_N-A	4ihp-assembly1.cif.gz_A	4ihp-assembly1.cif.gz_A Crystal structure of TgCDPK1 with inhibitor bound	6.171E-02	0.233	41	27	317	317	5	349	454	379	0.918	0.760
LOKIASV2_3899_ESMFold_N-A	7k10-assembly1.cif.gz_A	7k10-assembly1.cif.gz_A CryoEM structure of activated-form FATKIN domain of DNA-PK	1.969E-02	0.233	41	31	274	317	856	1146	1259	324	0.770	0.231
LOKIASV2_3899_ESMFold_N-A	7khj-assembly2.cif.gz_B	7khj-assembly2.cif.gz_B Crystal structure of KIT kinase domain with a small molecule inhibitor, PLX8512 in the DFG-in state	5.466E-01	0.214	40	27	303	317	16	259	261	330	0.874	0.935
LOKIASV2_3899_ESMFold_N-A	7khk-assembly2.cif.gz_B	7khk-assembly2.cif.gz_B Crystal structure of KIT kinase domain with a small molecule inhibitor, PLX9486 (bezuclastinib) in the DFG-in state	9.188E-01	0.214	40	27	302	317	20	264	266	339	0.871	0.921
LOKIASV2_3899_ESMFold_N-A	2dyl-assembly1.cif.gz_A	2dyl-assembly1.cif.gz_A Crystal structure of human mitogen-activated protein kinase kinase 7 activated mutant (S287D, T291D)	4.003E-01	0.214	40	32	311	317	18	271	272	332	0.883	0.934
LOKIASV2_3899_ESMFold_N-A	6yg6-assembly2.cif.gz_B	6yg6-assembly2.cif.gz_B Crystal structure of MKK7 (MAP2K7) covalently bound with type-II inhibitor TL10-105	8.282E-01	0.214	40	28	276	317	15	214	281	282	0.785	0.712
LOKIASV2_3899_ESMFold_N-A	4btk-assembly1.cif.gz_A	4btk-assembly1.cif.gz_A TTBK1 in complex with inhibitor	4.927E-01	0.214	40	28	312	317	11	277	287	349	0.899	0.930
LOKIASV2_3899_ESMFold_N-A	4bbm-assembly1.cif.gz_A	4bbm-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN CDKL2 KINASE DOMAIN WITH BOUND TCS 2312	1.212E-01	0.214	40	27	310	317	9	309	314	349	0.896	0.959
LOKIASV2_3899_ESMFold_N-A	5f9e-assembly1.cif.gz_A	5f9e-assembly1.cif.gz_A Structure of Protein Kinase C theta with compound 10: 2,2-dimethyl-7-(2-oxidanylidene-3~{H}-imidazo[4,5-b]pyridin-1-yl)-1-(phenylmethyl)-3~{H}-quinazolin-4-one	5.466E-01	0.214	40	30	292	317	7	240	336	312	0.830	0.696
LOKIASV2_3899_ESMFold_N-A	5myv-assembly4.cif.gz_D	5myv-assembly4.cif.gz_D Crystal structure of SRPK2 in complex with compound 1	5.190E-01	0.214	40	29	278	317	13	264	351	312	0.789	0.718
LOKIASV2_3899_ESMFold_N-A	6hv0-assembly1.cif.gz_A	6hv0-assembly1.cif.gz_A IRE1 kinase/RNase in complex with imidazo[1,2-b]pyridazin-8-amine compound 33	9.188E-01	0.214	40	33	142	317	14	104	377	117	0.347	0.241
LOKIASV2_3899_ESMFold_N-A	4pl3-assembly1.cif.gz_A	4pl3-assembly1.cif.gz_A Crystal structure of murine IRE1 in complex with MKC9989 inhibitor	1.714E+00	0.214	40	34	142	317	17	122	388	117	0.344	0.273
LOKIASV2_3899_ESMFold_N-A	3i79-assembly1.cif.gz_A	3i79-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1)	6.500E-02	0.214	40	27	308	317	4	344	455	378	0.890	0.749
LOKIASV2_3899_ESMFold_N-A	3upz-assembly1.cif.gz_A	3upz-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with bumpless BKI analog UW1243	6.847E-02	0.214	40	27	312	317	5	343	458	373	0.902	0.740
LOKIASV2_3899_ESMFold_N-A	4yjn-assembly1.cif.gz_A	4yjn-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with inhibitor UW1639	6.847E-02	0.214	40	27	312	317	6	345	460	372	0.902	0.739
LOKIASV2_3899_ESMFold_N-A	4lqq-assembly1.cif.gz_A	4lqq-assembly1.cif.gz_A Crystal structure of the Cbk1(T743E)-Mob2 kinase-coactivator complex in crystal form B	1.417E-01	0.196	39	8	235	317	4	198	388	287	0.719	0.503
LOKIASV2_3899_ESMFold_N-A	4ifg-assembly1.cif.gz_A	4ifg-assembly1.cif.gz_A Crystal structure of TgCDPK1 with inhibitor bound	8.427E-02	0.196	39	27	308	317	5	340	452	373	0.890	0.743
LOKIASV2_3899_ESMFold_N-A	3c4x-assembly1.cif.gz_A	3c4x-assembly1.cif.gz_A Crystal Structure of G protein coupled receptor kinase 1 bound to ATP and magnesium chloride at 2.9A	6.388E-01	0.196	39	12	141	317	136	277	496	155	0.410	0.286
LOKIASV2_3899_ESMFold_N-A	7ovk-assembly1.cif.gz_A	7ovk-assembly1.cif.gz_A Protein kinase MKK7 in complex with 5-bromo-2-hydroxyphenyl-substituted pyrazolopyrimidine	5.466E-01	0.179	38	32	270	317	19	183	256	252	0.754	0.645
LOKIASV2_3899_ESMFold_N-A	3vut-assembly2.cif.gz_B	3vut-assembly2.cif.gz_B Crystal structures of non-phosphorylated MAP2K4	1.074E+00	0.179	38	31	153	317	22	146	260	138	0.388	0.481
LOKIASV2_3899_ESMFold_N-A	6p8g-assembly1.cif.gz_B	6p8g-assembly1.cif.gz_B Crystal structure of CDK4 in complex with CyclinD1 and P27	1.714E+00	0.126	34	49	236	317	12	134	259	200	0.593	0.475
LOKIASV2_3899_ESMFold_N-A	8a66-assembly2.cif.gz_B	8a66-assembly2.cif.gz_B Crystal structure of MST2 in complex with XMU-MP-1	1.191E+00	0.126	34	32	312	317	12	281	282	352	0.886	0.957
LOKIASV2_3899_ESMFold_N-A	6zh2-assembly1.cif.gz_A	6zh2-assembly1.cif.gz_A Cryo-EM structure of DNA-PKcs (State 1)	1.345E-01	0.126	34	31	311	317	3273	3630	3704	392	0.886	0.097
LOKIASV2_3899_ESMFold_N-A	4jpd-assembly1.cif.gz_A	4jpd-assembly1.cif.gz_A The structure of CyaY from Burkholderia cenocepacia	2.880E+00	0.116	33	14	55	317	12	55	109	44	0.132	0.404
LOKIASV2_3899_ESMFold_N-A	4o2z-assembly1.cif.gz_A-2	4o2z-assembly1.cif.gz_A-2 Crystal Structure of MPK3 from Leishmania donovani, LdBPK_100540 in the presence of NVP-BBT594	2.261E-01	0.098	31	28	279	317	7	301	363	348	0.795	0.813
LOKIASV2_3899_ESMFold_N-A	1soy-assembly1.cif.gz_A	1soy-assembly1.cif.gz_A Solution structure of the bacterial frataxin orthologue, CyaY	5.658E+00	0.082	29	14	54	317	11	52	106	42	0.129	0.396
LOKIASV2_3899_ESMFold_N-A	1ew4-assembly1.cif.gz_A	1ew4-assembly1.cif.gz_A CRYSTAL STRUCTURE OF ESCHERICHIA COLI CYAY PROTEIN REVEALS A NOVEL FOLD FOR THE FRATAXIN FAMILY	5.960E+00	0.076	28	14	54	317	11	52	106	42	0.129	0.396
LOKIASV2_3899_ESMFold_N-A	4lqq-assembly2.cif.gz_D	4lqq-assembly2.cif.gz_D Crystal structure of the Cbk1(T743E)-Mob2 kinase-coactivator complex in crystal form B	1.019E+00	0.076	28	1	289	317	44	216	329	298	0.912	0.526
LOKIASV2_3899_ESMFold_N-A	5mwm-assembly1.cif.gz_A	5mwm-assembly1.cif.gz_A INOSITOL 1,3,4,5,6-PENTAKISPHOSPHATE 2-KINASE FROM M. MUSCULUS IN COMPLEX WITH IP6	2.222E+00	0.057	25	31	150	317	1	188	407	192	0.379	0.462
LOKIASV2_3899_ESMFold_N-A	6syt-assembly1.cif.gz_A	6syt-assembly1.cif.gz_A Structure of the SMG1-SMG8-SMG9 complex	1.191E+00	0.040	22	14	316	317	1522	1834	1896	376	0.956	0.165
